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ABSTRACT: 
 
TGF-β isoforms are important signalling molecules in wound repair in the skin.  
Transforming growth factor β3 (TGF-β3) has been implicated in scarless healing.  In 
both animal and human models the application of exogenous TGF-β3 causes a 
reduction in the inflammatory response and improves the architecture of the 
neodermis.  Research into the influence of TGF-β on scarring has tended to focus on 
fibroblasts.  However, keratinocytes play a major role in scarring both indirectly, as a 
result of their influence over the behaviour of fibroblasts and also by directly influencing 
wound contraction.  Thus, experiments were carried out to investigate the influence of 
TGF-β3 on the behaviours of a keratinocyte cell line (HaCaT).  Incubation with TGF-β3 
increased cell spreading and appeared to reduce cell-surface contacts indicated by 
both SPR imaging and a detachment assay.  TGF-β3 also caused a decreased cell 
alignment response to microcontact printed protein patterns, in part due to the 
deposition of laminin which is associated with the TGF-β induced cell migration. 
There is evidence that TGF-β isoforms differentially influence the outcome of wound 
healing.  Similar to the results produce following addition of exogenous TGF-β3, the 
neutralisation of TGF-β1 and 2 has been shown to reduce scar formation in the adult 
wounds.  During reepithelialisation keratinocytes experience a dynamic environment.  
Both extracellular matrix proteins and growth factors influence the progression of 
wound repair which includes both cell migration and proliferation.  Few studies have 
examined collective cell behaviour in response to TGF-β isoforms and ECM coated 
substrates.  Thus both wound closure and cell proliferation assays were conducted for 
different ECM proteins fibronectin, laminin and collagen type I and for TGF-β1, 2 and 3.  
Rates of wound closure were significantly reduced on laminin coated substrates while 
cell proliferation rates were increased.  TGF-β2 and 3 induced significant increases in 
wound closure rates.  This appeared to correspond with an increase in the number of 
cells independently migrating out from the wound margins.  Only TGF-β3 caused a 
significant decrease in cell proliferation over a 4 day period.   
Laminin332 deposition is central to the reepithelialisation process and is known to be 
induced in response to TGF-β.  Thus experiments were carried out to investigate 
HaCaT cell laminin332 deposition in response to TGF-β1, 2 and 3.  Both an 
immunofluorescence staining technique and an ELISA based semi-quantification 
method was used.  Following 4 day incubation all TGF-β isoforms significantly 
increased laminin332 deposition; however TGF-β2 and 3 caused the most significant 
increases. 
Integrin receptors enable cell-matrix interactions during wound repair.  TGF-β is known 
to influence the expression of integrin subunits.  Thus, experiments were carried out to 
compare the influence of each TGF-β isoform on the expression of subunits α3, α2, α5, 
β1 and β4. All TGF-β isoforms significantly increased all subunit expression.  TGF-β3 
caused the most significant increase in β4 and both TGF-β2 and 3 caused the most 
significant increase in α2.  While there were differences in cell responses to each 
isoforms, TGF-β3 did not stand out from the other two isoforms.  Interestingly, TGF-β2 
shared more similarities with TGF-β3 than it did with TGF-β1, in its role in enhancing 
wound closure and LN332 deposition.  These comparative studies have shown that 
differences exist in the way TGF-β isoforms influence HaCaT cell behaviour, namely 
migration, laminin deposition and integrin expression. 
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MAPK   Mitogen-activated protein kinase 
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RPMI-1640 Roswell Park Memorial Institute media 
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HBSS   Hank’s balanced salt solution 
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MCP    Micro-contact printing 
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immunoperoxidase staining of β1 integrin.  All TGFβ isoforms caused an 
increase in the extracellular expression of β1 compared to control (p<0.001).  
Standard error bars are shown, N=6.   
 
Figure 5.10 shows optical density readings (630nm) (arbitrary units) following 
immunoperoxidase staining of β4 integrin.  All TGFβ isoforms caused an 
increase in the extracellular expression of β4 compared to control (p<0.001).  
TGF-β3 was also shown to cause an increased expression relative to TGF-β1 
and 2 (p<0.001).  Standard error bars are shown, N=6.   
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1.1 THE SKIN 
 
The skin is the largest organ of the body contributing to approximately 15% of 
the body weight.  The most important function of the skin is the protection it 
provides from our environment and the pathogens that exists within it.  Other 
functions include sensation, thermoregulation, biochemical and immune 
functions (Wysocki 2007).    
 
The skin is divided into three principal components; the epidermis, the dermis 
and the underlying subcutaneous tissue, or hypodermis.  The epidermis can be 
further divided into layers; the basal cell layer, stratum spinosum, stratum 
granulosum and the outermost layer, the stratum corneum (Figure 1.1).  
Proliferating cells in the innermost layers differentiate as they move up through 
the strata, becoming the keratin filled keratinocytes. As these cells reach the 
surface layer of the epidermis they die and are lost.  The dermis consists of 
fibroblasts, collagen and elastic fibres, nerve endings, blood vessels, hair 
follicles and sweat glands. The blood vessels within the dermis provide nutrients 
to the skin.  The hypodermis connects the dermis to the muscle and bone.  The 
adipocytes within the hypodermis provide insulation for the body (McGrath et al. 
2004).  
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Figure 1.1: Structure of the skin (Adapted from McGrath et al. 2004) 
 
Keratinocytes are the major cell type within the epidermis and differ 
phenotypically throughout the various stratified layers.  The basal cell layer, 
directly above the basement membrane consists of basal keratinocytes derived 
from stem cells within the basal layer (Tomic-Canic et al. 1998).  These 
mitotically active basal cells are anchored to the basement membrane by 
hemidesmosomes and to each other by anchoring junctions known as 
desmosomes and adherens junctions.  Hemidesmosomes form between 
intracellular keratin filaments and laminin molecules within the extracellular 
matrix (ECM); these interactions occur via specific integrin receptors.  
Anchoring junctions are formed as a result of connections between intermediate 
filaments of neighbouring cells (Green and Jones 1996).  Cell-cell connections 
also occur via integrin receptors at the cell surface (Larjava et al. 1993).  
Basement membrane 
Stratum corneum 
Stratum granulosum 
Stratum spinosum 
Blood vessels 
Hair 
Epidermis 
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Dermal-epidermal 
junction (Basement 
Membrane) 
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Basal keratinocytes undergo division and as a result of overcrowding, some 
cells become detached from the basement membrane by dissociation of 
hemidesmosomes and move outward and become part of the next layer.  As 
cells move through the layers of epidermis they undergo differentiation.  Basal 
keratinocytes become suprabasal keratinocytes and give rise to the Stratum 
spinosum.  These cells retain cell-cell junctions or desmosomes, providing 
tensile strength to the epidermis.  Further differentiation causes cells to produce 
lipid filled granules which, together with tight cell-cell junctions, are responsible 
for the waterproofing properties of the skin.  This layer of cells is known as 
Stratum granulosum.  Finally, cells reach the outermost layer, the Stratum 
corneum. Here cells die and slough off.  New cells from the underlying stratum 
constantly replace these dead cells as the cycle continues (Fuchs 2008).               
   
Fibroblasts are the major cell type within connective tissue (Hunter 1973).  
These cells are responsible for the production and secretion of ECM molecules.  
The ECM of connective tissue is made up of fibrous proteins (namely collagen, 
fibronectin, laminin and elastin) and glycosaminoglycans (GAGs) in the form of 
proteoglycans.  As well as providing strength and elasticity, this fibrillar 
meshwork supports cell adhesion and migration, whilst providing an 
environment for the activity of growth factors such as transforming growth 
factor-β (Hocking et al. 1998, Bi et al. 2005). 
 
The main network of fibrous protein in connective tissue is collagen (Prockop 
1992).  Collagen is a helical structure made up of three polypeptide chains.  
There are upward of 20 types of collagen.  Collagens type I, II, III, V and XI are 
fibrilar collagens which are organised into bundles within the ECM.  Other types 
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of collagen bind the surface of these fibrilar structures, linking them to the ECM 
and to other fibrils such as elastin.  The collagen and elastin network within the 
connective tissue provides the dermis with both strength and elasticity (Gelse et 
al. 2003).   
 
Non-collagen proteins also play a structural role.  Fibronectin can be found in 
and around collagenous networks within the dermis (Repesh et al. 1982).  
Fibronectin is a large glycoprotein composed of two subunits joined by 
disulphide bonds (Hynes and Destree 1977).  Within each subunit there are 
repeating units, Type I-III.  In the ECM, fibronectin forms fibrils on or near the 
surface of fibroblasts.  Assembly into fibrils requires the activation of fibronectin.  
This occurs following the binding of specific integrins to specific recognition 
sequences within the amino acid chain of the protein (Schwarzbauer and 
Sechler 1999).  Various different integrins bind fibronectin; the classic example 
is α5β1 (Kim et al. 1992).  This receptor binds to the well known region of the 
fibronectin molecule; the RGD region (Arg-Gly-Asp) within the Type III repeats.  
The recognition of this sequence is also dependent on other features such as 
the flanking residues and the specific 3D presentation of the fibronectin 
molecule.  Fibronectin interacts closely with fibroblasts within connective tissue.  
Fibronectin fibrils align with intracellular actin filaments, influencing the 
orientation of fibronectin.  As well as binding to cells within the extracellular 
matrix, fibronectin also binds other molecules e.g. collagen and fibrin 
(Wierzbicka-Patynowski et al. 2003, Pankov and Yamada 2002).     
 
The basement membrane plays an important role in the maintenance and 
regeneration of the skin.  It is an area of extracellular matrix proteins which act 
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to compartmentalise the epidermis from the underlying dermis; hence it is also 
known as the epidermal-dermal junction.  Basement membrane constituents 
include collagens, laminins, proteoglycans and other structural proteins, lending 
to the mechanical strength of the matrix. Keratinocytes, mesenchymal cells and 
fibroblasts contribute to the synthesis of the basement membrane.  The major 
independent protein networks, namely, collagen type IV, and laminin, are 
connected via the binding protein nidogen, a product of fibroblasts (Burgeson 
and Christiano 1997, Smola et al. 1998).  The non-fibrillar collagen type VII is 
another anchoring filament that binds laminin 332 (Burgeson and Christiano 
1997).  These anchoring networks are important in order to protect the skin 
against physical stresses.   
 
1.1.1 Cell adhesion and integrins 
 
Cellular functions rely on the ability of cells to adhere to and communicate with 
each other and the surrounding environment.  Adhesion is essential for cell 
survival, as insufficient cell adhesion is known to cause cell apoptosis (Frisch 
and Francis 1994).  Keratinocytes within the epidermis form organised layers 
via cell-cell contacts and, in the case of basal layer cells, cell-matrix contacts.  
Cell-matrix interactions influence cellular processes such as cell proliferation 
and migration (Timpl and Brown 1996).  
 
Integrins are heterodimer transmembrane receptors made from one α and one 
β subunit.  There are at least 24 integrins known to exist in mammals and these 
are made up of a combination of 18α and 8β subunits.  Further functional 
diversity may result from the production of different α and β chain isoforms due 
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to alternative splicing (Santoro and Gaudino 2005).  Binding specificity relies on 
both subunits of any given combination (Hynes 2002).  Different integrins are 
known to have similar functions.  For example, there are multiple integrins 
known to be involved in adhesion on fibronectin, these include αvβ1, αvβ6 and 
α5β1 (Santoro and Gaudino 2005).  Integrins act as bi-directional signalling 
molecules allowing cells to communicate and respond to their extracellular 
matrix.  The integrin subunits known to be associated with the epidermis include 
α6, β4, α3, α2 and β1.  In intact epidermis, integrin expression is confined to 
basal layer cells.  During wound repair however, this expression extends to the 
suprabasal cells (Watt et al. 2002).  
 
In migrating keratinocytes integrins are associated with the formation of focal 
adhesions.  Following ligand binding, integrins form linkages with intracellular 
actin filaments via anchor proteins such as α-actinin.  Anchor proteins bind to 
the actin filaments and the cytoplasmic tail of the β subunit, providing a 
connection between the cell and the surrounding extracellular matrix 
(Brakebusch and Fässler 2003). 
 
The integrin α6β4 is an exception to the rule as this integrin associates with 
keratin intermediate filaments.  Unique to basal layer keratinocytes in intact 
skin, α6β4 is involved in the formation of hemidesmosomes (HDs) (Figure 1.2).  
These cell-matrix adhesions allow these cells to form stable attachments with 
the basement membrane (Jones et al. 1998).  Various proteins are involved in 
the stabilisation of HDs.  The most essential protein interaction is between the 
cytoskeletal linker protein, Plectin, and the cytoplasmic domain of the β4 chain 
(Geerts et al. 1999, Koster et al. 2001).  This is supported by other proteins 
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such as BP180 and BP230 (Koster et al 2001).  BP180 binds to both the α6 
domain and LN332 outside the cell whilst also binding to plectin and β4 inside 
the cell (Borradori and Sonnenberg 1999).  The ability of a cell to reorganise the 
cytoskeleton is essential for HDs. Deficiencies in remodelling proteins such as 
flightless I, has been shown to impair HD formation in mice (Kopecki et al 
2009).  
 
 Figure 1.2: Assembly of hemidesmosomes (Koster et al 2001). 
 
Keratinocytes also adhere to each other via desmosomes and adherens 
junctions.  These anchoring junctions are a feature of all epidermal cells, 
including basal layer cells.  Adherens junctions in the epidermis are mediated 
via the cadherin superfamily protein, E-cadherin (Young et al. 2003).  This 
transmembrane structure binds to other E-cadherins on neighbouring cells in a 
calcium-dependent manner.  The intracellular domain of E-cadherin associates 
with β-catenin which in turn binds α-catenin and facilitates interactions with the 
F-actin cytoskeleton (Vasioukhin and Fuchs 2001, Niessen et al. 2007).  
Desmosomes form the stronger adhesions via desmosomal cadherins such as 
desmoglobin (Dsg) that associate with plaque proteins such as desmoplankin 
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(Owen and Stokes 2010).   Strong cell adhesions are important for maintaining 
the structure of tissues, especially those subjected to mechanical stress.   
 
1.2 WOUND HEALING 
 
The skin functions to protect the body from the external environment.  It 
maintains homeostasis and acts as an important primary defence against 
pathogens.  Any loss of continuity provokes a rapid and highly organised 
response.  A wound is the loss of integrity of the skin and/or the damage to 
underlying tissues. The process of wound healing involves the interaction of 
many different mechanisms.  The main phases of the wound healing process 
are commonly grouped as follows: haemostasis and inflammation, tissue 
formation (proliferation or re-epithelialisation) and tissue remodelling/scar 
maturation.   
 
Following an injury (for the purpose of this introduction, this injury will be to the 
skin) the first reaction is the initiation of the coagulation cascade.  As a result of 
injury and the subsequent exposure of collagen and other coagulation factors, 
platelets, together with fibrin and fibronectin, almost instantaneously form a 
blood clot at the wound site (Grinnell et al. 1981, Repesh et al. 1982).  This clot 
provides a provisional matrix into which cells later migrate.  It also acts as a 
plug to prevent further blood loss and to reduce the risk of invasion by 
pathogens.  Alongside these activities, platelets also release growth factors 
contained within their alpha granules.  Amongst others, these include platelet 
derived growth factor (PDGF), transforming growth factor-β (TGF-β) and 
epidermal growth factor (Halloran and Slavin 2002, Stadelmann et al. 1998).  
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These growth factors play an important role in attracting cells involved in the 
next stage of the wound healing process; inflammation.  
 
Inflammation is the resulting effects of the body’s immune system reacting to 
injury.  The disruption of blood vessels allows the arrival of neutrophils to the 
wound site.  Neutrophils are the first of the immune cells at the wound site and 
are most frequent on day one of wound healing (Ross and Benditt 1962).  
These cells are actively recruited by platelets and endothelial cells that release 
neutrophil attracting growth factors such as TGF-β.  Fragments of extracellular 
matrix proteins, complement proteins and bacterial products also act as 
chemoattractants (Enoch and Leaper 2005).  Neutrophils infiltrate the damaged 
area of skin and begin to kill any invading bacteria by way of phagocytosis and 
degranulation.  Neutrophils themselves also attract more neutrophils by 
releasing chemokines such interleukin 8, a chemotactic factor for these cells 
(Gillitzer and Goebeler 2001).   
 
Monocytes/macrophages are the most common immune cell present on day 
two.  Resident cells including endothelial cells and basal keratinocytes attract 
macrophages to the wound site by releasing monocyte chemoattractant protein-
1 (MCP-1) (Gillitzer and Goebeler 2001).  Macrophages/monocytes play an 
important role in tissue repair.  Depletion of macrophages has been shown to 
delay the process of wound repair by several days.  It has been demonstrated 
(Leibovich et al. 1975) that events such as the persistance of neutrophils and 
the clearance of fibrin and other debris are delayed as a result of the absence of 
macrophages. 
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As part of the innate immune response macrophages act as phagocytes and 
present any foreign proteins e.g. bacteria to cells of the adaptive immune 
system; B and T lymphocytes.  Macrophages also promote inflammation and 
growth by releasing growth factors such as TGF-α, TGF-β, PDGF and insulin-
like growth factor (Rappolee et al. 1988).  These growth factors are important 
for the stimulation of fibroblasts, epithelial and smooth muscle cells and for the 
synthesis of extracellular matrix proteins such as collagen and proteoglycans 
(Enoch and Leaper 2005).  
 
Mast cells also play an important role in wound healing (Weller et al. 2006).  
The macrophage chemoattractant MCP-1 also attracts mast cells to the wound 
site (Trautmann et al. 2000).  Mast cells release active amines including 
histamine; this causes vessels to become leaky allowing access to inflammatory 
cells, heightening the inflammatory response.  These cells also release 
interleukin 4 (IL4) which stimulates fibroblast to undergo proliferation and 
promotes collagen synthesis. Mast cells also act to dampen the inflammatory 
response; the release of IL4 downregulates the expression of MCP-1 and IL8 
(Gillitzer and Goebeler 2001). 
 
The proliferation, or re-epithelialisation, phase of wound repair is already 
underway whilst the inflammatory cells are at work to clear debris and bacteria 
from the wound.  At approximately 12 hours following injury, epithelial cells, the 
majority of which are keratinocytes, begin to proliferate and migrate beneath the 
provisional matrix provided by the fibrin/platelet plug.  Utilising their 
characteristic lamellipodia, these cells migrate from the wound edges in a 
sheet- like manner until contact inhibition prevents their migration on meeting 
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other migrating keratinocytes.  This newly formed layer of keratinocytes re-
establishes the basement membrane and goes on to become the new 
epidermis.  The restoration of the basement membrane zone (BMZ) is important 
for the integrity of the skin (Enoch and Leaper 2005).   
 
Below this newly forming epithelium, the formation of granulation tissue begins.  
Fibroblasts, a major constituent of granulation tissue, begin to infiltrate the 
wound within 24-48 hours (Ross and Benditt 1962).  In response to 
chemoattractants released by platelets, macrophages and mast cells, 
fibroblasts begin to proliferate and migrate from the wound edges (Seppä et al. 
1982, Kendall et al. 1997).  Fibroblasts are key cells in wound repair as they are 
responsible for the production of certain extracellular matrix proteins such as; 
fibronectin, collagens, hyaluronan and proteoglycans.  The ECM is necessary to 
provide a structure within which cells can adhere, migrate and differentiate 
(Enoch and Leaper 2005).  Using an in vitro model (Tuan et al. 1996) the 
activities of fibroblasts within a fibrin matrix (simulating the provisional fibrin-
fibronectin matrix produced as a result of platelet activities) have been studied.  
Fibroblasts were shown to produce mainly collagen type I but also small 
amounts of type V and type III.  Collagen was apparent by day two but the 
development of collagen fibrils came later.  Collagen was also shown to replace 
much of the original fibrin matrix (Tuan et al. 1996). 
 
Fibroblasts have been shown to be directly associated with fibronectin within 
granulation tissue.  Using a rabbit model, Repesh and colleagues found that 
fibroblasts stained intensely for fibronectin and were surrounded by more 
fibronectin within the granulation tissue when compared to the wound periphery 
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in day eight linear incision wounds.  Fibroblasts were seen to align with the 
protein within the fibrillar network of the granulation tissue (Repesh 1982).  With 
the use of antibody staining similar results were established, this time using a 
guinea pig model (Grinnel et al. 1981). 
 
A porcine cutaneous gaping wound model has been used to study the 
interactions of wound fibroblasts with the surrounding fibronectin matrix leading 
up to and during wound contraction.  Day seven myofibroblasts were shown to 
express fibronectin receptors and were surrounded by a fibronectin matrix.  
These cells also showed coalignment with cell-cell and cell-matrix linkages.  
These cell activities became increasingly pronounced with wound contraction 
occurring at day fourteen (Welch et al. 1990).    
 
Shortly after the activation of fibroblasts, angiogenesis begins.  This is the 
formation of new blood vessels from the existing, broken vessels and involves 
the proliferation and migration of endothelial cells.  These cells organise into 
capillary tubes which in turn form networks of capillaries throughout the wound.  
Together with proliferating fibroblasts and the ECM, this microvascular network 
forms the granulation tissue, the appearance of which indicates the status of the 
wound (Enoch and Leaper 2005).   
 
During the formation of granulation tissue, the remodelling of the extracellular 
matrix takes place continuously.  Remodelling of the ECM occurs as a result of 
the degradation and formation of protein (Enoch and Leaper 2005).  Matrix 
metalloproteinases (MMPs) and serine proteases work together to breakdown 
matrix proteins including collagen (Saunders et al. 2005).  MMPs specific to the 
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breakdown of collagen are known as collagenases and play an important role in 
facilitating cell migration through collagen networks within the connective tissue 
(Saarialho-Kere et al. 1993, Pilcher et al. 1997).  As part of the collagen 
remodelling process, collagenase is tightly controlled by protease inhibitors 
secreted by cells within the matrix. Tissue inhibitors of metalloproteinases 
(TIMPs) are an example of such inhibitors.  These proteins bind to the activation 
site of MMPs, blocking their activity (Nagase et al. 2006).   
 
As part of the final stages of the healing process the wound contracts.  Wound 
contraction is associated with an increase in the presence of myofibroblasts.  
Myofibroblasts are characterised by their alpha smooth muscle actin filaments.  
These cells form junctions allowing the actin filaments inside the cells to attach 
to collagen fibrils within the extracellular matrix.  These activities are regulated 
by cytokines such as TGF-β, PDGF and FGF (Grinnell 1994).    
 
1.3 RE-EPITHELIALISATION 
 
The process of re-epithelialisation involves the restoration of the epidermis and 
occurs fairly rapidly following injury in order to limit exposure to the 
environment.  Restoration of the epidermis is not an isolated event; it also 
involves the restoration of the basement membrane and coincides with 
restructuring of damaged underlying tissues.  The mechanisms involved in re-
epithelialisation are poorly understood, particularly with regards to the order of 
events and the relationship between cells, growth factors and the extracellular 
matrix proteins.   
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Following injury keratinocytes adjacent to the wound bed become activated and 
undergo morphologic changes allowing cells to begin migration.  It has been 
suggested that the stimuli for keratinocyte cell migration includes the loss of 
contact with adjacent cells, the reduction in basement membrane proteins 
following injury and the alterations in extracellular matrix proteins and 
chemotactic factors in the wound bed (Patel et al. 2006).    As keratinocytes 
migrate into the wound, they begin to restore the basement membrane.  Behind 
the actively migrating cells keratinocytes begin to proliferate feeding the sheet 
of cells, often described as the epithelial tongue, across the wound bed.  
Growth factors such as interferon γ (IFN γ) control the later stages of re-
epithelialisation by inhibiting cell migration, proliferation and matrix deposition.  
Instead, cells begin to differentiate, cell-cell and cell-matrix junctions are re-
established and the new epidermis is restored (Nickoloff et al. 1988).  
 
Identification of keratin filaments present in different keratinocytes has enabled 
the activity or movements of cells during wound repair to be studied.  During 
wound repair keratins are up/down regulated depending on the activities of 
different cells.  As cells differentiate they alter their expression of keratin 
intermediate filaments.  In unwounded skin basal layer keratinocytes express 
K5 and K14 keratins and differentiating suprabasal cells express K1 and K10.  
Hyperproliferating cells express K6 and K16; these are also markers of 
hyperproliferative epidermal diseases.  K17 has also been shown to be present 
in keratinocytes activated by IFNγ (Patel et al. 2006).  
 
Anti-keratin antibodies have been used to identify subtypes of keratinocytes and 
their locations during re-epithelialisation (Patel et al. 2006).  The K5 and K14 
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keratin filaments found in basal layer cells were also seen in leading edge cells 
suggesting that the first cells to migrate into the wound bed are basal 
keratinocytes.  Suprabasal cells were shown to express different keratin 
filaments depending on their location during re-epithelialisation.  K10, a marker 
of differentiating keratinocytes was seen in cells at the wound periphery.  K6 
and K16, markers of hyperproliferation were seen in cells at the centre of the 
wound, supporting the theory that it is suprabasal cells that proliferate to fill the 
wound bed (Patel et al. 2006).  
   
1.3.1 Cell locomotion 
 
Cell locomotion is vital for many physiological processes including wound 
repair. The cyclical process of cell locomotion is influenced by chemical signals 
within the surrounding environment.  The activation of cell receptors by these 
signals activates signalling pathways within the cell, stimulating the cell 
cytoskeleton.  This crosstalk between the cytoskeleton and cell adhesion 
molecules directs cell migration (McCarthy and Turley 1993, Berrier and 
Yamada 2007).   
 
Keratinocyte migration following injury requires the dissociation of HDs, which 
frees up the intermediate filaments inside the cell.  As previously mentioned, the 
formation of HDs relies on interactions of other proteins such as Plectin, BP180 
and BP230 (Geerts et al. 1999).  During HD dissociation these proteins are 
redistributed from the basal surface to the cell cytosol.  This process is 
mediated by protein kinases and has been shown to occur in response to 
growth factors (Alt et al. 2001, Rabinovitz et al. 1999).   
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During migration the cell cytoskeleton undergoes reorganisation.  The front of 
the cell extends out over the substratum forming the flat, mostly organelle free 
region known as the lamella (Borm et al. 2005).  Here, membrane protrusions 
known as lamellipodia and filopodia are formed by the polymerisation of actin 
filaments (Borm et al. 2005).  In order to maintain the constant formation of 
lamellipodia necessary for cell migration, actin filaments within the cytosol are 
continuously assembled and disassembled (Pollard and Borisy 2003).  The 
assembly of actin filaments occurs as a result of integrin mediated activation of 
small GTPases such as Rac1 and cdc42 (Nobes and Hall 1995, Clark et al. 
1998).  Proteins of the ADF/Cofilin family are involved in the maintenance of 
these actin filament structures.  Disassembly occurs as these proteins are 
phosphorylated which prevents their interaction with actin (Theriot 1997).  Near 
the tips of membrane protrusions localisation of integrin receptors occurs and 
focal adhesions are formed, connecting the cell to the ECM.  These 
attachments give the cell anchorage allowing actin myosin powered 
contractions to occur.  Release of adhesions at the rear of the cell allows the 
cell to move forward (Ananthakrishnan and Ehrlicher 2007).   
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Figure 1.3: Adapted from (Lodish et al. 2000, Ananthakrishnan and Ehrlicher 
2007) A) The cell attaches to the substrate via adhesion sites.  B)  In response 
to environmental cues the cell reorganises the actin cytoskeleton and extends 
lamellipodia in the direction of migration.  C)  At the tip of this extended 
lamellipodia new focal adhesion sites are formed.  D)  The cell body is pulled 
forward by contractile forces.  E)  The cell releases itself from adhesions at the 
rear of the cell and the process continues.     
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1.3.2 Keratinocytes, integrins and the ECM 
 
Following injury cells are exposed to new levels of extracellular matrix proteins 
and growth factors.  In order to respond to this dynamic environment, cells alter 
their expression of integrins.  Under normal conditions keratinocytes interact 
with a basement membrane that consists mainly of laminin and collagen type IV 
protein networks.  Therefore, normal basal layer epidermal cells strongly 
express the integrin subunits α2, α3, α6 and β4 and weakly express αv. These 
cells show no expression of the integrin subunits α1, α4, α5 and β3 (Juhasz et 
al. 1993, Larjava et al. 1993).      
 
The formation of a provisional matrix exposes cells to other proteins including 
fibronectin, tenascin and vitronectin.  Early studies demonstrated that 
fibronectin has an important role in providing a scaffold for cell migration.  
During re-epithelialisation, fibronectin is deposited at the wound site via 
surrounding blood vessels and carried to the wound in the plasma (Grinnel et al. 
1981, Clark 1983).  Different animal models were used to study the distribution 
of fibronectin during wound healing in vivo (Repesh et al. 1982, Grinnell et al 
1981). Fibronectin was shown to be present within the fibrin clot, the underlying 
dermis and also the dermis surrounding the wound site (Repesh et al. 1982).  In 
response to fibronectin, migrating keratinocytes upregulate receptors α5β1, 
αvβ6 and αvβ5 (Carter et al 1990, Decline et al 2003).  α5 is expressed at high 
levels at the wound margins during migration, disappearing again once the 
epidermis is closed (Juhasz et al.1993, Larjava et al. 1993).  Keratinocytes in 
culture have been shown to deposit fibronectin during migration; a feature 
influenced by the presence of growth factors such as TGF-β and EGF (Nickoloff 
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et al. 1988, O’Keefe et al. 1984). Fibronectin has also been shown to enhance 
the adherence, spreading and motility of keratinocytes (Clark et al. 1985, 
Nickoloff et al. 1988, O’Keefe et al. 1985).              
 
Basal keratinocytes moving underneath the fibrin clot come into contact with 
type I collagen as they migrate over the exposed dermis.  Cells bind collagen 
type I via α2β1 integrins (Lange et al. 1994, Scharffetter-Kochanck et al. 1992).  
It has also been suggested that keratinocytes require collagenase-1 (MMP-1) 
for migration over collagen type I.  Collagenase 1 production by basal 
keratinocytes is induced by migration over collagen type I but not by other 
basement membrane or provisional matrix components (Pilcher et al. 1997).  
Furthermore, blocking the activity of MMP-1 prevents cell migration on collagen 
type I.  Pilcher and colleagues found that basal HaCat cells lacking MMP-1 
expression did not migrate over collagen even in the presence of other 
adhesion proteins.  They suggest that although cells may require the presence 
of other ECM proteins found in the provisional matrix (e.g. fibronectin), the 
activity of MMP-1 is still necessary for initiation and maintenance of migration 
during re-epithelialisation (Pilcher et al. 1997).  It was later determined (Stricker 
et al. 2001) that MMP-1 binds to keratinocytes via the I domain of the α2 subunit 
of α2β1.  Stricker and colleagues suggest that the activity of MMP-1 loosens the 
contact between the cell and collagen type I enabling cell migration to occur.  
Without this dissociation of attachment to the matrix, the cell remains firmly 
attached by its integrins-matrix interactions (Stricker et al. 2001). 
 
Cell exposure to collagen type I leads to the deposition of laminin.  Laminins are 
glycoproteins that exist as different tissue specific isoforms.  There are 
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approximately 15 laminin isoforms made from a combination of α, β and γ 
chains.  The laminin isoforms known to affect the behaviour of keratinocytes in 
skin are laminin 332 and 511. Most research to date has targeted the activity of 
laminin 332 during wound healing and has highlighted its role in epidermal cell 
adhesion via the α2β1, α3β1 and α6β4 integrins (Sugawara et al. 2008).    
 
1.3.3 Laminin 332 
 
Laminin 332 (LN332) was formerly known as kalinin, nicein, epiligrin and most 
recently laminin 5.  The new nomenclature system assigns laminin isoforms 
their names based on the α, β, and Ɣ chains of which they are comprised 
(Aumailley 2005).  The structure of LN332 is made up of an α3, β3 and Ɣ2 
chain, hence laminin ‘332’.  These chains are encoded by the genes LAMA3, 
LAMB3 and LAMC2 respectively.  The carboxyl (C) terminus of the α3 chain 
consists of a globular domain made up of five subdomains, G 1-5.  Whilst these 
domains are important for the binding of receptors and ECM proteins, they also 
play a role in the deposition of LN332.  The G3 domain of the α3 chain is 
associated with integrin binding and deletion of this domain causes loss of cell 
adhesion and motility (Hirosaki et al. 2000 and Kariya et al. 2003).  The G4/5 
domain is a binding site for receptor syndecan-1; an interaction that has been 
shown to be essential for cell migration (Bachy et al. 2008).  The Ɣ2 chain is 
also associated with increased cell adhesion (Ogawa et al. 2004).  The β3 chain 
contains a binding site for collagen VII and has also been shown to influence 
the deposition and cell adhesion activity of laminin 511 (Nakashima et al. 2005, 
Nakashima et al. 2007).   
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The α3 chain G4/5 and Ɣ2 chain NH2 terminal domains share similar roles.  
Genetic modification resulting in incomplete α3 and Ɣ2 chains lacking these 
domains have been reported to prevent LN332 deposition.  Whilst cells are still 
able to secrete LN332, the whole 460kDa molecule is required for the 
integration of LN332 into the extracellular matrix (Gagnoux-Palacious et al. 
2001, Sigle et al. 2004).  Either domain alone is also not sufficient for LN332 
deposition.   
  
 
  
Figure 1.4:  The structure of laminin 332 (Adapted from Sugawara et al. 
2008 and Gagnoux-Palacious et al. 2001). 
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As part of the matrix remodelling, LN332 undergoes proteolytic processing.  Not 
only does this processing play an important role in regulating the function of the 
LN332 molecule, the resulting proteolityic fragments also influence cell activity.  
Several different proteases have been associated with LN332 processing, with 
some contradictory findings.  The α3 chain of precursor LN332 undergoes 
cleavage, reducing it from 190-kDa to 160-kDa (Goldfinger et al. 1998).  Certain 
cell types, such as the pp126 epithelial cell line, produce matrices that contain 
unprocessed LN332 while others such as the human breast epithelial cell line 
MCF-10A produce the mature LN332 associated with hemidesmosomes 
formation.  These cell matrices have been used to examine the role of plasmin 
in lam322 processing (Goldfinger et al. 1998).  Plasmin is an enzyme produced 
from the cleavage of proenzyme plasminogen by plasminogen activators tPA or 
uPA (Wun 1988).  Plasmin was shown to induce proteolysis of the α3 chain but 
not the β3 or Ɣ2 chains.  Furthermore, both tPA and plasminogen co-localised 
with mature LN332 in MCF-10A matrices.  In pp126 cell matrices, only 
plasminogen was present suggesting that the lack of processed LN332 in these 
matrices is due to the absence of plasmin (Goldfinger et al.1998).     
     
The reduction of the Ɣ2 chain from 150 kDa to 105 kDa has been shown to 
affect the influence of LN332 on cell responses.  A study comparing the role of 
150 kDa and 105 kDa Ɣ2 chains found that processing of the Ɣ2 chain reduces 
the cell adhesion activity while increasing the cell migration activity of LN332 
(Ogawa et al. 2004).  Cleavage of the Ɣ2 chain has been associated with 
different proteases.  Membrane type I metalloprotease (MTI-MMP) has been 
shown to be responsible for cleavage of the Ɣ2 chain of rat LN332.  In gastric 
carcinoma cell line cultures (MKN45), MTI-MMP facilitates cell spreading and 
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migration on LN332 (Koshikawa et al. 2004).  However, MTI-MMP has been 
ruled out as being responsible for Ɣ2 cleavage of human LN332.  Instead, the 
BMP-1 isoenzyme, mammalian tolloid metalloproteinase (MTLD) has been 
shown to be responsible.  MTLD, but not MTI-MMP, is expressed by primary 
keratinocytes (Veitch et al. 2003).   
 
LN332 is associated with various different receptors and signalling molecules.  
During cell migration, collagen-dependent adhesion via α2β1 switches to LN332 
dependent adhesion via α3β1 (Scharffetter-Kochanck et al. 1992, Nguyen et al. 
2000).  The necessity of the α2β1 receptor in wound re-epithelialisation has 
proved controversial.  It has been demonstrated that migration on laminin 
requires the collagen receptor α2β1 and that this receptor interacts with the Ɣ2 
chain of the laminin molecule (Decline and Rousselle 2001).  Blocking the 
function of α2β1 using anti-α2 antibodies impeded cell spreading and migration 
over ECM coated substrates including both fibronectin and LN332 (Decline and 
Rousselle 2001).  Similarly, an in vitro study (Grenache et al. 2007) found that 
primary keratinocytes taken from α2-null mice displayed impaired adherence 
and migration on collagen.  However, an in vivo study using α2β1-null mice 
reported contradictory findings.  These mice did not show a significant alteration 
in the rate of wound re-epithelialisation, nor did this deletion affect the rate of 
collagen deposition or wound strength (Grenache et al. 2007).          
     
The integrin α3β1 was reported to play a role in the paracrine effects of LN332.  
Blocking the function of either LN332 or α3β1 caused the inhibition of cell 
motility (Zhang and Kramer 1996).  Others suggested this inhibition may have 
been due to the antibodies interfering with cell adhesion (Decline and Rouselle 
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2001). As previously mentioned the Syndecan-1 receptor is a key mediator of 
cell-LN332 interactions and is necessary for the localisation of α3β1 (Bachy et 
al. 2008).  Reducing the expression of Syndecan-1 in keratinocytes has been 
reported to prevent the formation of fascin-containing protrusions on precursor 
LN332 thereby preventing cell migration (Bachy et al. 2008).   
 
Tiam1 and the downstream regulator of signalling pathways, Rac, are essential 
for the production and secretion of LN332 by keratinocytes (Hamelers et al. 
2005).  In wild type keratinocytes, the binding of LN332 to integrin α3β1 signals 
to Tiam1 which in turn activates Rac.  This results in an increase in the 
production and secretion of LN332.   It also causes the remodelling of actin 
filaments within the cell leading to cell spreading.  It has been demonstrated 
(Hamelers et al., 2005) that cells lacking Tiam1and the subsequent activation of 
Rac are unable to adhere and spread on glass substrate via integrin α3β1.  The 
ability of keratinocytes to reepithelialise mouse wounds was also impaired 
which further supports that Tiam1 is necessary for deposition of LN332 and 
migration of keratinocytes (Hamelers et al. 2005).   
 
It has been suggested that the use of integrin α3β1 by keratinocytes is a result 
of the activation of phosphoinositide 3-OH kinase (PI3K) via integrin α6β4.  
Interactions between LN332 and α6β4 cause an increase in the activity of PI3K 
and an increase in the phosphorylation of the downstream target protein, JNK, 
stimulating keratinocytes to utilise integrin α3β1.  Elimination of LN332 or the 
integrin α6β4 in keratinocytes leads to inhibition of PI3K dependent cell 
migration, suggesting that the deposition LN332 and subsequent ligation by 
α6β4 is required for the spreading and migration of these cells (Hamelers et al. 
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2005, Nguyen et al. 2000).  See Figure 1.5 for a diagrammatically 
representation of the above findings.        
 
There have also been studies looking at the effect of the LN332-α3β1 
interactions on the cellular responses to other ECM proteins namely fibronectin 
and collagen.  Although blocking the alpha 3 integrin subunit caused reduced 
migration on LN332, it was also found to enhance cell adhesion and migration 
on fibronectin and collagen (Hodivala-Dilke et al. 1998).  Hodivala-Dilke and 
colleagues found that in α3-null keratinocytes there was a redistribution of F-
actin and focal contact proteins but no alterations in the expression of other 
integrins.  They suggest that this redistribution or ‘freeing up’ of protein may be 
associated with the upregulation of other integrin receptors as these proteins 
are available for the formation of new focal contacts.  Alpha3-null cells were 
seen to have more focal contact points demonstrated by the increase in tyrosine 
phosphorylation at these sites.  In normal cells, the ligation of LN332 to the 
α3β1 receptor occupies these focal contact proteins preventing their use 
elsewhere.  It is also suggested that the LN332-α3β1 interaction enhances 
α3β1 activity by inhibiting the activity of the fibronectin and collagen receptors 
(Hodivala-Dilke et al. 1998).    
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Figure 1.5:  (adapted from Nguyen, et al. (2000) and Hamelers et al. (2005)).  Under normal conditions 
basal layer keratinocytes express integrins α6β4, α3β1 and α2β1.  Keratinocytes form hemidesmosomes 
with laminin-332 in the basement membrane via α6β4.  Following injury to the skin, these 
hemidesmosomes undergo dissociation and cells begin to express α5β1 in response to fibronectin.  
Leading edge keratinocytes begin to migrate into the wound bed.  MMP-1 (collagenase-1) facilitates 
α2β1 mediated migration over exposed dermal collagen type I.  Cell adhesion via α2β1 switches to 
α3β1.  It has been suggested that α6β4 facilitates the upregulation of α3β1 via the activation of signalling 
molecules; P13K and JNK.  As keratinocytes migrate over collagen type I they begin to deposited 
precursor laminin-332.  Binding of α3β1 to its ligand precursor laminin-332 causes an increase in the 
deposition of precursor laminin-332 via the activation of Tiam-1 and Rac.  Following migration and the 
restoration of the basement membrane, keratinocytes proliferate to fill the wound bed.  Precursor 
laminin-332 undergoes processing by plasmin and cells re-establish hemidesmosomes with mature 
laminin-332.        
Rac Tiam 1
JNK
P13K
Collagen Type I Cell spreading Direction of 
migration 
α6β4 α3β1 α2β1 Precursor Laminin-332 
MMP1 Fibronectin rich 
provisional matrix 
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1.4 TRANSFORMING GROWTH FACTOR β 
 
The transforming growth factor-β (TGF-β) super-family encompasses various 
different proteins, including bone morphogenetic proteins (BMPs), Mullerian 
inhibiting substance, nodals, activins, inhibins and of course, TGF-β.  These 
structurally related proteins play different roles in a variety of different 
processes, from development to disease (Gordon and Blobe 2008).   
 
TGF-β is a key cytokine involved in many normal physiological and pathological 
processes, including the immune response and tumour metastasis (Letterio and 
Roberts 1998, de Caestecker et al. 2000).  It exists as 3 isoforms in mammals; 
TGF-β1, 2 and 3 which share between 74 and 82% homology (Kingsley 1994); 
and acts in either a paracrine or autocrine manner (Krasagakis et al.1994, 
Kaplan et al. 2007).  Different cell types, including epithelial, endothelial, 
lymphoid and mesenchymal cells, produce TGF-β.  Characteristics of cells 
under the influence of TGF-β include down-regulation of cell-cell junctions, 
increased motility and decreased proliferation. In mesenchymal cells however, 
TGF-β stimulates cell growth (Shipley et al. 1986).  Also, the influence of TGF-β 
on cell activity can be affected by the physiologic state of the target cell and its 
environment, i.e. receptor expression and the presence of other growth factors.  
For example, when fibroblasts are grown in monolayers in the presence of 
epidermal growth factor, TGF-β causes a decrease in proliferation.  Conversely, 
when these cells are grown in serum, the inhibitory effects of TGF-β are 
overcome by EGF (Roberts et al.1985).      
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TGF-β is secreted in its latent form as a complex with other peptides; the 
latency associated peptide (LAP) and one of four latent TGF-β binding proteins 
(LTBP).  Together this complex is known as the large latent complex.  In this 
form, TGF-β is unable to associate with its signalling receptors (Koli et al. 2001).  
LTBP is involved in matrix association (Unsold et al. 2001).  It is thought that 
this matrix association allows storage of TGF-β in the ECM which enables a 
rapid TGF-β response.  Proteolytic cleavage of LTBP allows the release of 
TGF-β from matrix molecules and following conformational change of the LAP 
region, the TGF-β binding site is exposed for receptor binding (Koli et al. 2001).  
Activated TGF-β binds the TGF-β receptor (TβR) complex made up of serine-
threonine kinase receptor dimers TβR I and II.  These bind to a third receptor, 
betaglycan.  This membrane anchored proteoglycan binds to the TGF-β ligand 
presenting it to the type I/II receptor complex allowing signal transduction to 
occur.   Interestingly, this betaglycan has been shown to act as a dual 
modulator of TGF-β activity.  The soluble form of this protein, no longer 
anchored to the cell membrane, acts as an inhibitor of TGF-β signalling (Lopez-
Casillas et al. 1994). 
 
The most commonly associated intracellular effectors of TGF-β signalling are 
the Smad proteins.  There are 8 different smad proteins which include receptor 
associated smads (1, 2, 3, 5 and 8), a co-smad (4) and inhibitory smads (6 and 
7).  Following ligand binding, TβRs undergo phosphorylation which in turn 
activates Smad proteins 1, 2 and 3 (Shi and Massague 2003).  This ligand-
dependent activation of Smad 2/3 requires internalisation of the Smad/TβR 
complex via endocytic vesicles (Penheiter et al. 2002).  Activated smads are 
known as R-Smads.  The signalling events continue as the co-smad (Smad 4) 
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joins the R-Smad complex which is followed by translocation to the nucleus, the 
site of gene transcription.  Smad signalling inhibitors (Smad 6 and 7) prevent 
the activation of R-Smads (Shi and Massague 2003) (Figure 1.6).  The activity 
of inhibitory smads is regulated by growth factors such as IFNƔ and the TGF-β 
ligand itself, in a negative feedback manner (Nakao et al. 1997, Ulloa et al. 
1999). 
 
 
 
 
  
Figure 1.6:  Simplified representation of the TGFβ smad signalling pathway 
(Adapted from Shi and Massagué 2003). 
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In order to provide the variety of cell responses associated with TGF-β, the 
basic smad pathway interacts in an interdependent manner with other non-
smad signalling molecules.  The mitogen activated protein kinase (MAPK) 
pathway has been shown to regulate Smad signalling.  Activation of signalling 
molecules, Ras and downstream ERK1 has been shown to regulate the TGF-β 
induced phosphorylation of R-Smad 1 in epithelial cells (Yue et al. 1999).  
Similarly, the phosphorylation of Smad 2 by ERK1 increases the amount of 
Smad 2 thereby enhancing transcriptional activity (Funaba et al. 2002).  The 
activation of Ras has also been associated with the inhibition of TGF-β 
signalling.  Ras induced phosphorylation of the MAP kinase sites in the linker 
region of the Smad 2/3 complex has been shown to prevent accumulation of 
Smad 2 and 3 in the nucleus, thereby preventing transcriptional responses to 
TGF-β (Kretzschmar et al. 1999).  Another pathway involved in cross talk with 
smad signalling is the JNK pathway.  Following smad-independent activation of 
JNK by a Rho family GTPase, JNK phosphorylates Smad 3.  This activation by 
JNK facilitates phosphorylation of Smad 3 by the TβR I (Engel et al. 1999).   
 
1.4.1 Transforming Growth Factor-β and wound healing  
 
Different studies have examined the expression of TGF-β in normal human skin.  
In one study, TGF-β1 was found to be expressed at low levels throughout both 
the dermis and epidermis; TGF-β2 was strongly expressed throughout the 
epidermis and in some dermal cells, while TGF-β3 was most prominent in the 
lower layers of the epidermis (Quan et al. 2002).  In an earlier study, in which 
TGF-β mRNA levels were analysed, TGF-β1 and 2 were not detected (Schmid 
et al. 1993).     In porcine skin, TGF-β2 and 3 have been shown to be strongly 
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expressed throughout the epidermis and are associated with smooth muscle 
cells within the dermis.  TGF-β1 on the other hand, was shown to be weakly 
expressed in the outermost layers of the epidermis and was absent in the 
dermal layer (Levine et al. 1993).   
 
TGF-β plays a central role in wound repair.  The release of TGF-β1 by platelets, 
macrophages and endothelial cells mediates further chemotaxis of immune 
cells.  The paracrine effects of TGF-β cause keratinocytes and fibroblasts to 
produce further TGF-β; stimulating cell motility, extracellular matrix synthesis 
and remodelling (Singer and Clark 1999).  Several studies have examined the 
post injury expression of TGF-β.  Different models show slightly different results.  
In a murine model TGF-β1, 2 and 3 were all shown to be expressed by 
inflammatory cells as early as 12 hours post injury (Cowin et al. 2001).  In pig 
skin, the infiltration of inflammatory cells 24 to 72 hour post-wounding carried 
little or no TGF-β1 whereas the expression of TGF-β 2 and 3 was shown to be 
strong (Levine et al. 1993).  In the epidermis of the mouse, all TGF-β isoforms 
were found to be strongly expressed (Cowin et al. 2001).  Post-injury staining of 
porcine skin found an increase in levels of TGF-β 2 and 3 in migratory basal 
layer epidermal cells by day 3.  While expression of TGF-β1 was not detected in 
the undifferentiated epidermis of pig skin, it has been shown to be a feature of 
the regenerating epidermis in human skin (Levine et al. 1993, Schmid et al. 
1993).  The expression of TβR I and II was seen in inflammatory cells, 
fibroblasts and at the leading edge of the migrating basal epidermal cells 
(Cowin et al. 2001).   
  
33 
 
1.4.2 The fetal model 
 
The realisation that human fetal wound healing occurs without the formation of 
a scar led to the development of many different animal models.  A study 
published in 1977 (Goss et al. 1977) used Sprague Dawley rats as a model with 
which to assess the way in which orofacial wounds healed in utero.  This model 
provided information about the re-epithelialisation and the inflammatory 
response.  In these rats, rapid and complete re-epithelialisation of the skin and 
oral wounds occurred within 72 hours with a complete lack of inflammatory 
response (Goss et al. 1977).   
 
Whitby and Ferguson used a mouse model to study the extracellular matrix of 
lip wounds, making comparisons between the fetus, neonate and the adult.  
Distinct differences in the distribution of certain extracellular matrix components 
were observed between fetal, neonatal and adult mice.  They also found the 
rate of wound healing differed between these groups; most rapid in the fetus 
and slowest in the adult.  The early appearance of tenascin, which prevents cell 
attachment to fibronectin, was associated with the rapid closure of fetal wounds.  
Collagen deposition also differed between groups; collagen patterns observed 
in the fetus were shown to resemble normal dermis, whilst scar formation was 
seen in the adult.  This suggested the importance of collagen in the process of 
scarless healing (Whitby and Ferguson 1991).       
 
Of course, animal models have been extremely beneficial to the study of fetal 
wound repair.  However, as a result of the variations existing between different 
species they have also presented research with several limitations.  In a study 
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using a fetal lamb model it was demonstrated that fetal healing occurred without 
scar formation and wounds contracted rapidly (Burrington et al. 1971).  In 
contrast, a study using fetal rabbits found wounds healed without contraction 
(Krummel et al. 1987).  This provides one example of how it became difficult to 
compare and interpret results universally.   
 
These limitations and variations provoked the development of a human model.  
Lorenz et al grafted human fetal skin, both cutaneously and subcutaneously, 
onto nude mice in order to eliminate any cell-mediated xenograft rejection.  
Fetal skin was studied in the postnatal environment.  The characteristics of fetal 
skin during wound repair were recorded.  They found that the subcutaneous 
grafts healed without scar formation (Lorenz et al. 1992).   
 
Research is continuing to build a picture of the mechanisms involved in the 
process of scarless healing in the fetus.  Various aspects of the fetal 
environment have been studied.  For the purpose of this report, the effects of 
the growth factor TGF-β will be the focus.  It has been demonstrated that the 
TGF-β isoforms are expressed differently in fetal and adult wounds (Nath et al. 
1994). These differences are mainly attributed to the lesser immune response in 
the fetus (Goss et al. 1977).   Immunolocalisation was used to detect the 
presence of TGF-β1 and TGF-β2 in the skin wounds of rabbits.  It was noted 
that although TGF-β1 and 2 was expressed in the dermis of the fetus, 
upregulation of the cytokines at the site of wound healing, did not occur.  In 
adults, however, the expression of TGF-β1 and 2 at the wound site was 
markedly increased after approximately 7 days (Nath et al. 1994).  This study 
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highlighted TGF-β as a possible factor involved in the differences observed 
between fetal and adult wound healing.   
 
A subsequent study using both fetal and postnatal human skin biopsies 
examined the expression of TGF-β isoforms during the gestational period; this 
time including TGF-β3 (Chen et al. 2005).  In fetal skin at early gestation, TGF-
β3 expression was higher when compared to both TGF-β1 and 2.  As 
gestational age increased, the levels of TGF-β3 decreased whereas the levels 
of TGF-β1 and 2 together with TβR I and II increased (Chen et al. 2005).  This 
highlighted TGF-β3 as a possible cause for the scarless healing seen during 
fetal wound repair.               
 
The use of antibodies against TGF-β1, 2 and the use of exogenous TGF-β3 
enabled the effects of these cytokines to be studied.  The presence of 
extracellular matrix proteins collagen type I, type III and fibronectin were 
markedly reduced in wounds treated with anti-TGF-β1 and 2.  Similarly, wounds 
treated with exogenous TGF-β3 stained less intensely for the above 
extracellular matrix proteins.  Wounds treated with a combination of anti-TGF-β 
1 and 2 were also less vascularised.  In contrast, the addition of exogenous 
TGF-β, especially TGF-β3, caused an increase in the vascularity seen at wound 
sites.  The architecture of the neodermis at 70 days post wounding was also 
studied.  Wounds treated with anti-TGF-β1 and 2 or exogenous TGF-β3 were 
shown to resemble the normal dermis, i.e. the healing of these wounds was 
markedly better than that seen with controls.  As well as the architecture of 
wounds, the inflammatory response was also studied.  A decrease in the profile 
of mononcytes and macrophages within the wound was shown to correlate with 
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the elimination of TGF-β1 and 2 using antibodies and with the addition of TGF-
β3 (Shah et al.1994, Shah et al.1995).   
 
The study of fetal wound healing, or scarless healing, is a major tool in research 
into the mechanisms involved in scar formation in adults.  The fetal model has 
provided important insights into the possible avenues open to research in the 
quest to find treatments for the prevention of scarring.   
 
1.5 ABNORMAL HEALING 
 
Fibrosis is the excessive accumulation of scar tissue as a result of an abnormal 
healing process. In the skin, this leads to the formation of hypertrophic scarring 
and keloids.  In excess, scar tissue can cause a range of clinical problems in 
areas other than the skin.  These include tendon adhesions, transmission 
blockages in neurones and liver cirrhosis.  While the aetiology of abnormal 
scarring is not fully understood, possible causes are thought to include 
mechanical load, biochemical, endocrinologic and genetic factors (Aarabi et al. 
2007, Brissett and Sherris 2001).      
 
Hypertrophic scars and keloids are fibroproliferative disorders characterised by 
the excess accumulation of collagen.  Hypertrophic scars are characterised by a 
red and sometimes itchy scar, elevated above the surface of the skin but limited 
to the area of injury. This type of scarring is also characterised by nodules 
containing large amounts of randomly organised collagen fibres and the 
permanent presence of α-smooth muscle actin containing myofibroblasts.  Over 
time, hypertrophic scarring may regress; otherwise, they can be surgically 
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revised.  Keloids, often described as benign tumours, develop beyond the 
boundaries of the original wound site, invading the surrounding normal skin.  
These scars do not regress with time and are difficult to revise surgically.  
Keloid scars are characterised by the presence of a dense mass of thick 
collagen fibres and the overproduction of ECM molecules and growth factors.   
 
Fibroblasts play a central role in abnormal scarring. Firstly, the imbalance 
between fibroblast proliferation and apoptosis leads to an increase in cell 
numbers.  It has been shown that keloid keratinocytes increase the proliferation 
rate of normal fibroblasts in vitro, suggesting that keratinocytes may influence 
the numbers of fibroblasts in keloid tissue (Lim et al. 2001).  Keloid fibroblasts 
show an elevated synthesis of fibronectin and collagen I and VI (Babu et al. 
1989, Peltonen et al. 1991). The increased production of collagen by fibroblasts 
has also been shown to be caused by mast cells and keloid keratinocytes (Lim 
et al. 2002, Kofford et al. 1997).  Similarly, fibroblasts from hypertrophic scars 
have been shown to over-produce collagen types I and III.     
 
During the normal wound repair process, ECM proteins are produced in 
response to growth factors, including TGF-β.  The release of TGF-β by 
inflammatory and endothelial cells causes fibroblasts to produce their own TGF-
β.  In hypertrophic and keloid scars, the levels of TGF-β1 are elevated 
(Jagadeesan and Bayat 2007, Dabiri et al. 2008).  Together with this, the 
fibroblast cell response to TGF-β is heightened, demonstrated by the elevated 
levels of collagen expression (Peltonen et al. 1991, Younai et al. 1994).  This 
has been attributed to an overexpression of Smad 3 and a reduction of Smad 6 
and 7 in fibroblasts.  Connective tissue growth factor (CTGF), a mediator of 
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TGF-β activity, is increased in keloid and hypertrophic fibroblasts at both basal 
levels and after stimulation with TGF-β1 when compared to normal cells 
(Colwell et al. 2005).  The natural inhibitor of TGF-β signalling, Decorin, is also 
altered in keloids (Yamaguchi et al. 1990).   
 
1.6 SCARRING: A CLINICAL PERSPECTIVE 
 
Although scars are often considered to be unimportant in terms of health and 
well-being, they do cause significant problems in some patients where the 
wound healing process has occurred with complications.  With severe scarring, 
especially those scars which are not easily covered with clothing, the patient 
may struggle to come to terms with the deformity and consequently may suffer 
certain psychological effects such as post-traumatic stress and loss of self-
esteem (Abdullah et al. 1994, Robert et al. 1999).  Not only does scarring have 
the potential to affect the mental well being of a patient, it may also lead to 
physical difficulties (Procter 2010). 
 
Millions of people in the developed world acquire scars as a result of elective 
surgery or trauma.  Burns victims make up a significant number of these trauma 
patients with approximately 70% being children (Bayat et al. 2003).  There are a 
variety of abnormal scar types.  Widespread scarring occurs when a healed 
wound undergoes stretching and widening.  This may also occur without breach 
of the epidermis, these scars are known as stretch marks and occur as a result 
of expansion of the skin, e.g. during pregnancy or weight gain.  Following 
chickenpox and or acne, scarring is common.  These scars are often small and 
depressed and are described as atrophic.  Raised scars are grouped as either 
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hypertrophic or keloid scars and involve the excessive accumulation of scar 
tissue (Bayat et al. 2003).  Scar contractures are caused by a contractile wound 
healing process and may cause significant difficulties in movement, limiting the 
patients’ activities.  These contractures may affect muscle, tendons and the 
skin.  Skin contractures reduce the elasticity of the skin limiting the ability of the 
skin to stretch.  This causes particular problems when it occurs across joints 
(Brissett and Sherris 2001). 
 
1.7 THERAPEUTIC INTERVENTION  
 
There are currently no drugs on the market that prevent scarring following 
surgery and trauma or that improve existing scarring.  The current therapies 
available to those patients experiencing problematic scarring can be grouped 
into the categories; invasive, non-invasive and ‘leave alone’ management 
(Bayat et al. 2003).  Invasive treatment may involve surgical excision of the 
scarred tissue.  However, this usually only occurs if the surgeon feels the 
second attempt at healing would occur with less inflammation.  A more 
improved surgical technique may also be adopted.  Other invasive treatments 
include injections of corticosteroids, fluorouracil, interferon gamma or 
bleomycin, radiotherapy, laser therapy and cryosurgery (Bayat et al. 2003).        
 
International clinical recommendations on scar management (Mustoe et al. 
2002) suggest that an evidence based approach should be adopted when 
assessing the effectiveness of treatments.  The report highlights the most 
successful treatments, based on evidence, are silicone gel sheeting and 
intralesional corticosteroids (Mustoe et al. 2002).  Silicone gel sheeting has 
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been shown to be both safe and effective.  A study by Katz et al found 79% of 
patients undergoing corrective surgery for hypertrophic scarring did not 
redevelop a scar.  Secondly, 56% of chronic scarring was improved (Katz 
1995).  Recent evidence found that although silicone gel sheeting is an effective 
method, the intralesional corticosteroid treatment was shown to have a more 
rapid and longer lasting effect (Kelemen et al. 2007).     
 
Non-invasive treatments may include compression therapy with the use of 
pressure garments, casts, antihistamines, lotions, oils and creams.  Counselling 
may also be provided to those patients suffering from the psychological effects 
of a disfigurement.  Scars can sometimes take months, even years, to fully 
mature and therefore clinicians may advise that the best option for treatment is 
to leave the scar alone for some time before any action is taken.  The scar may 
in some cases begin to regress (Bayat et al. 2003).  
 
Research into TGF-β and its importance in wound healing has led to the 
development of potential therapeutics.  Juvista (also known as Avotermin), a 
recombinant TGF-β3 has proven to be effective in reducing scarring, allowing 
the regeneration of more normal skin following injury.  This drug has also 
proven safe and tolerable (Ferguson et al. 2009).  Unfortunately however, the 
latest clinical trial failed to meet the primary or secondary efficacy endpoints.   
Both injectable and topical forms (Adaprev and Juvidex) of mannose-6-
phosphate, an inhibitor of TGF-β1 and 2, are also undergoing clinical trials.  As 
previous studies have shown, a reduction in the activity of these cytokines 
correlates with the development of a more normal dermis following injury (Shah 
et al. 1994, Shah et al. 1995).  Results of the Phase 2 efficacy trial showed that 
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topical Juvidex was well tolerated and improved overall appearance of the skin 
following skin grafts when compared to the placebo (Renovo 2011).      
 
1.8 PROJECT AIMS 
 
While it is clear that the TGF-β isoforms differentially influence the repair 
process; it is not clear as to why this occurs.  The mechanisms by which the 
scarless healing effects are mediated, i.e. the extracellular matrix proteins, 
integrins and signalling pathways under TGF-β control, have yet to be fully 
elucidated.  Also, there is a gap in the literature with regards to the comparative 
effects of TGF-β isoforms on the behaviour of different cell types present in 
skin.  Research into the influence of TGF-β on scarring has tended to focus on 
fibroblasts either directly or indirectly via the influence of keratinocytes (Colwell 
et al. 2006, Li et al. 2004, Le Poole and Boyce 1999, Amjad et al. 2007).  While 
keratinocytes play a major role in scarring as a result of their influence over the 
behaviour of fibroblasts, keratinocytes are also important in their own right in 
terms of wound contraction.  In skin models, keratinocytes have been shown to 
directly drive the contraction of the dermis (Chakrabarty et al. 2001).  This was 
also shown to be independent of fibroblasts and any effect these cells may have 
on contraction (Chakrabarty et al. 2001).  While keratinocytes have an obvious 
role to play in the quality of wound healing and scar formation, these cells have 
been somewhat overlooked when researching TGF-β and scarless healing.  
There are several studies comparing keratinocyte expression of TGF-β1, 2 and 
3; however there has been very little research comparing the effects of TGF-β 
isoforms on keratinocyte behaviours important in wound repair (Hakvoort et al. 
2000, Cho et al. 2004).  
42 
 
Thus the purpose of this study was to examine the differences between TGF-
β1, 2 and 3 on human keratinocytes at a basic cellular level.  More specifically, 
to investigate whether the effects of TGF-β isoforms on scarring could be due to 
differences in the way these cytokines influence keratinocyte behaviours 
important in wound repair.  Important features of the re-epithelialisation process 
include keratinocyte cell migration, protein deposition and also integrin 
expression.  During migration, keratinocytes interact with ECM proteins 
including collagen type I and fibronectin via α2β1 and α5β1 receptors 
respectively (Scharffetter-Kochanck et al. 1992, Carter et al. 1990).  The 
deposition of laminin alters the immediate environment of the cells; interactions 
with collagen and fibronectin are replaced by interactions with LN332.  One of 
the major integrin receptors associated with migration on LN332 is α3β1.     
 
Major limiting factors in keratinocyte migration are the deposition of laminin and 
the cell interactions with this newly restored basement membrane protein, both 
of which are known to be influenced by TGF-β.  Therefore this project aims to 
investigate the following hypothesis;  
 
TGF-β3 facilitates scarless healing by enhancing the speed of keratinocyte 
migration as a result of its effect on the deposition of laminin.  These cellular 
responses are mediated via the upregulation of integrin receptors α3β1 and 
downregulation of those receptors responsible for interactions with collagen 
type I and fibronectin, namely α2β1 and α5β1. The hypothesis also states that 
TGF-β isoforms 1, 2 and 3 differ in their effects on cellular response to laminin 
and cell deposition of laminin.  It is expected that TGF-β3 will increase the 
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deposition of laminin relative to TGF-β1 and 2 therefore enhancing cell 
migration and thus the wound repair process.           
 
Specific project aims will be to:   
 
1. Study the behaviour of cultured keratinocyte (HaCaT) cells in response 
to treatment with TGF-β3.  This will include a cell adhesion assay and the 
use of the widefield surface plasmon microscope (WSPR).  Using WSPR 
cells will be imaged in order to optically assess how cell attachment 
changes in response to treatment with the TGF-β3. The WSPR enables 
interfacial interactions between cells and surfaces to be imaged, thus it 
may be possible to determine how a cell attaches to a surface in terms of 
distribution of focal contacts and how the arrangement of those focal 
contacts change in response to cytokines such as TGF-β3.  
 
2. Study the responses of HaCaT cells to different extracellular matrix 
proteins patterned onto glass substrate using PDMS stamp sizes ranging 
from 1.8µm to 100µm.  Measurements will be taken of cell length, width 
and angle of alignment in response to each pattern.  The proteins used 
will be fibronectin, laminin and collagen type I in the first instance.  This 
will provide information about which extracellular matrix molecules 
promote cell attachment, spreading and guidance and thus provide 
information about potential integrin associated with the signalling 
pathways.  
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3. Study the effects of TGF-β3 in relation to the alignment, elongation and 
proliferation of HaCaT cells cultured on microcontact printed extracellular 
matrix patterns. It is expected that TGF-β3 will modify cell behaviour and 
the relative changes in behaviour will provide information about the way 
integrin expression changes in relation to TGF-β treatment. This will 
result in the identification of candidate integrins. 
 
4. Determine how different extracellular matrix proteins and TGF-β1, 2 and 
3 influence cell proliferation and collective migration of a monolayer 
during wound closure or ‘scratch’ assays.  Cells will be imaged and 
analysed using Image J software.   
 
5. Qualitatively and quantitatively assess laminin secretion in vitro in 
relation to treatment with the different TGF-β isoforms. The relative 
secretion of laminin in response to the different TGF-β isoforms will be 
quantified by an ELISA based method.  
 
6. The above will allow the identification of candidate integrins associated 
with TGF-β isoforms function in controlling cell behaviour. This will lead 
onto an immunostaining study aimed at determining exactly which 
integrins are being up and down regulated in response to the different 
TGF-β isoforms.  The use of antibodies raised against the extracellular 
domains of the integrins identified above will allow the function of these 
integrins in terms of cell behaviour to be verified.   
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CHAPTER TWO 
INFLUENCE OF TGF-β3 ON HACAT CELL BEHAVIOUR AND RESPONSE 
TO PATTERENED PROTEINS 
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2.1 INTRODUCTION 
 
The exogenous addition of TGF-β3 has been shown to reduce or eliminate 
scarring following injury (Shah et al.1995, Ferguson et al. 2009).  Normal, intact 
skin experiences fluid exchange with circulating blood plasma.  This plasma 
contains very low amounts of TGF-β3 (Wakefield et al. 1995).  Following injury 
keratinocytes are exposed to serum which contains higher levels of TGF-β3 
(Bandyopadhyay et al. 2006).  The role of keratinocytes in the scar process is 
not fully understood.   Studying the way in which TGF-β3 influences 
keratinocyte behaviour and in particular cell-protein interactions is important in 
determining the role of TGF-β3 in modulating keratinocyte behaviour during 
scarless healing.    
 
Wound healing involves many different cell-protein interactions.  Extracellular 
matrix proteins may influence cell behaviour either directly via specific receptors 
or indirectly by mobilising growth factors which in turn act on the cell via specific 
receptors (Paralkar et al. 1991, Taipale and Keski-Oja 1997). These cell-matrix 
or cell-growth factor interactions influence cell functions via intracellular 
signalling pathways.  Growth factors are known to alter cell responses to ECM 
proteins.  For example, TGF-β1 has been shown to decrease keratinocyte cell 
adhesion to processed laminin 332 (LN332) coated surfaces (Decline et al. 
2003).   For example, the interaction of PDGF and FGF with ECM components 
such as fibronectin has been shown to have a synergistic effect on the 
stimulation of trophoblast cell outgrowth in vitro (Haimovici and Anderson 1993).  
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Studies have suggested that TGF-β influences integrin receptor expression in 
keratinocytes thus altering the way in which these cells adhere to surfaces or 
substrates (Decline et al. 2003, Decline and Rouselle 2001).  These interactions 
may also be altered by the deposition of new matrix proteins.  Characterising 
these changes in cell adhesion may allow a better understanding of the effects 
of TGF-β3 in cell migration and wound repair.  The present study uses different 
techniques to investigate the effects of TGF-β3 on cell-substrate interactions; 
these techniques include the use of widefield surface plasmon resonance 
(WSPR) microscopy and microcontact printing.  
 
Surface Plasmon resonance (SPR) occurs at the interface of two media, one 
less optically dense than the other (e.g. glass and air).  If P-polarised light is 
applied to the material (glass coverslip) at a specific angle, total internal 
reflection occurs within an electromagnetic field (evanescent field) that is 
generated at the interface between the glass and the air.  If the glass is then 
coated with a conductive material e.g. 50nm gold coating, and P-polarised light 
is applied to the interface, free electrons within the conductive metal are 
excited.  This excitation of electrons causes the oscilation of surface plasmons, 
which occurs at a specific angle known as the surface plasmon resonance 
(SPR) angle.  This propagation of surface plasmons occurs laterally along the 
interface and light is re-emitted with no loss of energy (Rothenhausler and Knoll 
1988, Stabler et al. 2004).  The binding of a molecular species to the conductive 
material alters the SPR angle and the degree of change is directly related to the 
size and optical properties of the molecules.  Thus, surface plasmon systems 
can be used to detect the binding of small molecules to a surface with a high 
degree of sensitivity.  Unfortunately surface plasmon systems have very poor 
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lateral resolution as the electron resonance (oscilation of surface plasmons) 
propagates for several microns along the interface. The limitation is overcome 
by the WSPR microscope which uses a high numerical aperture lens together 
with a diffuser.  This diffuser scatters the light source so that the sample is 
illuminated by millions of micron scale points, i.e. surface plasmons are 
generated at multiple points.  The reflected signal from these points can then be 
averaged by rotating the diffuser, thus generating a wide field image of the 
substrate (Stabler et al. 2004, Jamil et al. 2008). 
 
WSPR systems are therefore useful for imaging the cell-substrate interface.  As 
cells adhere and spread on a surface the polymerisation of actin filaments 
causes cells to extend lamellipodia.  At the tips of lamellipodia, cells form focal 
adhesions with the substrate (Ananthakrishnan and Ehrlicher 2007).  The 
WSPR microscope may be configured so that these areas of high cell-substrate 
interaction are visible as brighter areas on the image (Jamil et al. 2008).   
 
Microcontact printing (MCP) is much the same as conventional printing in that it 
involves the ‘stamping’ of a solution onto a substrate.  This printing method has 
been adapted to allow the transfer of micro or even nanoscale monomolecular 
layers onto flat glass or metal surfaces (Ruiz and Chen 2007).  The fabrication 
of PDMS stamps from a master mould allows relief patterns of different sizes to 
be used.  MCP has been commonly used for the patterning of protein 
monolayers onto surfaces (Yeung 2001, Liu et al. 2006).     
 
The specific patterning of protein on substrates provides a tool with which to 
study or effect changes in cell behaviour.    It also acts as a means of controlling 
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the positioning of cells; an application important in tissue engineering and for 
cellular biosensors (Lauer et al. 2001, Elloumi Hannachi et al. 2009).  Cell 
shape or the extent to which a cell spreads on a surface has been shown to 
influence processes such as DNA synthesis (Folkman and Moscona 1978).  
Cell attachment and spreading is also associated with cell survival, growth and 
proliferation (Folkman and Moscona 1978, Chen et al. 1997).  Protein patterns 
of different shapes have been used to influence cell positioning, spreading and 
thus cell functions (Chen et al. 1998).   
 
2.2 AIM 
 
The present study aimed to investigate the behaviour of cultured HaCaT 
keratinocytes in response to treatment with TGF-β3.  For the first part, this 
included a cell adhesion assay and the use of the widefield surface plasmon 
microscope (WSPR) to examine cell-substrate interactions in an attempt to 
understand how TGF-β3 influences cell adhesion.  The second part of this study 
examined responses of HaCaT cell alignment to different extracellular matrix 
protein patterns and how these responses were altered by TGF-β3.     
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2.3 METHODS 
 
2.3.1 Maintenance of HaCat cells in Culture 
 
For this study a human adult, low calcium, high temperature (HaCaT) cell line 
was used. HaCaT cells were taken from a frozen stock and grown in 25cm2 
non-vented flasks at 37°c in RPMI-1640 medium containing HEPES buffer.  To 
ensure adequate growth conditions and to limit any infections, medium was 
supplemented with Fetal Calf serum (10%), L-Glutamine (4mM), Penicilin-
streptomycin (100 units of penicillin and 100μg streptomycin per ml of media) 
and Amphotericin B (0.5μg per ml of media).  
  
When confluent, cells were washed thoroughly in Hanks Balanced Salt Solution 
(HBSS) and trypsinized, using 0.25% Trypsin-EDTA solution, for 4-5 minutes at 
37°c.  Trypsin was neutralized with the addition of 5ml 10% FCS RPMI and the 
cell solution was centrifuged at 1600rpm for 5 minutes to pellet cells.  Cells 
were resuspended in 6ml 10% FCS RPMI.  This cell suspension was plated 
with additional 10% FCS RPMI to give the required dilutions.   
 
2.3.2 Influence of TGF-β3 on HaCaT cell behaviour 
 
2.3.2.1 HaCaT cell culture with and without TGF-β3 
 
HaCaT cells were grown in 25cm2 culture flasks with and without TGF-β3 over a 
4 day period.  Normal culture conditions were used (as described in Section 
2.3.1).  It is important to note that control cells may encounter small amounts of 
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TGFβ due to the use of FCS, however this is standardised throughout all 
experiments.  Cells were plated at a density of approximately 5x104/cm2 to 10% 
FCS RPMI.  TGF-β3 was diluted in a solution of distilled water and 4mM HCL 
together with bovine serum albumin (BSA) (mg/ml) as a carrier molecule.  TGF-
β3 was added to the medium to give a final working concentration of 50ng/ml in 
a final volume of 4 ml.  This concentration of 50ng/ml has been shown to 
produce optimal result in wound closure assays with fibroblasts (Beggs et al. 
2010).  Cells were imaged every 24 hours.  Measurements of cell length and 
width were taken on day 4 using Image J software.   
 
2.3.2.2 Imaging of TGF-β3 treated cells using Widefield Surface Plasmon 
microscopy (WSPR) 
 
HaCaT cells were cultured in Petri dishes with prefabricated gold-coated glass 
coverslips for 48hours.  Culture conditions were used as described above.  
Following incubation with or without TGF-β3, cells were fixed using 1% 
formaldehyde in HBSS.  Fixed cells were then dehydrated using a series of 
alcohol dilutions, from 10% to 100%.  Cells were incubated with each alcohol 
solution for 5 minutes and after the final wash (100% ethanol) were left to air 
dry. The gold coverslip was mounted into the sample holder and imaged using 
WSPR.  The WSPR microscope was developed as part of an EPSRC funded 
project between Dr. M Denyer, at the School of Life Sciences, University of 
Bradford and Prof. M. Somekh at the School of Electrical and Electronic 
Engineering, University of Nottingham.  
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2.3.2.3 Cell adhesion assay using time-lapse imaging: influence of TGF-β3 on 
cell detachment time 
 
HaCaT cells were cultured for 4 days with or without TGF-β3 as described 
above.  In addition, a carrier control was also carried out whereby cells were 
incubated with the same concentration of HCL/BSA solution as used in the 
TGF-β3 assay.  Cells were incubated at 37°C and imaged every 24 hours for 4 
days.  On day 4 cells were washed in HBSS.  Culture flasks were positioned on 
the microscope stage (phase contrast microscope) and cells were imaged using 
visicapture software.  For the cell adhesion assay, 1ml trypsin for each 25cm2 
flask was added and cells were imaged every 20 seconds for 12 minutes using 
Image J software.  Cells were maintained at 37°C during imaging.  Images were 
analysed and rounded cells were counted and the percentage number of cells 
detached at each time interval was determined.   
 
2.3.3 Microcontact Printing 
 
2.3.3.1 Preparing the Master Templates and PDMS Stamp production 
 
Master templates were micro-fabricated at the Department of Electronics and 
Electrical Engineering, University of Glasgow.  Prior to making the 
polydimethylsiloxane (PDMS) stamps, master templates were cleaned.  The 
glass templates were placed in a large glass Petri dish and covered with 
Digesil for between 3 to 7 days depending on the level of debris stuck to the 
glass surface.  Digesil residues were washed off with warm soapy water.  
Initially, this step was followed by the addition of 70% w/w nitric acid for around 
53 
 
24 hours.  This was used to ensure the thorough cleaning of Digesil from the 
glass templates.  This generic protocol however, proved unsuccessful in the 
removal of debris resulting from previous stamp production.  Various attempts 
were made to clean debris from the glass; these included repeating the 
digesil/nitric acid process, bathing in alcohol and sonification of the templates, 
all of which proved inadequate.  The final and most affective attempt involved 
physical removal of debris using friction.  Lens tissue was wrapped around the 
end of forceps as a tool to remove debris.  This process was carried out with 
great care as the ridges on the surface of the glass are extremely delicate.     
 
i)  ii)  
Figure 2.1: Micrographs i) and ii) show a 50μm stamp template before and after 
(respectively) cleaning with lens tissue and 70% ethanol.  Scale bar = 100µm 
approx. 
 
Once thoroughly cleared of debris (as seen in image ii above) the master 
templates were placed inside a fume cupboard and covered with a hydrophobic 
coating consisting of a 44:1ml mixture of Trichloroethylene and 
Dichlorodimethylsilane respectively.  This was applied to the templates and left 
overnight.  The coating was then removed and any residues were left to 
evaporate for a further 24 hours.   
54 
 
To produce the stamps, the stamp templates (ensuring the patterned surface 
was facing upwards) were covered with the Sylgard silicon mixture.  This 
Sylgard Silicone Elastomer Kit consisted of a silicon base and curing agent, 
used at a 9:1ml ratio.  In order to adequately cover the templates within the 
glass Petri dish, a 27:3ml ratio was used.   Air bubbles were removed using a 
vacuum and the silicon was left to set for approximately 2-3 days.  Once set, the 
individual stamps were cut to size and marked to identify the patterned surface. 
 
2.3.3.2 Protein concentrations 
 
Fibronectin (from human plasma) and laminin (from human placenta) were 
diluted to give final working concentrations of 200µg/ml and 50µl/ml 
respectively. A collagen type I solution (from rat tail) was serially diluted to 
achieve a working concentration of 0.01%. All proteins were diluted using 
sterilised distilled water.  The distilled water was sterilised by filtration using a 
syringe and a 0.22μm filter. 
 
2.3.3.3 Microcontact printing: Effects of TGF-β3 on cell alignment to Fibronectin, 
Laminin and Collagen type I 
 
Prior to use, both stamps and substrates (glass coverslips) were thoroughly 
cleaned to ensure that any dust, debris or chemical residues were removed.  A 
stamp or substrate covered with debris may interfere with protein transfer.  
Cleaning involved sonication in warm soapy water for approximately 5 minutes.  
Any soapy residues were rinsed by sonication in distilled water.  The latter 
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stage was repeated at least twice.  Between uses, stamps were kept in 70% 
ethanol. 
 
The microcontact printing assay was carried out under sterile conditions.  Glass 
coverslips and stamps were left to air dry of any alcohol.  Proteins were diluted 
as described above.  Approximately 30 μl of protein was placed into a small 
Petri dish with the lid in place to prevent evaporation.  The stamp was placed 
patterned surface down into the protein for approximately 1 minute to ensure 
thorough coating of the surface.  The stamp was then left to air dry until the 
protein solution had evaporated; leaving a slightly tacky surface.  For collagen 
stamping, this evaporation time was extended to approximately 30 minutes.  
During production, acetic acid is added to collagen to break it down into 
solution.  In order to prevent cell death, 30 minutes is required for the 
evaporation of acetic acid, leaving only collagen on the stamp.  Following 
drying, the stamp was then placed patterned surface down onto the glass 
substrate which had been placed onto a microscope slide as shown in Figure 
2.2.  A second microscope slide was used to apply gentle, evenly distributed 
pressure onto the stamp for around 1 minute.  The stamp was then gently 
removed from the substrate. This process was repeated for stamps with repeat 
gratings consisting of 1.8μm, 5μm, 10μm, 25μm, 50μm and 100μm ridges 
interspaced by grooves with dimensions of 1.8μm, 5μm, 10μm, 25μm, 50μm 
and 100μm respectively. 
  
56 
 
 
 
 
Figure 2.2: Microscope slides were used to sandwich the stamp and substrate.  
Gentle pressure was applied to ensure transfer of protein. 
 
Figure 2.3: Overview of the Microcontact printing process 
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Following protein transfer, substrates were placed protein side up, into 
individual Petri dishes.  Previously prepared cell suspension (see section 2.3.1), 
was diluted in 10% FCS RPMI to each Petri dish.  Cells from a 15μl sample of 
the cell suspension taken from a culture flask at full confluence were counted 
using a Neubauer counting chamber.  
 
For each substrate, cells were added at a density of approximately 1.5 x104 
cells/ml into a final volume of 4ml 10% FCS RPMI media. Substrates were 
incubated with cells for 24 hours at 37°c.   Incubation for longer periods allowed 
cell replication and the formation of cell clusters.  Clustering of cells masked the 
response of individual cells to the patterned substrates and as such had to be 
avoided.   
 
Analysis was carried out using phase contrast microscopy with a 10x objective.  
Images were captured via a digital camera connected to a phase contrast 
microscope (XDS-2 inverted microscope).  Cell length, width and angle of 
alignment to the MCP patterns were analysed using Image J software (NIH) and 
calibration was achieved by imaging a structure of known dimensions.  Cell 
alignment was determined by measuring the angle between the long axis of 
individual cells and the stamp pattern such that an angle of 0° represents 100% 
alignment and an angle of 45° represents a random cell orientation.  For each of 
the six stamp sizes, images were collected from areas of substrate on which 
cells were most responsive to the protein pattern.  Cell length, width and angle 
of alignment were recorded.  If no protein pattern was visible, a line of best fit 
was chosen in order to measure cell alignment.   It is important to note that the 
use of serum, although standardised across all experiments, would introduce 
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other ECM proteins such as vitronectin to the culture substrate.  Any cell that 
displays alignment would therefore be favouring microcontact printed ECM 
patterns over serum proteins that may cover the substrate in the spaces 
between MCP patterns.    
 
2.3.3.4 Cell alignment with TGF-β3 
 
Proteins were patterned as described above.  The 50µm stamp was used for 
this experiment.  50µl of reconstituted TGF-β3 was added to the media to give a 
working concentration of 50ng/ml.  Cells were incubated with patterned 
substrates for 24 hours and imaged and analysed as described previously. 
 
2.3.4 HaCaT cell migration: Immunoperoxidase Staining for Laminin 
 
Under sterile conditions HaCaT cells were seeded into 6mm Petri dishes at a 
density of approximately 7.5x103 cells/ml per glass coverslip.  Substrates were 
cultured in normal 10% FCS RPMI or in 50ng/ml TGF-β3 containing media at 
37°C for 4 days and then fixed in 1% formaldehyde in HBSS for 10 minutes.  
Subsequent immunostaining for laminin was achieved using a Laminin 
immunohistology kit.  Immunostaining with this kit involved quenching 
endogenous peroxidase with 3% hydrogen peroxide for 5 minutes, before 
washing the cells in HBSS and incubation with 4% bovine serum albumin for 15 
minutes to prevent non-specific binding.  Following this blocking step, cells were 
incubated with primary rabbit anti-laminin antibody for 60 minutes, washed and 
incubated with the biotinylated secondary goat anti-rabbit IgG antibody for 20 
minutes.  Cells were washed and incubated with the ExtrAvidin® peroxidase 
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reagent for a further 20 minutes.  During the final wash step, the substrate 
reagent was prepared in the mixing vial provided.  Reagents were added to the 
vial in the following order; 4ml deionised water, 2 drops acetate buffer, 1 drop 
AEC chromogen and 1 drop 3% hydrogen peroxidase.  Substrate reagent was 
then added to cells following washing and chromogen development was left to 
occur for 10 minutes before a final wash in water.  All incubations were carried 
out inside a humidity chamber to avoid the evaporation of reagents.   
 
As a positive control measure, laminin was coated onto the surface of a petri 
dish and left to incubate at 4°C overnight.  The immunostaining protocol was 
carried out as described above. 
 
2.3.5 Statistical Analysis 
 
The statistics packages SPSS (IBM) and GraphPad Prism (GraphPad Software) 
were used to carry out statistical analysis.  Following tests for normality, the 
One-way Anova, followed by the Bonferroni post-hoc test, was used to compare 
more than 2 groups.  The non parametric test used if data was not normally 
distributed was the Kruskal-Wallis test.  For comparisons between 2 groups, an 
unpaired T-Test or the non parametric equivalent, the Mann-Whitney U test was 
used.  Significant differences were taken as *p<0.05, **p<0.01 and ***p<0.001.  
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2.4 RESULTS 
 
2.4.1 HaCaT cells in culture with and without TGF-β3 
 
HaCaT cells were cultured with and without TGF-β3 over a 4-day period in 
order to examine the effects on cell density and morphology (Figure 2.4).  On 
Day 1 there were no apparent morphological differences between treated and 
control cells.  On Day 2, differences started to appear as treated cells were less 
grouped, however, in terms of cell density, Day 1 and 2 cells appeared relatively 
similar for both groups.  By Day 3 there was a marked difference in cell density 
with what appeared to be lower numbers of treated cells compared to the 
control, indicating that TGF-β3 causes a reduction in cell proliferation.  TGF-β3 
treated cells appeared morphologically different from control cells by Days 3 
and 4 with treated cells taking on a migratory phenotype; spreading over a 
greater area and becoming more elongated.  Measurements (μm) of cell length 
and width were taken for control and TGF-β3 treated cells on day 4 (Figure 2.5).  
TGF-β3 treated cells were significantly longer and wider when compared to 
control cells (p<0.0001).     
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Figure 2.4; Micrographs A-D show HaCaT cells in culture under control conditions 
on days 1-4 respectively.  Micrographs E-H show cells treated with TGF-β3 on 
days 1-4 respectively.  Scale bar = 100µm approx.    
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Figure 2.5; Charts represent cell length (μm) (A) and width (B) measurements for 
control and TGF-β3 treated cells following 4 day incubation. N=100     
 
A 
B 
63 
 
2.4.2 Imaging of TGF-β3 treated cells using Surface Plasmon microscopy 
 
In order to examine the effects of TGF-β3 on cell morphology and determine 
how treatment with TGF-β3 influenced cell surface interactions, cells were 
cultured on gold coated substrates and imaged using surface plasmon 
microscopy.  The WSPR microscope allowed cells to be imaged at the cell-
substrate interface.  Points of contact are highlighted at the outer perimeter of 
each cell.  Further banding patterns underneath the cell show that cell-substrate 
interactions are not restricted to the cell perimeters.   
 
Control cells were often rounded with surface contact points covering the 
majority of the cell area, as shown in Figure 2.6.  There was little evidence of 
cells extending protruding lamellipodia which indicates these cells are stationary 
and firmly fixed to the substrate.  Cells treated with TGF-β3 displayed a very 
different morphology.  Firstly, these cells covered a much larger area of the 
substrate as a result of the extension of lamellipodia.  Here, the concentric 
contacts were confined to the centre of the cell and did not cover the whole cell 
area.  Cells were also shown to be more polarised, indicating the direction of 
migration.       
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Figure 2.6: HaCaT cell imaging using WSPR.  Micrographs show HaCaT cells 
under control conditions.  Lighter areas of the cell represent cell-substrate 
interactions.  Scale bar represents approximately 50μm.     
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Figure 2.7: Micrographs show HaCaT cells imaged using WSPR following 
treatment with TGF-β3.  Scale bar represents approximately 50μm.     
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2.4.3 Cell adhesion assay using time-lapse imaging: influence of TGF-β3 on cell 
detachment time 
 
In order to quantify the differences in cell adhesions when cells are treated with 
TGF-β3 cells were incubated with trypsin.  Trypsin is a protease that is used to 
detach cells from culture surfaces.  This works by digesting the proteins that 
bind the cell to the substrate causing the cell to round up and lift off into the 
media.  Cells were imaged (Figure 2.8) over a period of 12 minutes and cell 
‘rounding’ was determined as a percentage of the total number of cells visible in 
the image.  A comparison of the findings are displayed in Figure 2.9.   
 
The percentage cell detachment at the 2 and 4 minute points did not show 
differences between treatments.  However, by 6 minutes, TGF-β3 showed an 
increase in the number of cells rounding.  This difference increased further after 
8 minutes (p<0.05).  As the sham control presented very similar results to the 
standard control it can be said that the effects seen with TGF-β3 are solely due 
to the growth factor and not a result of the HCL/BSA carrier molecules.    
  
67 
 
 
Figure 2.8: Micrographs representing HaCaT cell detachment during 
trypsinisation.  Images A and E show control and TGF-β3 treated cells 
(respectively) prior to treatment with 0.25% trypsin-EDTA solution.  Images B, 
C, and D represent control cells at 4, 8 and 12 minutes (respectively) following 
the addition of trypsin-EDTA.  The same time intervals are also shown for TGF-
β3 treated cells (F, G and H). 
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Figure 2.9: Graph represents HaCaT cells detachment following treatment with 
0.25% trypsin-EDTA solution.  Points represent mean value ± Standard error of 
the mean. *p<0.05.  N=4. 
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2.4.4 Microcontact printing 
 
2.4.4.1 Microcontact printing: Effects of TGF-β3 on cell alignment to Fibronectin, 
Laminin and Collagen type I 
 
Microcontact printing was used to examine HaCaT cell responses to different 
extracellular matrix proteins with and without treatment with TGF-β3.  PDMS 
stamps were successfully prepared from glass templates.  A variety of pattern 
sizes were used; 1.8μm, 5μm, 10μm, 25μm, 50μm and 100μm (See Figure 2.10 
for examples).   
 
 
 
   
  
  
Figure 2.10: Micrographs show examples of stamp patterns used.   
A) 10μm B) 25μm C) 50μm and D) 100μm stamps.  Scale bar = 100µm 
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In order to ensure the successful transfer of protein to the substrate, glass 
coverslips were thoroughly cleaned using sonication.  Of the three proteins, 
collagen type I was the only one that was not visible on the substrate following 
transfer.  Figure 2.11 shows the glass substrate following the application of a 
50μm stamp coated with fibronectin.   
 
 
 
Figure 2.11 Micrograph shows a 50μm fibronectin pattern on glass substrate.  
Scale bar = 100µm approx.  
 
Following a 24 hour incubation period with cell suspension, substrates were 
analysed and images were taken using Visicapture.  The optimal images 
contained visible protein patterns.  Images were taken of those areas in which 
cells appeared to be aligning to the protein.  Most patterning disappeared from 
view once media and cell suspension was added, often making it difficult to 
determine cell alignment; thus a line of best fit was drawn across the image and 
alignment to that plane was determined.  Figures 2.12, 2.13 and 2.14 show cell 
responses to the extracellular matrix proteins without TGF-β3 treatment 
(control).     
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Figure 2.12: Micrographs show cell alignment to 100µm (A), 50µm (B), 25µm 
(C), 10µm (D), 5µm (E) and 1.8µm (F) fibronectin patterns.  Scale bar = 100µm 
approx. 
A B
D
E F
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Figure 2.13: Micrographs show cell alignment to 100µm (A), 50µm (B), 25µm 
(C), 10µm (D), 5µm (E) and 1.8µm (F) laminin patterns.  Scale bar = 100µm 
approx. 
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Figure 2.14: Micrographs show cell alignment to 100µm (A), 50µm (B), 25µm 
(C), 10µm (D), 5µm (E) and 1.8µm (F) Collagen Type I patterns. Scale bar = 
100µm approx. 
 
 
 
A B
D
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HaCaT cells responded to each of the three proteins, fibronectin, laminin and 
collagen type I.  For each protein the best alignment was seen with the larger 
pattern, 50µm.  As a larger pattern provides wider intervals this allows cells to 
respond to the edge of the pattern without interference from any adjacent edges 
suggesting it is the smaller feature of the wide pattern that cells preferentially 
align to.  Cell elongation was often characteristic of strong alignment to the 
patterned protein.  When compared to fibronectin and collagen, laminin patterns 
were associated with an increase in cell density, especially in areas of strong 
cell alignment.  Figure 2.15 shows long collections of cells following the laminin 
pattern. 
 
Figure 2.15: Micrograph shows cell alignment to 50um laminin pattern.  There 
appears to be an increase in cell numbers responding to laminin.   Scale bar = 
100µm approx.    
 
From the images, data was collected on the length, width and angle of 
alignment for each cell.  Where protein patterning was not visible, a line of best 
fit was used to measure alignment.  The same line was used for all cells within 
a single image.  Those cells grouped in clusters were not counted as these cells 
would influence each other and therefore skew results.  Cell measurements 
were collected using Image J and data was displayed and analysed in Excel.   
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Table 2.1 shows average cell length, width and angle of alignment for 
Fibronectin, Laminin and Collagen type I with standard errors for each data set.  
For fibronectin, laminin and collagen type I, the smallest average angle of 
alignment was seen with the 50µm pattern (mean 7.52°± 1.73, mean 6.52 ± 
1.33 and mean 17.97 ± 3.42 respectively). The 1.8µm pattern produced good 
alignment for fibronectin (12.52 ± 1.69) and laminin (15.08 ± 2.52); however 
these results were not replicated for collagen (27.98 ± 4.02).  In general, the 5, 
10 and 25µm patterns did not produce optimal alignment for any of the three 
proteins.   Figure 2.16 shows cell alignment for each pattern size while Figure 
2.16 shows cell length.  When comparing the two charts it appears that, in 
general, the better the cells alignment, the greater the cell length.  However this 
does not apply to all stamp sizes. 
 
 
 
 
Figure 2.16:  Chart shows mean angle of alignment (°) for each protein and 
pattern size.  Standard error bars are shown. See Table 2.2 for statistics. 
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Statistical analysis enabled the assessment of consistency and variability within 
each data set.  Figure 2.16 shows that of the three proteins, cells align most 
consistently to fibronectin; the smaller standard error bars show there is less 
variability in this data set.  With the exception of the 50µm laminin pattern, cells 
respond with less consistency to laminin and collagen type I.  The variability 
within these data sets is reflected in the larger error bars.  The small error bars 
for each data set shown in Figure 2.17 demonstrates a consistency in HaCaT 
cell length in response to protein pattern.       
 
Table 2.2 shows the significant differences that exist between each data group 
presented in Figure 2.16.  As the data groups were not normally distributed the 
Figure 2.17:  Chart shows mean cell length (μm) for each protein and pattern 
size.  Standard error bars are shown. 
 79 
 
Kruskal-Wallis test was used to determine significance at the 95%, 99% and 
99.9% confidence levels.  When comparing the number of significant 
differences (at at least the 95% level) between data groups, the fibronectin 
50μm, laminin 50μm and the collagen 5μm patterns each differed from 8 other 
protein pattern groups.  These were closely followed by the laminin 100μm 
pattern which differed from 7 other groups.  As the fibronectin and laminin 50μm 
patterns produced the highest degree of alignment (7.52° and 6.52° 
respectively) of the above mentioned data groups these were shown to be the 
most statistically different.  
 
2.4.4.2 Cell alignment with TGF-β3 
 
Based on these findings, the 50µm pattern was selected for the experiments 
with TGF-β3.  In order to study the effects of TGF-β3 on cell alignment to the 
different extracellular matrix proteins, TGF-β3 was added to the growth media of 
cells for the 24 hour incubation period.  HaCaT cells were successfully culture 
with each protein in TGF-β3 conditioned media.    Cells were scored and results 
were compared with non-treated cells (See Table 2.3 and Figure 2.18).  Figure 
2.19 shows images of cell alignment to each protein.  Treatment with TGF-β3 
caused a decrease in HaCaT cell response to each of the three 50 µm protein 
patterns.  Following 24 hour incubation with TGF-β3, the mean angle of 
alignment to each protein was increased when compared to the cell alignment 
data collected from non treated cells.  TGF-β3 treatment increased the angle by 
10.61° (from 7.52° to 18.13°) (p<0.01) for fibronectin, 9° (from 6.52° to 15.52°) 
for laminin and 5.03° (from 17.97° to 23°) for collagen type I. 
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Figure 2.18: Chart shows comparison of cell alignment (°) to each protein for 
the control and the TGF-β3 treated cells.  TGF-β3 caused a decrease in cell 
alignment to each protein when compared to control.  Standard error bars 
are shown.  ** p<0.01 
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2.4.5 HaCaT cell migration: Immunoperoxidase stain for Laminin 
 
In order to investigate how TGF-β3 causes decreased cell alignment, substrates 
were stained for the deposition of laminin.  Control cells were shown to cluster 
in groups and remain attached to the surface with little evidence of migration 
(Figure 2.20 A and B).  Control cells and the immediate surrounding area 
stained positive for laminin (brownish red colour).  TGF-β3 treated cells on the 
other hand did not appear to cluster in groups and showed enhanced spreading 
on the substrate.  Positive staining of cell laminin trails (Figure 2.20 C and D) 
provided evidence of enhanced laminin deposition and the ‘snail trails’ indicated 
enhanced cell migration, a feature not seen with controls (Figure 2.20 A and B).  
Positive and negative controls are also shown in Figure 2.20.  The red/brown 
staining of the laminin coated petri dish demonstrated that the red/brown trails 
were indeed laminin. As there was no red/brown stain seen with the negative 
controls, this demonstrated that any staining was not a result of unspecific 
antibody binding.       
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Figure 2.20: Micrographs show immunoperoxidase staining of glass substrate 
on which HaCaT cells have been cultured for 5 days with (C and D) and without 
(A and B) TGF-β3.  Images E and F represent positive and negative controls 
respectively.  Image E shows positive staining of a laminin-coated petri dish.  
Image A was taken using x10 objective and the scale bar represents 
approximately100µm.  Images B-D and F were taken using x25 objective and 
the scale bar represents approximately 50µm.     
A
C 
B 
E F 
D 
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2.5 DISCUSSION 
 
Treatment with Avotermin (TGF-β3) following surgery improves the quality of 
wound repair.  This is demonstrated by a reduction in the presence of 
inflammatory cells, less abnormal orientation of collagen fibres and reduced 
scarring when compared to untreated wounds (Ferguson et al. 2009).  Although 
TGF-β3 is known to be important in wound healing, the mechanisms by which 
its scarless healing effects are mediated, e.g. the integrins and signalling 
pathways under TGFβ control, have yet to be fully elucidated. There are a 
number of studies examining keratinocyte cell signalling pathways associated 
with the TGFβ family of cytokines (Davies et al. 2005, Hosokawa et al. 2005); 
however few studies have examined how TGF-β3 mediates behavioural 
changes in keratinocyte cells and how these behaviours relate to the 
improvements in wound repair seen with TGF-β3.  This study aimed to address 
this by taking the bottom up approach of characterising cell behaviours induced 
by TGF-β3 and relating those behaviours to what is known about the wound 
repair process.  
 
Initial examination of HaCaT cells in culture found that after 24 hours, TGF-β3 
causes an increase in cell scattering and cell spreading.  Unlike control cells 
which tended to cluster in groups, treated cells appeared more independent of 
each other.  There also appeared to be a decrease in cell density which was 
apparent by day 3 of the incubation period.  However, further cell proliferation 
assays will be required to confirm this.    
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Studying the changes in cell morphology in response to extracellular cues 
provides information about the state of the cell.  An asymmetrical cell shape or 
polarisation indicates that a cell is undergoing cytoskeletal changes.  
Reorganisation of the cytoskeleton is influenced by extracellular factors such as 
ECM proteins and growth factors (Ananthakrishnan and Ehrlicher 2007).   Using 
WSPR imaging cell-substrate interactions were further examined.  Control cells 
were often more rounded and did not show large lamellipodia extensions.  Also, 
a rosette-like pattern of focal adhesions covered the majority of the cell area.  
Interestingly, this rosette-like pattern occurs with α6 integrin expression and 
laminin deposition in keratinocyte cells (Sehgal et al 2006, Hamil et al 2009, 
Ozawa and Tsuruta 2011).  As the α6 integrin subunit is associated with 
hemidesmosomes formation on laminin matrices, it is likely that the focal 
adhesion patterning seen with the present WSPR images is at least in part a 
result of cell adhesion on laminin.  TGFβ treated cells expressed a different 
morphology, clearly spreading over a larger area of the substrate and often 
becoming polarised with more irregular shapes.  With these cells, the pattern of 
contact points was restricted to the centre and the cell perimeter.  The formation 
of focal adhesions has been studied in fibroblast cells whereby the density or 
spacing of the ECM nano-patterns were shown to influence cell behaviour and 
the formation of focal adhesions.  Cells cultured on ECM with particle spacing of 
108nm displayed more migratory behaviour and cell adhesions were restricted 
to the periphery of the cell.  Conversely, with a denser nano-pattern (spacing of 
58nm) these adhesions sites were shown to cover the majority of the cell area 
and cell migration was limited (Ada Cavalcanti-Adam et al. 2007).  Together, 
these findings point to a possible link between TGF-β3 and the deposition of 
 87 
  
proteins whereby the patterning and/or density of these proteins may be 
influencing cell behaviour.        
 
In order to study how TGF-β3 influenced the adhesive properties of the cells, 
detachment rates were analysed.  TGF-β3 was shown to increase the rate of 
detachment demonstrating that these cells were less adherent or had fewer 
points of contact for the trypsin-EDTA to digest.  A migrating cell extends 
lamellipodia and forms adhesions at tips of lamellipodia.  Bearing in mind the 
reduced detachment time for treated cells, it is possible that adhesion sites may 
be concentrated at the outer perimeter of the cells.  As trypsin digests these 
outer adhesions, the cell would more quickly retract as seen in the adhesion 
assay.  While the WSPR images found TGF-β3 treated cells display large areas 
of cell-surface contact, these light areas may not necessarily indicate focal 
adhesion sites or areas of high cell-substrate interaction.  Conversely, these 
areas of cell-surface contact may be due to the weight of intracellular organelle 
causing deformation of the cell membrane and thus causing the cell membrane 
to rest on the substrate.   
 
Cells adhesion and spreading on extracellular matrices occurs via membrane 
receptors.  Ligand binding initiates intracellular signalling pathways enabling the 
cell to respond to the new environment.    The patterning of extracellular matrix 
proteins onto glass substrate allowed HaCaT cell responses, both with and 
without TGF-β3, to be examined.  Initial experiments, or the control experiment, 
investigated the cellular response to proteins in the absence of TGF-β3.  Of the 
six different pattern sizes (1.8-100µm) used, HaCaT cell alignment favoured the 
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50µm pattern for each protein.  The best alignment was seen with the 50µm 
laminin pattern, closely followed by the 50µm fibronectin pattern (Table 2.2).   
 
Microcontact printing of collagen type I failed to achieve good alignment as 
seen with laminin and fibronectin.  This suggests that cultured HaCaT cells 
adhere with integrins that favour laminin and fibronectin over collagen type I.  
Following injury, a fibrin clot rich in fibronectin provides a provisional matrix 
across the wound bed onto which cells migrate.  In response to this increase in 
extracellular fibronectin cells upregulate the required integrin receptors.  A study 
by Gailit et al found the primary fibronectin receptor α5β1 was increased at the 
cell periphery of migrating basal and suprabasal keratinocytes in 3-7 days 
wounds (Gailit et al. 1994).  Other fibronectin receptors are also upregulated 
during the early stages of the healing process; these include the 
fibronectin/vitronectin receptor αvβ5 and the fibronectin/tenascin receptor αvβ6 
(Decline et al. 2003). 
 
Although keratinocytes constitutively express the collagen receptor α2β1 these 
cells are not normally in direct contact with collagen type I which is found in the 
dermis.  During the initial stages of re-epithelialisation leading edge 
keratinocytes are exposed to dermal collagen (collagen type I).  In response to 
this interaction with collagen type I, cells begin to produce and deposit laminin 
(Frank and Carter 2004).  The rapid restoration of the basement membrane by 
leading edge cells means that keratinocyte exposure to collagen type I is short- 
lived and is limited to those cells at the wound periphery, this may explain the 
lesser response to collagen type I during the cell alignment assay.    
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Laminin patterns were associated with an increase in cell density, particularly in 
areas of strong alignment. This may have been a result of an increase in 
proliferation in response to laminin.  Further experiments will need to be carried 
out to confirm these findings.  However, the deposition and proteolytic 
processing of laminin-332 is central to the re-epithelialisation process which 
involves both cell migration and proliferation (Goldfinger et al. 1998, Frank and 
Carter 2004, Garlick and Taichman 1994).  This suggested in vitro response to 
laminin indicates that keratinocytes respond to these laminin patterns in the 
same way they respond to new basement membrane in the wound.       
 
HaCaT cells were cultured with pattern substrates in the presence of TGF-β3.  
Cells showed a reduced response to each protein patterned substrates i.e. the 
average angle of alignment for the sample of cells measured was greater when 
compared to the control.  This altered response to patterned ECM proteins 
highlights possible roles for TGF-β3.  As cells were less responsive to the 
patterns following treatment with the growth factor, this suggests that either the 
expression of integrin receptors had been modified or that cells were 
responding to other newly deposited proteins.     
 
TGF-β is known to cause the deposition of laminin by keratinocytes (Hamelers 
et al. 2005).  Further experiments went on to examine the influence of TGF-β3 
on laminin deposition in order to confirm that the decreased cellular response to 
patterned proteins was influenced, at least in part, by additional laminin 
deposition during TGF-β3 induced cell migration.  HaCaT cells were stained for 
laminin using an immunoperoxidase staining technique.  Immunostaining 
confirmed that TGF-β3 induced the deposition of laminin ‘snail trails’ over the 
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surface of the glass substrate while non-treated cells remained comparatively 
stationary in groups.   The TGF-β3 induced laminin deposition provides a 
reason for the decreased alignment to the extracellular matrix proteins, 
fibronectin, laminin and collagen type I following the same TGF-β3 treatment.   
 
In summary, the results presented in this study suggest a possible role for TGF-
β3 in the changing response to extracellular matrix proteins during keratinocyte 
migration in wound healing; potentially by modifying laminin secretions.  Further 
work will aim to identify how TGF-β3 compares with other TGFβ isoforms in its 
influence on cell responses important in wound repair.   
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CHAPTER THREE 
ROLE OF EXTRACELLULAR MATRIX PROTEINS AND TGF-β ISOFORMS 
ON WOUND CLOSURE AND PROLIFERATION 
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3.1 INTRODUCTION 
 
The restoration of the epidermis following injury is an important event in wound 
healing.  In order to fill the void left by injury, keratinocytes must repopulate the 
wound bed and re-establish the stratified layers of the epidermis.  Mechanisms 
involved in this process include cell migration, proliferation and differentiation 
(Garlick and Taichman 1994).   
 
As a result of injury and the subsequent repair process keratinocytes are faced 
with a changing environment.  Major proteins that keratinocytes interact with 
during re-epithelialisation include, amongst others, collagen type I, fibronectin 
and laminin (Repesh et al. 1982, Lange et al. 1994, Hamelers et al. 2005).  
Type I collagen is a major component of the dermis and its exposure following 
injury stimulates haemostasis.   Activation of the coagulation cascade results in 
the formation of a fibrin clot.  Rich in fibronectin, the fibrin clot provides a 
provisional matrix onto which keratinocytes can migrate (Repesh et al. 1982).  
As leading edge keratinocytes migrate into the wound bed they deposit proteins 
including laminins (Larjava et al. 1993).  Keratinocytes interact with these 
protein networks via membrane receptors, the expression of which is influenced 
by the wealth of growth factors released following injury (Decline et al. 2003, 
Andreadis et al. 2001).   
 
The stimulation of keratinocytes during wound healing involves a multitude of 
different chemical mediators that influence cell behaviour both directly and 
indirectly via different cell populations.   Different cell populations including 
neutrophils, monocytes and macrophages are attracted to the wound site as a 
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result of damage to the epidermis; together with platelets these cells release a 
range of growth factors including PDGF, EGF, TGF-α and TGF-β (Grayson et 
al. 1993, Assoian et al. 1983).  Other cells, such as fibroblasts and 
lymphocytes, produce further growth factors including FGF and KGF (Werner 
1992, Blotnick 1994).  These growth factors act on keratinocytes, influencing 
cell migration and proliferation (Kiritsy et al. 1993).  These events are mediated 
by changes in cell surface receptors which are also under growth factor control 
(Decline et al. 2003, Zambruno et al. 1995).  Cell surface receptors such as 
integrins effect downstream signalling pathways and in turn mediate cell 
cytoskeleton reorganisation (Hamelers et al. 2005).             
 
TGF-βs have been the focus of research into anti-scarring therapies.  While the 
TGF-β isoforms are highly homologous there are apparent differences in the 
way these isoforms influence the degree of scar tissue formation.  With the use 
of antibodies against TGF-β1 and 2, these isoforms were shown to be 
associated with the presence of inflammatory cells and collagen deposition 
(Shah 1995), both of which are associated with scarring.  Increasing the levels 
of TGFβ 3 by addition of exogenous TGF-β3 on the other hand has been shown 
to reduce the presence of immune cells and decrease the deposition of 
fibronectin and collagens thus improving the architecture of the skin during 
repair (Shah et al. 1995). 
 
Many in vitro studies addressing cell responses to ECM proteins and growth 
factors have focused on solitary cells as opposed to the collective behaviour of 
cell monolayers (Guo et al. 1990, O’Toole et al.1999, O’Keefe et al. 1985, 
Sogabe et al. 2006).  There are different theories as to the movements of 
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keratinocytes during wound repair; the first of which suggests that basal layer 
cells at the wound margins move into the wound bed maintaining cell-cell 
contacts, thus pulling the epithelial sheet along (Woodley 1996).  The second 
theory involves a ‘leap frog’ or rolling mechanism whereby suprabasal layer 
cells set back from the wound edge reduce desmosomes and proliferate, 
moving out over the stationary basal layer cells to form the new basal layer in 
the wound bed (Krawczyk 1971).  Regardless of whether cells are crawling over 
each other or being pulled along as a sheet, keratinocytes remain closely 
packed together.  Cell-cell interactions have been shown to influence cell 
responses such as migration and the deposition of ECM proteins (Frank and 
Carter 2004).  Therefore the examination of collective cell behaviours in 
response to different chemical signals has an important part to play.  The 
present study adopts the commonly used scratch assay.  The scratch assay is a 
simple and inexpensive method, commonly used to assess cell behaviour in 
response to “wounding” of cultured cell monolayers (Li et al. 2004, 
Bandyopadhyay et al. 2006).  While studying the cell monolayer response to 
different factors in vitro may not replicate in vivo conditions, it remains a useful 
tool with which to study collective cell responses to different ECM substrates 
and growth factors that influence wound repair.   
 
3.2 AIM 
 
The aim of this study was to identify both ECM proteins and TGFβ isoforms that 
influence ‘wound closure’ in vitro.  In addition, the influence of cell monolayer 
density was examined.  This was carried out using a scratch assay whereby 
decreasing wound width was measured over a 10 hour period.  As cell 
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proliferation is also an important aspect of re-epithelialisation, i.e. it may 
influence rates of wound closure; this was also investigated for each protein and 
growth factor.     
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3.3 METHODS 
 
3.3.1 The influence of ECM proteins on cell proliferation 
 
HaCaT cells were cultured with protein coated substrates and cell proliferation 
was studied over a 6 day period.  Under sterile conditions fibronectin, laminin 
and collagen type I (for protein concentrations see Chapter 2) were coated onto 
the surface of 25cm2 culture flasks.  For each protein, three different flasks were 
coated for cell counts on Days 2, 4 and 6.  Cells were seeded at approximately 
8x102 cells/cm2 and cultured in 6ml 10% FCS RPMI at 37°C.  For cell counts, 
cell monolayers were washed with HBSS and incubated with trypsin for up to 5 
minutes or until all cells were lifted from the surface of the flasks.  Serum 
containing RPMI media was added to neutralise the trypsin and cells were 
counted using a counting chamber. 
 
3.3.2 The influence of TGF-β on cell proliferation 
 
HaCaT cells were seeded at a density of 1.3x104cells/cm2 with each TGF-β 
isoforms for 4 days.  On day 4 cell counts were performed as described above. 
 
3.3.3 The influence of ECM proteins, TGF-β isoforms on rates of wound closure 
 
For scratch assays, cells were cultured with ECM proteins, TGF-β1, 2 and 3.  
As described above, fibronectin, laminin and collagen type I were coated onto 
the surface of 25cm2 culture flasks at the concentrations described in chapter 2.  
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HaCaT cells were seeded at a density of 2x104cells/cm2 and cultured with each 
protein for 48 hours until confluency was reached. 
 
TGF-β1, 2 and 3 were diluted in HCL/BSA solution (as described in Chapter 2) 
and added to 4ml 10% FCS RPMI to give final working concentrations of 5ng/ml 
for each isoform.  As part of the TGF-β wound closure investigation, the effect 
of HCL on wound closure was also examined.  Recent studies examining the 
effects of HCL on bone cell monolayers suggest that hydrogen ions may 
influence cell behaviours including cell adhesion and migration (Sefat et al. 
2009, Sefat et al. 2010).  As HCL is a component of the TGF-β solution used in 
the present study, it was necessary to investigate whether HCL influenced 
wound closure rates seen with the TGF-β isoforms.  Therefore HCL was diluted 
in 10% FCS RPMI to give a concentration of 50μM, the same concentration 
present in the 4ml TGF-β containing 10% FCS RPMI.  For both the TGF-β and 
HCL assays cells were seeded at approximately 1.5x104cells/cm2 and cultured 
for 4 days.  This 4 day incubation period was shown to be optimal in Chapter 2; 
after this period the phenotype of TGF-β3 treated cells clearly differs from 
control cells, any longer and cell quality is lost. 
 
In order to measure wound closure, monolayers were “wounded” by scraping 
the surface of the flask using a 1ml pipette.  Wound sites were imaged using 
Visicapture software every 2 hours.  Wound widths were measured at each time 
point using Image J software.   
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3.3.4 The influence of cell density on rates of wound closure 
 
HaCaT cells were seeded at different densities (approximately 1.5x104/cm2, 
2x104/cm2 and 3x104/cm2) into 25cm2 culture flasks and 10% FCS RPMI media 
was added up to a total of 6ml in each flask.  Cells were cultured at 37°C for 48 
hours to allow cells to reach confluency.  Monolayers were wounded and 
imaged as described above.  Following the scratch assay, cell counts were 
taken to determine the approximate cell density of each monolayer.  For cell 
counts cell monolayers were washed with HBSS and incubated with trypsin for 
up to 5 minutes or until all cells were lifted from the surface of the flasks.  If 
necessary, a cell scraper was used to lift any remaining cells.  Serum containing 
RPMI media was added to neutralise the trypsin and cells were counted using a 
counting chamber. 
 
3.3.5 Statistical analysis 
 
The results are presented as means ± standard errors of the means.  Following 
tests for normality, the One-way Anova, followed by the Bonferroni post-hoc 
test, was used to compare more than 2 groups.  The non parametric test used if 
data was not normally distributed was the Kruskal-Wallis test.  Significant 
differences were taken as *p<0.05, **p<0.01 and ***p<0.001.  
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3.4 RESULTS 
 
3.4.1 The influence of ECM proteins on cell proliferation 
 
In order to investigate how ECM proteins influence cell proliferation rates, 
HaCaT cells were cultured with each protein and cell counts were taken on Day 
2, 4 and 6.  Results show that on each day, average cell counts (x104) are 
greatest on laminin coated substrates and on Day 6 laminin is significantly 
different to fibronectin (p<0.05).  Although the difference in cell numbers for 
laminin compared to control did not prove significantly different at the 95% level, 
results show a clear trend that suggests laminin increases cell proliferation over 
a 6 day period.  Larger sample sizes may allow statistical significance to be 
achieved.      
 
 
 
 
 
Figure 3.1: Chart shows cell counts (x104/ml) on Days 2, 4 and 6 for each ECM 
protein and control.  Standard error bars are shown. N=4    *p<0.05 Laminin vs 
fibronectin. 
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3.4.2 The influence of ECM proteins on rates of wound closure 
 
As Day 2 cell counts did not present any significant differences in the cell 
proliferation rates this incubation time was chosen for the wound closure assay 
on ECM proteins.  Any results obtained would not be influenced by differences 
in cell proliferation rates.     
 
Within the first 2 hours following ‘wounding’ there was an adjustment period 
during which the wound size either widened or did not alter at all.  This widening 
has been described before and is perhaps a result of the damage to cells 
following scratching (Thielecke et al. 2006).  Bordering cells may become 
permeable when neighbouring cells are torn following scratching.  Including the 
data collected in the first 2 hours would have affected trend lines and therefore 
wound closure was measured from the 2 hour point and was called 100%.   
 
The micrographs presented in Figure 3.2 show examples of wound closure for 
each protein at the 2, 4 and 6 hour time points.  When comparing laminin 
(images D-F) to control (images A-C) there are clear differences in wound 
widths at each of the time points.  The protein coated substrates do not appear 
to cause any differences in monolayer distribution, i.e. all cell monolayers are 
similar in density and cells do not present any obvious morphological 
differences.  The wound margins remain tightly packed together, moving 
forward in an orderly manner.  The cells seldom migrated independently from 
the margins out into the ‘wound bed’.   
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Figure 3.2: HaCaT cells under control conditions at 2, 4 and 6 hours (A-C 
respectively); HaCaT cells plated on Laminin (D-F), Fibronectin (G-I) and 
Collagen type I (J-L) at 2, 4 and 6 hours post wounding. Scale bars = 100μm 
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Figure 3.3 shows rates of wound closure (μm/hour) for different time intervals.  
The major difference in the rate of wound closure for laminin was seen between 
the 2 and 6 hour time points.  Here, the wound margins progressed on average 
approximately 10μm/hour less than the other treatment groups.  When 
compared to control the average wound closure rate for laminin was 
significantly different (p<0.01) between the 2 and 4 hour period only.  For all 
groups, rates of wound closure peaked between 6 and 8 hours.   
 
Raw measurements (µm) of the wound at each time point were normalised and 
average data was plotted as shown in Figure 3.4 A.  HaCaT cells on laminin 
achieved 35% closure at 6 hours compared to a 53% closure with control, 51% 
on fibronectin and 53% on collagen type I.  At 8 hours, these differences 
increased to 61% closure on laminin compared to 87% for control, 84% on 
fibronectin and 83% on collagen type I.   
 
Trend lines were added for each normalised data set.  The equation y=mx+c 
and R2 values for each trend line were used to determine the gradient (value of 
‘m’) and reliability (R2) of the trend line.  Average R2 values for the control, 
laminin, fibronectin and collagen type I were 0.98, 0.97, 0.99 and 0.99 
respectively.  As these R values are close to 1 we can assume that the trend 
lines representing the actual data plots are an accurate measure and that 
therefore the gradient values are a fair representation of the raw data.  Mean 
gradient values were used to compare the mean rate of wound closure for each 
protein.  From Figure 3.4B we can see that wound closure rates on laminin 
significantly differ from the control.  Statistical analysis shows that the rate of 
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wound closure on laminin is significantly slower when compared to fibronectin 
(p<0.01), collagen type I (p<0.01) and control (p<0.001). 
 
 
 
 
 
 
 
Figure 3.3: Graph represents rates (μm/hour) for wound closure for each 
protein at different time intervals.  Standard error bars are shown. N=15. ** 
p<0.01 when comparing laminin to control.  
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Figure 3.4:  Graphs show percentage wound width between 2 and 10 
hours for each protein (A) and comparison of gradient values (B).  
Standard error bars are shown. N=15.  * p<0.05 ** p<0.01 *** p<0.001  
A 
B 
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3.4.3 The influence of TGF-β on cell proliferation 
 
TGF-β is known to cause growth arrest in some cell types (Takehara et al. 
1987, Spender and Inman 2009).  HaCaT cells were cultured with each TGF-β 
isoform for 4 days.  On day 4 cells were trypsinized and counted using a 
haemocytometer.  Average cell counts (x104) for each growth factor after 4 days 
are shown in Figure 3.5.  TGF-β3 caused a decrease in cell numbers compared 
to control (p<0.05).  Although TGF-β1 and 2 also appeared to cause a slight 
decrease when compared to control, these differences were not shown to be 
significant at the 95% significance level. 
 
 
 
 
 
Figure 3.5: Chart shows number of cells (x104/ml) on Day 4 following 
treatment with TGF-β1, 2, 3 or control conditions.  Standard error bars are 
shown. N=6 *p<0.05 when compared to control. 
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3.4.4 The influence of TGF-β isoforms on rates of wound closure 
 
TGF-β is known to induce keratinocyte cell migration (Bandyopadhyay et al. 
2006).  In order to compare the influence of each TGF-β isoforms on cell 
migration during wound repair we adopted the commonly used in vitro scratch 
assay.  HaCaT cell monolayers were ‘wounded’ and the rate of wound closure 
following treatment with TGF-β1, 2 or 3 was assessed.  
 
 
 
 
 
 
 
 
 
Figure 3.6: Graph represents rates (μm/hour) for wound closure for each 
protein at different time intervals.  Standard error bars are shown. N=18   
* p<0.05 ** p<0.01 *** p<0.001 (a) TGF-β2 vs control (b) TGF-β3 vs control. 
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Figure 3.7: Charts show rate percentage wound width (A) and mean gradient 
values (B) for each TGF-β isoform and control.   Standard error bars are 
shown N=18. ** p<0.01 *** p<0.001 (a) TGF-β2 vs control (b) TGF-β3 vs 
control. 
A 
B 
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Figure 3.6 shows rates of wound closure (μm/hr) for different time intervals.  
The trends in wound closure rates for each TGF-β isoform between the 2 and 
10 hour period show significant differences.  Rates for the control and TGF-β1 
show a fairly steady increase throughout the duration of the 10 hour period, 
starting at 21.89 and 24.32 μm/hr (2 to 4 hour period) and ending at 42.52 and 
46.69 μm/hr (8 to 10 hour period) respectively.  TGF-β3 shows an opposite 
trend.  For TGF-β3, wound closure starts more rapidly (42.89μm/hr between 2 
to 4 hours) and gets progressively slower as the wound closes (17.06 μm/hr 
between 8 to 10 hours).  Whether an increasing or decreasing trend, the 
control, TGF-β1 and β3 results show fairly steady changes in closure rates over 
the 10 hours.  TGF-β2 on the other hand shows a more dramatic trend.  While 
rates start and end relatively similarly (33.73 and 31.55 μm/hr respectively) 
there is a steep increase, peaking at 61 μm/hr, between the 6 to 8 hour period.  
The most dramatic differences occur between the 6 and 8 hour time points 
when rates for TGF-β2 and 3 were 61.8 and 28.94 μm/hr respectively.  
 
Figure 3.7A shows normalised averages for each treatment. TGF-β3 treated 
cells had advanced more than the other groups at the 6 hour point with a 
percentage wound closure of approximately 60% (40% gap still remaining) 
compared to approximately 27%, 32% and 46% for control, TGF-β1 and TGF-
β2 respectively.  At the 8 hour point figures for control andTGF-β1 were 50%, 
54% respectively, while TGF-β2 and 3 both show closure of approximately 81%.  
At each time point, TGF-β2 and 3 are significantly different to control (p<0.01 or 
p<0.001).  Average R2 values for the control, TGF-β1, 2 and 3 were 0.98, 0.98, 
0.97 and 0.95 respectively.  Again, this indicates that the goodness of fit 
between the trend line and the raw data is high and therefore the gradient 
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values are a fair representation of the trends within the raw data.  From Figure 
3.7B we can see there are clear differences between monolayer wound closure 
rates following treatment with TGF-β2 and 3 when compared to the control and 
TGF-β1 (p<0.01).   
Cell behaviour at the wound edges appeared to differ between control and 
TGFβ treated monolayers (Figure 3.8).  At around the 8 hour point TGFβ, 
particularly TGF-β3, caused cells to migrate into the ‘wound bed’ in a more 
random scattered fashion.  As individual cells were migrating into the space, 
this caused the monolayer near the wound margins to become less densely 
populated.  Control cell monolayers on the other hand advanced in a much 
more orderly manner; the wound margins tended to be straighter and cells were 
more tightly packed together, indicating the maintenance of cell-cell junctions. 
 
 
 
 
 
Figure 3.8: Micrographs show control (A) and TGF-β1, 2 and 3 (B, C, D 
respectively) treated HaCaT cell monolayers at 8 hours stage of wound closure.  
TGFβ treated cells migrate into the wound in a more random and independent 
manner (arrows). The closure of control wounds occurs more uniformly with 
fewer cells migrating out from the wound margins. Scale bar=100μm.   
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In order to ensure that HCL was not influencing wound closure rates seen with 
TGF-β, scratch assays were carried out on HaCaT cell monolayers that had 
been cultured with 50μM HCL for 4 days.  Figure 3.9 shows percentage wound 
closure and the corresponding rates of wound closure following treatment with 
50μM HCL when compared to control.  Results show no significant differences 
between HCL treatment and control at any time points during wound closure.  
Also, the gradients, or rates of closure for each line did not significantly differ at 
the 95% level.  Together this indicates that collective migration is unaffected by 
the addition of HCL and therefore wound closure rates seen with TGF-β 
treatments are the result of cell responses to the cytokine and not due to any 
affect of HCL. 
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Figure 3.9:  Charts show percentage wound closure (A) and mean gradient 
values (B) for 50μM HCL and control.  Standard error bars are shown, N=8.  
   
A 
B 
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3.4.5 The influence of cell density on rates of wound closure 
 
Previous experiments found that both laminin and TGF-β3 significantly altered 
cell proliferation and wound closure rates.  While laminin caused an increase in 
cell proliferation and a decrease in the rate of wound closure, TGF-β3 had the 
opposite effect; causing a decrease in cell proliferation whilst increasing wound 
closure rates.  In order to determine how cell density effects wound closure 
rates, cell monolayers were plated at different densities (approximately 
1.5x104/cm2, 2x104/cm2 and 3x104/cm2) and scratch assays were carried out 
after 48 hours.  These differences in seeding densities are not mirrored in the 
final monolayer densities given in Figure 3.10.  Within a given area the density 
of a cell monolayer will reach a plateau as cells reach confluency.  In 25cm2 
culture flasks this plateau appears to be approximately 9.6x104/cm2.  This 
plateau in monolayer density coincides with a plateau in the rates of wound 
closure.  When comparing mean wound closure rates for 8.6x104/cm2 and 
9.6x104/cm2 to that of 4.8x104/cm2 the differences were shown to be significant 
at the 95% and 99.9% levels respectively (Figure 3.10).  The lack of significant 
difference between wound closure rates for 8.6x104/cm2 and 9.6x104/cm2 is 
likely to be a result of the smaller difference in monolayer density due to the 
density plateau.  However, the general trend is clear; the more densely packed 
the cell monolayer, the faster the wound closure rate.  These results 
demonstrate that any increase or decrease in monolayer densities, due to the 
influence of laminin or TGF-β3 (respectively) on cell proliferation rates, is not 
responsible for the corresponding decrease or increase in wound closure rates 
respectively.   
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Figure 3.10:  Chart shows mean gradient values for each monolayer density. 
Standard error bars are shown.  Significant differences were taken as * p<0.05 
**p<0.01 ***p<0.001 when compared to 4.8x104/cm2.  N=8 
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3.5 DISCUSSION 
 
In intact skin, under normal conditions, keratinocytes are not readily migratory.  
Basal layer keratinocytes couple tightly together and to the basement 
membrane where they form attachments known as hemidesmosomes with 
mature laminin332 (LN332) and other protein networks (Jones et al. 1998).  
Suprabasal and outer epidermal layers maintain cell-cell adhesions via 
adherens junctions and integrin receptors (De Luca et al. 1990, Green and 
Jones 1996).  Although keratinocytes do temporarily release these adhesions in 
order to divide, differentiate and move upward through the epidermis, these 
cells are not required to migrate in a lateral sense.  In culture, HaCaT cell 
keratinocytes have also been shown to form many focal adhesion contacts with 
the surface (Jamil et al. 2008).  However, keratinocytes are adapted for wound 
repair and are therefore able to migrate laterally over new protein networks that 
these cells are not normally exposed to.  This occurs as cells respond to their 
changing environment by regulating the expression of cell surface receptors 
and expressing new matrices and growth factors (Larjava et al. 1993, Levine et 
al. 1993). 
 
A number of studies have addressed the way epithelial cells repair monolayer 
wounds in vitro (Poujade et al. 2004, Li et al. 2004, Wang et al. 2010).  In a 
study using Madin-Darby canine kidney (MDKC) epithelial cell monolayers, 
motility was shown to be due to a combination of collective and individual 
behaviours (Poujade et al. 2004).  While leader cells at the wound edge are 
thought to initiate migration, cells further back from the wound edge also extend 
lamellipodia.  It has been suggested that cell movement is a result of active 
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migration as opposed to leader cells pulling adjacent cells along (Farooqui and 
Fenteany 2005).  Wound closure of MDCK cell monolayers has been linked to 
different signalling molecules including the GTPase, Rac, phosphoinositides 
and the MAP kinase, JNK (Fenteany et al. 2000, Altan and Fenteany 2004).   
 
A previous study using a scratch assay to assess motility in primary human 
keratinocytes found that in the absence of growth factors, control cells did not 
close the wound gap within a 24 hour period (Li et al. 2004).  In the present 
study, control cell monolayers were shown to complete wound closure within 
approximately 10 hour after ‘injury’.  The media used here contain fetal calf 
serum and therefore will likely contain various growth factors that may enhance 
wound closure of control cells.  However, HaCaT cells in culture in the presence 
of FCS-containing RPMI media were not found to express a migratory 
phenotype (Chapter 2). This suggests that any growth factors present in the 
FCS are not the sole cause of this HaCaT cell motility. It has been suggested 
that sudden release of the available surface is sufficient to trigger collective 
motility (Poujade et al. 2004).   
 
Previous studies have shown that the rate and duration of migration of a 
monolayer is limited by the initial density of cells in that monolayer (Rosen and 
Misfeldt 1980, Bindschadler and McGrath 2007).  In other words, the more 
densely packed a monolayer, the quicker wound closure will occur after ‘injury’.  
The present study confirms these findings.  Scratch assays performed on 
monolayers of different densities found that the more cells in a monolayer, the 
faster the rate of wound closure.  Taking this into account, cell proliferation 
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experiments were carried out for each protein and TGF-β treatment in order to 
identify whether monolayer density influenced wound closure. 
 
In order to investigate whether cell proliferation was affected differently by 
protein coated substrates, cells were cultured with each protein and cell counts 
were taken every 48 hours over a 6 day period.  Proliferation studies found that 
cells cultured on laminin proliferate at a slightly faster rate than those cultured 
on plain surfaces or surfaces coated with fibronectin or collagen type I.  These 
differences were seen more clearly by Day 6; however, statistical significance 
was only seen between laminin and fibronectin.  Larger sample sizes may have 
identified significant differences between laminin and the control and would 
therefore support the findings presented in chapter 2 whereby HaCaT cells 
appeared to respond to laminin patterns with an increase in cell density.  As cell 
proliferation did not differ with each protein after 48 hours, initial monolayer 
density should not have contributed to the differences in wound closure rates 
seen on the ECM proteins.   
 
Previous studies have shown that fibronectin and collagen type I enhance the 
migration of solitary cells (Woodley et al. 1988, Kim et al. 1992, Li et al. 2004).  
Therefore, it was expected that migration of the monolayer may occur more 
rapidly on fibronectin and collagen.  Perhaps contrary to expectations, cells 
plated on fibronectin or collagen type I did not show any difference in wound 
closure rates when compared to control cells.  These findings have identified 
possible differences in the way in which solitary cells and cell monolayers 
behave in response to ECM proteins.  This highlights the importance of 
considering both individual and collective cell responses when carrying out in 
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vitro studies; particularly as collective cell movements are very relevant to the 
re-epithelialisation process.   
 
Wound closure rates on laminin were shown to be significantly slower when 
compared to fibronectin, collagen and control substrates.    Although a slower 
rate of wound closure was seen with cells plated on laminin, cell migration 
again, did occur.  Following laminin deposition, collagen-dependent adhesion 
via α2β1 is thought to switch to laminin dependent adhesion via α3β1 (Nguyen 
et al. 2000).  However, α3β1 has been shown to be a limiting factor in 
keratinocyte cell migration.  Studies have shown wound healing to be faster in 
the absence of integrin α3β1 (Margadant et al. 2009).  The α3-deficient 
keratinocytes migrate with an increased velocity and persistence (Margadant et 
al. 2009).  This suggests that in the present study, wound closure on laminin 
may have been limited by α3β1.  Although the laminin used here is not LN332, 
laminin isoforms share certain similarities and this may explain the keratinocyte 
response to this protein.   
 
This rate limiting role of laminin may play an important role in controlling the rate 
of migration during in vivo re-epithelialisation.  Perhaps a slower rate of 
migration is valuable in wound repair.  Time is required to allow immune cells to 
clear foreign bodies and damaged cells from the wound bed.  If keratinocytes 
were to restore the epidermis immediately without immune cells clearing the 
wound, infection would be a likely outcome.   
 
In a study examining HaCaT cell differentiation, TGF-β isoforms were 
suggested to play different roles during epidermal differentiation.  While TGF-β1 
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expression increased during calcium induced HaCaT cell differentiation, TGF-
β2 and 3 expression decreased.  It was suggested that TGF-β2 and 3 may be 
associated with a more proliferative state, whereby these isoforms prevent 
excessive cell growth (Cho et al. 2004).  TGF-β2 deficiencies are associated 
with hyperproliferation as seen with psoriasis (Wataya-Kaneda et al. 1996).  
The findings of the present study found only TGF-β3 reduced the proliferation 
rate of HaCaT cells.  In general, average cell numbers following 4 day 
incubation with TGF-β isoforms were shown to decrease when compared to 
control.  However, statistical significance was seen only with TGF-β3.  TGF-β3 
has been shown to reduce proliferation in small intestine (IEC-6) and colonic 
(T84) epithelial cell lines (McKaig et al. 1999).  The present study supports that 
TGF-β3 effects skin keratinocytes in the same way.  Further experimental 
repeats may have found significant differences between control and TGF-β1 
and 2.  Perhaps concentrations and length of incubation time may influence the 
effect TGF-β has on cell proliferation.   
 
As previously mentioned, therapeutic strategies aimed at reducing cutaneous 
scarring have involved either blocking TGF-β1 and TGF-β2 or enhancing the 
levels of TGF-β3.  The present study found that at a concentration of 5ng/ml, 
TGF-β isoforms influence HaCaT cell monolayer wound closure differently; 
TGF-β2 and 3 both enhanced the speed of wound closure compared to TGF-β1 
and control.  Assuming this enhanced keratinocyte migration is replicated in 
vivo following treatment with exogenous TGF-β3, it could be suggested that an 
increase in the rate of re-epithelialisation may be a contributory factor in the 
reduction of scarring.  In support of this, keratinocytes have been implicated in 
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the outcome of the repair process as a result of their influence on the activity of 
fibroblast cells (Machesney et al. 1998).    
 
As wound closure assays on TGF-β1, 2 and 3 were performed after a 4 day 
incubation period, cell density of these monolayers would be different.  
According to the result, TGF-β3 caused a significant reduction in the rate of cell 
proliferation compared to the other isoforms and the control.  Here, cell density 
did not influence wound closure in the same way it does under control 
conditions.  It may have been expected that as TGF-β3 decreased the density 
of the monolayer, this may have reduced the rates of wound closure.  Wound 
closure rates in the presence of TGF-β3 however, were shown to be 
significantly faster than control.  This shows that other mechanisms are 
responsible for the closure rates. 
 
During wound closure control cell monolayers remained tightly coupled together 
and wound margins progressed in a very orderly and uniform manner.  The 
monolayer moved together as a collective sheet of cells with very few cells 
separating from the leading edge to move into the free space independently.  
Conversely, TGF-β treatment caused a less ordered response.  TGF-β treated 
cells were more spread and not as tightly coupled together as seen with control. 
Wound closure following treatment, more so with TGF-β2 and 3, was shown to 
involve the active migration of individual cells into the wound bed in an 
independent manner.   
 
This cell behaviour is characteristic of epithelial to mesenchymal transition, or 
EMT.  EMT, which is known to be induced by TGF-β, is characterised by the 
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dissociation of cell-cell adhesion structures, adherens junctions and 
desmosomes, together with cell cytoskeleton reorganisation, cell elongation and 
motility (Xu et al. 2009).  EMT is not an all or nothing event; while in extreme 
cases, epithelial cells differentiate into mesenchymal cells, some epithelial cells 
display partial EMT involving a spectrum of characteristics, often occurring only 
transiently.  Some features of EMT are shared by epithelial cells during re-
epithelialisation.  This high plasticity allows cells to adapt to their changing 
environment and restore tissue integrity.  In response to TGF-β HaCaT cells do 
not display mesenchymal markers indicating that the response to TGF-β is one 
of partial EMT (Rasanen and Vaheri 2010).  TGF-β isoforms may differentially 
enhance aspects of the EMT spectrum allowing an enhanced wound closure 
response.  The rates of wound closure in the present study seem to be 
determined by the rate of individual cell migration into the wound space.  As 
TGF-β2 and 3 caused the fastest wound closure rate and appeared to increase 
cell scattering into the wound space, it could be suggested that these TGF-β 
isoforms have more influence over the signalling mechanisms involved in EMT.  
Both smad-dependent and independent pathways have been linked to EMT in a 
variety of different types of epithelial cells.  In keratinocytes, TGF-β induced 
EMT has been associated with the Smad, MEK/ERK MAPK and Notch 
pathways (Davies et al. 2005, Zavadil et al. 2001).  TGFβ isoform specific 
signalling has been demonstrated in mesenchymal cells whereby isoforms 
differentially attenuated EGF signalling via the MAPK pathway (Lee et al. 1997). 
 
Cells undergoing EMT display a reduction in cell-cell contacts.  The 
downregulation of epithelial junction proteins, ZO-1 and E-cadherin has 
previously been described in HaCaT cell treated with TGF-β1 (Rasanen and 
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Vaheri 2010).  Together with cell scattering, the loss of E-cadherins is linked to 
a reduced adhesion to the ECM as a result of the redistribution of cell 
cytoskeleton (Geiger et al. 2008).  TGF-β3 was previously shown to cause 
reduced cell adhesion and redistribution of focal contacts which supports the 
idea that during wound closure TGF-β3 caused partial EMT (see chapter 2).  
E-cadherins are under transcriptional control of the Snail family of transcription 
factors, Snail and Slug, which are themselves regulated by growth factors such 
as TGF-β (Choi et al. 2007, Peinado et al. 2003).  In a study examining cell 
behaviour during re-epithelialisation, Slug expression in keratinocytes was 
shown to influence rates of in vitro wound closure and cell behaviours including 
cell spreading and desmosome dissociation (Savagner et al. 2005).  
Interestingly the overexpression of Slug produced very similar cell behaviours 
and wound closure rates as shown in the present study with TGF-β treatments.  
This suggests there may be a link between TGF-β isoforms and the expression 
of Slug during re-epithelialisation.  Perhaps the differences in wound closure 
rates and cell individualisation seen in the present study result in part, from the 
differential expression of Slug in response to each isoform.  
 
Together with TGF-β, LN332 has associated with the induction of a partial EMT 
phenotype in a Hepatocellular carcinoma cell line (Giannelli et al. 2005).  The 
deposition of LN332 is an important feature of the re-epithelialisation process 
and is known to occur in response to TGF-β (Kainulainen et al. 1998).  Further 
experiments will aim to identify whether there are differences in the way TGF-β 
isoforms influence the deposition of LN332.  This will allow further insight into 
the different mechanisms involved in the wound closure seen with TGF-β2 and 
3.   
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 CHAPTER FOUR  
COMPARING THE INFLUENCE OF TGF-β1, 2 AND 3 ON 
LAMININ-332 DEPOSITION 
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4.1 INTRODUCTION 
 
The basement membrane (BM) is a specialized network of proteins that acts to 
compartmentalise tissues whilst supporting different cellular functions including 
differentiation, proliferation and migration.  The structural molecules common to 
all basement membranes include multiple laminin isoforms, collagens, nidogen 
and the heparansulfate proteoglycan perlecan (Timpl and Brown 1996).  
Laminins are major structural components of the BM.  This family of 
glycoproteins bind other ECM molecules such as fibulin, nidogen and collagen 
IV (Sasaki et al. 2001, Chen et al. 1999).  These protein networks play an 
essential role in supporting tissue integrity.  Specific to the dermal-epidermal 
BM in skin is laminin 332 (LN332) which acts as an anchor for cells.  Basal layer 
keratinocytes opposed to the BM interact with LN332 to form stable 
attachments or hemidesmosomes.  The integrin α6β4 has been identified as the 
principal receptor involved in the formation of these adhesions.     
 
The importance of LN332 is demonstrated by its role in skin disorders.  
Mutations in the LN332 genes lead to epidermolysis bullosa, a severe blistering 
disease associated with defects in the hemidesmosome associated 
components of the laminin molecules.  As a result of these defects, minor 
mechanical stresses lead to the rapid loss of cell adhesion above the BM 
(Schneider et al. 2007).   
 
The assembly of ECM networks is an essential part of the wound repair 
process. During re-epithelialisation, stable adhesions are lost and the epithelial 
sheet proceeds across the wound bed, rebuilding the BM.  Keratinocytes, 
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particularly those at the leading edge are associated with the deposition of 
LN332.  This ECM deposition has been shown to be independent of injury type.  
Whether the injury is a full thickness wound or a blister in which remnants of BM 
LN332 may still remain, LN332 deposition occurs (Kainulainen et al. 1998).   
Keratinocyte migration is regulated by cell-LN332 interactions.  At first glance 
there appears to be contradictions in the literature regarding cell responses to 
LN332.  LN332 has been said to both promote and inhibit keratinocyte migration 
(Frank and Carter 2004, O’Toole et al. 1997).  This is due to different factors 
influencing the way in which cells respond to LN332.  Cell density influences 
how cells respond to LN332 in culture.  Cells plated on LN332 at a low density, 
limiting cell-cell interactions, are stimulated to migrate and deposit precursor 
LN332.  As cell-cell interactions increase, migration declines (Frank and Carter 
2004).  The ECM of confluent keratinocytes cultured under normal conditions 
contains mainly processed LN332, demonstrating that keratinocytes rapidly 
process precursor LN332 after deposition (Decline and Rouselle 2001).  This 
processing influences the function of LN332.  During the rebuilding of the BM, 
precursor LN332 undergoes proteolytic cleavage (Marinkovich 1992).  
Reduction of the alpha3 chain of the LN332 molecule inhibits cell migration 
(Goldfinger et al. 1998). This processed form of LN332 is associated with 
hemidesmosomes formation.  LN332, it has been suggested, functions to 
stabilize migrating cells during re-epithelialisation enabling the reconstruction of 
the basement membrane (O’toole et al. 1997).  
 
The production and remodelling of extracellular matrix proteins is influenced by 
growth factors.  TGFβ is known to stimulate the production and secretion of 
ECM proteins such as collagens, fibronectin and proteoglycans by a range of 
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different cell types from fibroblasts and glomerular cell to optic nerve astrocytes 
(Border and Ruoslahti 1990, Fuchshofer et al. 2005, Nugent and Edelman 
1992).  On the contrary some cell types have been reported to respond with a 
reduction in protein, in this case laminin, production (Kelly and Rizzino 1989).  
Growth factors and inflammatory cytokines, including TGF-β1 found in wound 
exudates have been shown to increase the deposition of LN332 by 
keratinocytes during healing (Amano et al. 2004).   
 
TGFβ is therefore an important influential factor on the re-epithelialisation 
process.  TGF-β1, 2 and 3 have been identified as limiting factors in the quality 
of scarring.  Identifying possible differences between these TGFβ isoforms and 
the way in which they differentially influence ECM and more specifically, LN332 
deposition by keratinocytes may aid the understanding of the role of TGFβ in 
scarless healing.       
 
4.2 AIM 
 
In Chapter 2, TGF-β3 caused a reduced cell alignment response to patterned 
proteins suggesting that TGF-β3 influences cell matrix deposition and/or integrin 
regulation.  Chapter 3 highlighted differences in wound closure rates in 
response to each TGFβ isoform; as LN332 deposition is central to cell migration 
and the re-epithelialisation process, these differences in wound closure rates 
may be a result of differences in LN332 deposition.  Therefore, the aim of this 
study was to compare the effect of TGFβ isoforms 1, 2 and 3 on deposition of 
LN332.   
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4.3 METHODS 
 
4.3.1 Immunofluorescence staining for LN332 following TGF-β1, 2 and 3 
treatment 
 
HaCaT cells were seeded into 6mm Petri dishes at a density of approximately 
1x104/ml per glass cover slip (22mmx22mm).  Substrates were cultured in 4ml 
normal 10% FCS RPMI or in TGF-β1, 2 or 3 (5ng/ml) containing media at 37°C 
for 4 days.  Cells were rinsed in PBS and fixed with 4% formaldehyde for 6 
minutes.  Fixation was followed by three 5 minute washes in PBS, the second of 
which contained 0.1M glycine in order to prevent any autofluorescence. Cells 
were then blocked with 4 drops Image-iT™ FX signal enhancer for 30 minutes 
followed by a thorough washing in PBS. The primary antibody, mouse anti-
human LN332 (10μg/ml) was added for 60 minutes at room temperature 
followed by the secondary antibody, anti-mouse IgG Alexa Fluor® 488 
(2.5µg/ml) for a further 60 minutes at room temperature in the dark.  All 
incubations were performed in a humidity chamber to avoid the evaporation of 
reagents.  Stained coverslips were incubated in DAPI (4,6’-diamidino-2-
phenylindole) for 15 minutes and mounted onto microscope slides.  Cells were 
imaged using confocal microscopy and LN332 deposition was analysed.      
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4.3.2 Elisa based method for detection of LN332 following TGF-β1, 2 and 3 
treatment 
 
Cells were cultured in 25cm2 culture flasks under control conditions or with 
either TGF-β1, 2 or 3.  On day 3 cells were trypsinised and seeded into a 96 
well plate at a density of 1x104 cells per well for a further 24 hours under the 
same conditions as described above.  Following this 24 hour period cells were 
stained for LN332.  Medium was rinsed and cells and proteins were fixed with 
4% formaldehyde for 6 minutes.  Cells were washed again in PBS and any 
endogenous peroxide was quenched using 3% hydrogen peroxide for 5 
minutes.  Following another wash, 1% BSA in PBS was added for 15 minutes to 
prevent non-specific binding.  Cells were incubated with the primary antibody, 
mouse anti-human LN332 (10μg/ml) for 60 minutes at room temperature.  For 
negative controls, the primary antibody incubation was replaced with a 1% BSA 
incubation.  Wells were rinsed and the secondary antibody anti-mouse IgG 
peroxidise conjugate (8µg/ml) was added for a further 30 minutes at room 
temperature.  Tetramethylbenzidine (TMB) substrate was added and 
absorbance readings were taken at 630nm after 10minutes.  This experiment 
was repeated six times.  Absorbance readings for control and TGFβ isoforms 
were corrected by subtracting the negative control.      
 
To ensure that any differences in LN332 deposition where not due to 
differences in cell proliferation rates, 24 hour proliferation studies were carried 
out.  HaCat cells were seeded (1.8x104 cells/ml) into 6 well plates with 3 ml 
normal 10% FCS RPMI (control) or TGF-β1, 2 or 3 containing media.  Cells 
were cultured at 37°C for 24 hours.  For cell counts, cells were washed with 
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HBSS and incubated with trypsin for up to 5 minutes or until all cells were lifted 
from the surface of the flasks.  Serum-containing RPMI medium was added to 
neutralise the trypsin and cells were counted using a counting chamber.    
 
4.3.3 Statistical Analysis 
 
The results are presented as means ± standard errors of the means.  Following 
normality testing, mean results were assessed by one way ANOVA to 
determine any significant differences between groups.  The Bonferroni 
adjustment was used for post hoc comparisons. 
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4.4 RESULTS 
 
4.4.1 Immunofluorescence staining for LN332 following TGF-β1, 2 and 3 
treatments 
 
During cell migration keratinocytes are known to deposit LN332, a feature 
central to wound repair.  In order to compare the effects of TGF-β1, 2 and 3 
treatment on LN332 deposition HaCaT cells were fixed and stained with anti-
human LN332 followed by secondary antibody Alexa Fluor® 488.    Following 4 
day incubation with TGFβ isoforms, all of the isoforms appeared to cause an 
increase in LN332 deposition when compared to control.  This increase was 
particularly evident with TGF-β3 (Figure 4.1).   
 
 
 
 
Figure 4.1 shows immunofluorescence staining of LN332 (green) following 4 day 
incubation with TGF-β1 (B), 2 (C) and 3 (D).   Image A represents control 
conditions. Individual cell nuclei are stained blue (Dapi stain).  The scale bar 
represents approximately 100μm.   
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4.4.2 Elisa based method for detection of LN332 following TGF-β1, 2 and 3 
treatments 
 
In order to achieve a more accurate comparison and to quantify any differences 
between TGFβ isoforms, LN332 deposition was identified using an 
immunoperoxidase technique and the substrate reaction was determined using 
a spectrophotometer.  As a four day incubation period was required, cells were 
grown for 3 days in culture flasks and then re-seeded into a 96-well plate for a 
further 24 hours before fixing and staining.  If cells were cultured for 4 days in 
the presence of TGFβ cell numbers would have been different on day 4 due to 
the differential influence of TGF-β1, 2 and 3 on cell proliferation rates.  To 
ensure that the 24 hour period was not long enough for the TGFβ isoforms to 
have an effect on cell proliferation a cell count assay was performed.  Cell 
counts (x104/ml) for control, TGF-β1, 2 and 3 were 1.35 ± 0.16, 1.36 ± 0.15, 
1.36 ± 0.17 and 1.31 ± 0.15 respectively.  At the 95% confidence level cell 
counts did not significantly differ between treatments at the 24 hour point.  Any 
differences in laminin deposition were therefore a result of the influence of 
TGFβ and not of cell numbers.  Figure 4.2 shows absorbance readings at 
630nm for each treatment.  Optical density readings for control, TGF-β1, 2 and 
3 were as follows; 0.61 ± 0.03, 0.86 ± 0.02, 0.94 ± 0.02 and 0.94 ± 0.02 
respectively.  All TGFβ treated cells were shown to deposit significantly more 
LN332 compared to control (p<0.001).  TGF-β3 was also shown to cause an 
increased deposition relative to TGFβ 1 (p<0.001). 
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Figure 4.2 shows optical density readings (630nm) following immunoperoxidase 
staining of deposited laminin 332.  All TGFβ treated cells were shown to deposit 
more laminin 332 compared to control (p<0.001).  TGF-β3 was also shown to 
cause an increased deposition relative to TGFβ 1 (p<0.001).  Standard error bars 
are shown, N=6.   
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Figure 4.3 shows cell counts following 24 hours incubation with each TGFβ 
isoform (5ng/ml).  Cell counts were not significantly different at the 95% level.  
Standard error bars are shown.  N=6 
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4.5 DISCUSSION 
 
Various studies have investigated the influence of TGFβ on the expression of 
LN332 genes, LAMA3, LAMB3 and LAMC2.  In human epidermal keratinocytes 
and HaCaT cells, 24 hour incubation with TGFβ was reported to cause a 
significant increase in the levels of LAMA3 and LAMC2 in a dose dependent 
manner (Korang et al. 1995).  The same study was carried out using dermal 
fibroblasts (Korang et al. 1995); these cells did not show any expression of 
LN332 which demonstrates that rebuilding of the laminin component of the 
basement membrane is the work of keratinocytes alone.  The activity of 
keratinocytes has been shown to influence other features of the healing process 
including the behaviour of fibroblasts (Duplan-Perrat et al. 2000, Matsue et al. 
1992).  The deposition of LN332 is an important regulator of keratinocyte 
behaviour during repair and may therefore play a larger role in scarring.   
 
While TGFβ has been identified as a cause of LN332 deposition there has been 
limited comparison between isoforms.  Studies investigating the influence of 
TGFβ isoforms on ECM deposition during wound repair are often limited to 
certain isoforms and proteins.  For example, in a study examining all three 
TGFβ isoforms only fibronectin and collagens were investigated; TGF-β1 and 2 
caused an increase in the presence of these proteins and TGF-β3 caused a 
significant decrease during the first week of wound repair (Shah et al. 1995).  
Previous studies quantifying LN332 production by human keratinocytes have 
been limited to TGF-β1 (Amano et al. 2004).           
  
 134 
  
The present study compared LN332 deposition by HaCaT cell keratinocytes in 
response to TGF-β1, 2 and 3.  Results demonstrated that TGFβ isoforms 
differentially influences production of precursor LN332 in culture.  While all 
isoforms significantly increased LN332 deposition compared to control cells, 
TGF-β2 and 3 caused the most dramatic increase.  The scratch assays in the 
previous chapter found that wound closure was fastest in the presence of TGF-
β2 and 3 therefore enhanced cell migration corresponds to an increase in 
LN332 deposition.  Firstly, this poses a ‘chicken or egg’ question; does the 
increase in cell motility cause the increase in laminin production as a product of 
migration, or does the increase in LN332 production allow the increase in cell 
motility?  Secondly, how do these TGFβ isoforms differentially influence this 
laminin deposition?   
 
In answer to the first question, studies have shown that in order for keratinocyte 
migration to occur, LN332 must be deposited which suggests the LN332 
deposition comes first (Decline and Rouselle 2001, Hamelers et al. 2005).  In 
the wound bed, keratinocytes are exposed to collagen.  Keratinocytes migrating 
over collagen replace this substrate with exogenous LN332 at the rear of the 
cell (Frank and Carter 2004).  By blocking the function of LN332 it was 
demonstrated that this deposition of LN332 is required for migration over 
collagen substrates (Frank and Carter 2004).  As discussed in the previous 
chapter, TGFβ isoforms appeared to differentially induce an EMT phenotype 
during wound closure assays.  This is likely to be, at least in part, due to cell 
responses to LN332.  TGFβ and LN332 appear to play a synergistic role in 
EMT.  In a study looking at EMT in hepatocellular carcinoma cells, LN332 
caused the upregulation of snail, slug and a down regulation of E-cadherins.  A 
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combination of both LN332 and TGF-β1 extended the EMT process allowing 
cell scattering to occur (Giannelli et al. 2005).   
 
The production of laminin has been linked to different receptors and signalling 
molecules.  These mediators may be under differential control by each of the 
TGFβ isoforms.  TGFβ signalling, mediated via TGFβ receptors, is associated 
with the upregulation of laminin gene expression (Korang et al. 1995).  The 
actions of TGFβ isoforms can be limited by the binding affinity of TGFβ 
receptors TβR I and II and also by dual-modulating co-receptor betaglycan 
(Cheifetz et al. 1990, Lopez-Casillas et al 1994).  Structural differences between 
isoforms have been shown to effect receptor binding affinity.  The higher 
binding affinity of TβR II for TGF-β1 and β3 has been attributed to residues 
Arg25 and Arg94 which are conserved only in these two isoforms (Baardsnes et 
al 2009).  Conversely, TβR I binds with higher affinity to TGF-β2 and β3 over 
TGF-β1 (Radaev et al 2010).  Cell-specific differences in responsiveness to 
isoforms have also been attributed to the binding affinity of TβR I and II 
(Cheifetz et al. 1990).  The differences in LN332 deposition seen in the present 
study may, therefore, be linked to differences in TGFβ receptor binding affinity.       
 
During re-epithelialisation, keratinocytes deposit the unprocessed precursor 
form of LN332 which later undergoes proteolytic cleavage to form the mature 
laminin of the basement membrane (Nguyen et al. 2000).  In vitro, the 
processing of LN332 is influenced by cell culture conditions. The ECM of 
keratinocytes cultured with TGFβ contains mainly unprocessed precursor 
LN332.  Conversely, confluent keratinocytes under control conditions rapidly 
process precursor LN332 after deposition (Decline and Rouselle 2001).  This 
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demonstrates that TGFβ regulates the mechanisms involved with the 
processing of the laminin molecule.  It is possible that TGFβ isoforms are 
different in the way they influence the processing of LN332.  The extent of 
LN332 processing may influence production.  Integrins α3β1 and α2β1 bind the 
α3 chain and Ɣ2 chain domains of the LN332 molecule, both of which are 
targets for proteolytic cleavage during processing (Goldfinger et al. 1998, Veitch 
et al. 2003, Decline and Rousselle 2001).  Cell-LN332 interactions are likely to 
be influenced by the availability of integrin receptor and/or the availability of 
binding domains on the laminin molecule.  The extracellular matrix surrounding 
a cell influences the integrin expression of that cell as it responds to its 
environment e.g. the presence of fibronectin following injury correlates with an 
upregulation of α5β1 in keratinocytes.  The ratio of unprocessed-to-processed 
LN332 may alter integrins expression to favour binding on precursor LN332.  
The binding of keratinocytes to LN332 via α3β1 initiates downstream signalling 
via Tiam1 and Rac leading to an increased LN332 production (Hamelers et al. 
2005). The presence of more unprocessed LN332 may have a positive 
feedback effect on the production of LN332 as a result of an altered integrin 
repertoire. 
 
In addition to indirectly influencing integrin expression as a result of LN332 
processing, TGFβ may also alter LN332 production by directly regulating 
integrin expression.  The following chapter will address how integrin subunits 
important in wound repair are altered by TGF-β1, 2 and 3. 
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CHAPTER FIVE 
COMPARING THE INFLUENCE OF TGF-β1, 2 AND 3 ON 
INTEGRIN EXPRESSION 
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5.1 INTRODUCTION 
 
Integrins are required for normal development of the skin and play a vital role 
during wound healing (Raghavan et al. 2000, Dipersio et al. 1997).  As 
bidirectional receptors integrins mediate signalling in both an outside-in and 
inside-out manner, allowing cells to respond to and manipulate the ECM (Qin et 
al. 2004).  The ability of a cell to reorganise the repertoire of integrins enables 
the cell to react to a dynamic environment.  This reaction may be via up/down 
regulation of integrin expression at a transcription level or the reorganisation of 
subunits to allow redistribution to different areas of the cell surface which may 
involve clustering and the formation of focal adhesions.  Epidermal cells 
express integrin receptors α2β1, α3β1, α6β4 (Peltonen et al. 1989, De Luca et 
al. 1990).  The α3, α2 and β1 subunits facilitate cell-cell adhesion and are 
localised at sites within the suprabasal layer and to a lesser extent, the basal 
layer.  In basal layer cells these integrins are located on the lateral surfaces (De 
Luca 1990).  The α6β4 integrin is confined to the basal layer of the epidermis 
where it plays a vital role in attaching basal layer keratinocytes to the basement 
membrane (De Luca et al. 1990, Jones et al. 1998).    
 
During the initial stages of re-epithelialisation cells at the wound margins are 
faced with extracellular matrix proteins they would not normally interact with.  
Such proteins include the exposed dermal collagen type I, vitronectin, tenascin 
and fibronectin within the fibrin clot (Pilcher et al. 1997, Mackie et al. 1988, 
Repesh et al. 1982, Preissner and Seiffert 1998).  As a result, keratinocytes 
upregulate a variety of receptors including α5β1, αvβ6 and αvβ5 (Carter et al. 
1990, Decline et al. 2003).  Integrin subunit β1 is particularly important for 
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keratinocyte migration on collagen type I and fibronectin (Guo et al. 1990).  
Receptors α2β1, α3β1and α6β4 are of particular interest; these integrins are 
important facilitators of cell-LN332 interactions which are necessary for cell 
migration and restoration of the basement membrane.  Research continues to 
identify the various roles for each receptor and how these functions are 
coordinated.  During re-epithelialisation keratinocytes employ integrin switching 
mechanisms; for example, collagen-dependent adhesion via α2β1 switches to 
LN332 dependent adhesion via α3β1 (Scharffetter-Kochanck et al. 1992, 
Nguyen et al. 2000).  Similarly, interactions between newly deposited LN332 
and α6β4 cause keratinocytes to utilise integrin α3β1 (Hamelers et al. 2005, 
Nguyen et al. 2000).  Integrin switching suggests that α2β1 becomes redundant 
in favour of α3β1; however studies have also shown that this receptor can play 
a primary role in cell migration.  While α2β1 is most commonly known as a 
collagen receptor, later studies have identified it as the primary receptor 
responsible for cell migration over LN332 (Decline and Rouselle 2001). 
 
Stimulation of cell migration during wound repair depends on the presence of 
growth factors such as TGF-β (Santoro and Gaudino 2005).  TGF-β functions to 
stimulate alterations in integrin expression as well as altering binding affinity 
(Heino et al. 1989, Jeong and Kim 2004).  Different cell types and different 
integrin subunits are influenced in different ways.  Again, with regards to 
keratinocytes, most studies have addressed the function of either TGF-β1 or 
have simply discussed TGF-β without referring to a specific isoform.  In primary 
keratinocytes, TGF-β1 increases expression of α2 and α5 integrin subunits 
while decreasing expression of α3 and α6 (Decline et al. 2003).      
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5.2 AIM 
 
Results gathered from previous chapters have identified differences in the way 
in which each TGF-β isoform influences collective cell migration.  Factors 
limiting this migration may be ECM deposition and/or the availability of integrin 
receptors with which cells can interact with this laminin.  Thus, the aim of this 
study was to examine integrin expression in HaCaT keratinocytes following a 4 
day treatment with each of the three TGF-β isoforms.  For the first part, 
extracellular subunits were identified using immunofluorescence staining and 
confocal microscopy in order to identify any differences in integrin distribution 
patterns.  Secondly, integrin expression was compared by an ELISA based 
immunoperoxidase quantification method. 
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5.3 METHODS 
 
5.3.1 Immunofluorescence staining for Integrin subunits α3, α2, α5 and β1 
following TGF-β1, 2 and 3 treatment 
 
HaCaT cells were seeded into 6mm Petri dishes at a density of approximately 
2x104/ml per 22mm2 glass cover slip.  Substrates were cultured in 4ml normal 
10% FCS RPMI (control and negative control) or in TGF-β1, 2 or 3 (5ng/ml) 
containing media at 37°C for 4 days.  Cells were fixed and immunostained 
according to the procedure described in chapter 4 (4.3.1).  Primary antibodies, 
mouse anti-CD49b, anti-CD49c, anti-CD49e and anti-CD29 (Integrin Sampler 
Kit) were diluted in 1% BSA to give the following final working concentrations; 
1µg/ml, 1µg/ml, 0.3µg/ml and 0.5µg/ml respectively.  Primary antibody 
incubations were carried out overnight at 4°C.   
 
5.3.2 ELISA based method for detection of Integrin subunits α3, α2, α5, β1 and 
β4 following TGF-β1, 2 and 3 treatment 
 
Cells were cultured and immunostained according to the procedure described in 
Chapter 4 (4.3.2). Primary antibodies mouse anti-CD49b, anti-CD49c, anti-
CD49e, anti-CD29 and anti-CD104 (Integrin Sampler Kit) were diluted in 1% 
BSA to give 1µg/ml, 1µg/ml, 0.3µg/ml, 0.5µg/ml and 1µg/ml respectively.  
Primary antibody incubations were carried out overnight at 4°C.  This 
experiment was repeated six times.   
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5.3.3 Statistical Analysis 
 
The results are presented as means± standard errors of the means.  Following 
normality testing, mean results were assessed by one way ANOVA to 
determine any significant differences between groups. The Bonferroni 
adjustment was used for post hoc comparisons. 
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5.4 RESULTS 
 
5.4.1. Immunofluorescence staining for Integrin subunits α3, α2, α5 and β1 
following TGF-β1, 2 and 3 treatment 
 
Immunofluorescence staining was carried out to investigate possible differences 
in integrin localisation when HaCaT cells were treated with TGF-β1, 2 and 3.  
Control cells showed positive and fairly uniform staining for each of the integrin 
subunits α3 (CD49c), α2 (CD49b), α5 (CD49e) and β1 (CD29).  No specific 
staining was observed in the negative controls confirming the specificity of the 
primary antibodies.  The most apparent difference in integrin staining was seen 
with anti-α3 whereby all TGF-β isoforms caused an increase in α3 clustering.  
Elongation of cells often appeared to concur with a more intense expression of 
α3 along the extended region of the cell or towards one end of the cell (Figure 
5.1).  There were often brighter areas toward the centre of the cell around the 
site of the nucleus.  Other integrin subunits presented with less obvious 
differences.  The α2 and α5 subunits were shown to localise to a greater extent 
toward the edges of the cell following TGF-β treatment.  This perimeter staining 
was more pronounced with TGF-β2 and 3.  Lastly, the β1 stain was fairly 
consistent for each the control and the TGF-β isoforms in terms of localisation 
of staining.  For each integrin subunits, the intensity and localisation of staining 
patterns following TGF-β treatment was not seen with every cell in any given 
area.  The most obvious examples of this inconsistent staining are with α2, α5 
and β1 subunit expression following TGF-β3 treatment.  In general, there were 
discrepancies between the number of Dapi stained nuclei and the number of 
identifiable Alexa Fluor® 488 labelled cells.  These differences in integrin 
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expression between cells under the same conditions suggest there may be a 
time course to integrin expression.  In other words, cells may be responding to 
the TGFβ isoforms and expressing integrin receptors at different times. 
 
 
  
Figure 5.1. Micrograph represents an example of the extracellular 
localisation of integrin subunit α3 following HaCaT cell incubation with TGF-
β1. Scale bar = approximately 25µm 
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Figure 5.2. Localisation of α3 integrin subunit (CD49c) following 4 day 
incubation under control conditions (B) or TGF-β1, 2 and 3 treatment (D, 
F, H).  Micrographs A, C, E and G show corresponding negative control 
with Dapi stain.  Scale bar = approximately 50μm 
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Figure 5.3. Localisation of α2 integrin subunit (CD49b) following 4 day 
incubation under control conditions (B) or TGF-β1, 2 and 3 treatment (D, 
F, H).  Micrographs A, C, E and G show corresponding negative control 
with Dapi stain.  Scale bar = approximately 50μm 
 147 
  
  
 Figure 5.4. Localisation of α5 integrin subunit (CD49e) following 4 day 
incubation under control conditions (B) or TGF-β1, 2 and 3 treatment (D, 
F, H).  Micrographs A, C, E and G show corresponding negative control 
with Dapi stain.  Scale bar = approximately 50μm 
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Figure 5.5. Localisation of β1 integrin subunit (CD29) following 4 day 
incubation under control conditions (B) or TGF-β1, 2 and 3 treatments (D, 
F, H).  Micrographs A, C, E and G show corresponding negative control 
with Dapi stain.  Scale bar = approximately 50μm 
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5.4.2. ELISA based method for detection of Integrin subunits α3, α2, α5, β1 and 
β4 following TGF-β1, 2 and 3 treatment 
 
In order to carry out a more quantitative analysis of any differences in integrin 
expression induced by 4 days incubation with TGF-β1, 2 and 3, an ELISA 
based immunoperoxidase staining method was used.  Optical density readings 
were compared for control and each TGFβ isoform.  When comparing the basal 
expression of each integrin subunit in control cells, β4 and α3 (0.15 ± 0.009 and 
0.12 ± 0.0013 respectively) were identified as having the highest absorbance 
readings suggesting that these subunits are more highly expressed in HaCaT 
cells.  Integrin subunits α2 and β1 produced absorbance readings of 0.075 ± 
0.0017 and 0.06 ± 0.0009.  The lowest absorbance reading was obtained for α5 
at only 0.04 ± 0.001.  
 
For each integrin subunit tested, all TGFβ isoforms caused an increase in 
absorbance readings indicating an increase in expression when compared to 
the controls (p<0.001).  The most dramatic increase, of approximately 0.2 OD 
units, was seen with α3.  When comparing TGFβ isoforms, TGF-β3 seemed to 
cause an increase in expression of α3 when compared to TGF- β1 and 2 which 
both displayed very similar results (Fig 5.6).  There was a slight increase in β1 
expression following TGF-β2 and 3 treatments when compared to TGF-β1.  For 
all remaining subunits (α2, α5 and β4) there appeared to be a trend whereby 
absorbance readings increased slightly with each isoform TGF-β1, 2 and 3 
respectively (Figures 5.7, 5.8 and 5.10 respectively).  Significant differences 
were limited to the following findings; TGF-β2 and 3 treated cells produced 
higher absorbance readings for the α2 subunit when compared to TGF-β1 
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(p<0.001) TGF-β3 caused an increase in readings for β4 when compared to 
TGF-β1 and 2 (p<0.01)(Figures 5.7 and 5.10 respectively).  These increases in 
absorbance readings indicate increases in subunit expression.     
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 Figure 5.6 shows optical density readings (630nm) (arbitrary units) following 
immunoperoxidase staining of α3 integrin.  All TGFβ isoforms caused an 
increase in the extracellular expression of α3 compared to control (p<0.001).  
Standard error bars are shown, N=6.   
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Figure 5.7 shows optical density readings (630nm) (arbitrary units)  following 
immunoperoxidase staining of α2 integrin.  All TGFβ isoforms caused an 
increase in the extracellular expression of α2 compared to control (p<0.001).  
TGF-β2 and 3 were also shown to cause an increased expression relative to 
TGF-β1 (p<0.001).  Standard error bars are shown, N=6.   
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Figure 5.8 shows optical density readings (630nm) (arbitrary units) following 
immunoperoxidase staining of α5 integrin.  All TGFβ isoforms caused an 
increase in the extracellular expression of α5 compared to control (p<0.001).  
Standard error bars are shown, N=6.   
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Figure 5.9 shows optical density readings (630nm) (arbitrary units)  following 
immunoperoxidase staining of β1 integrin.  All TGFβ isoforms caused an 
increase in the extracellular expression of β1 compared to control (p<0.001).  
Standard error bars are shown, N=6.   
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Figure 5.10 shows optical density readings (630nm) (arbitrary units) following 
immunoperoxidase staining of β4 integrin.  All TGFβ isoforms caused an increase 
in the extracellular expression of β4 compared to control (p<0.001).  TGF-β3 was 
also shown to cause an increased expression relative to TGF-β1 and 2 
(p<0.001).  Standard error bars are shown, N=6.   
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5.5 DISCUSSION 
 
Integrins are important regulators of cell behaviour.  They mediate cell-ECM 
communications and modulate cytoskeleton organisation enabling cell adhesion 
and motility (de Rooij et al. 2005).  Here, HaCaT cells were shown to express 
integrin subunits α3, α2, α5, β1 and β4.  When comparing absorbance readings 
from each of the control data sets, the highest readings for the integrin subunits 
were found with β4 and α3.  This was perhaps to be expected as α6β4 and 
α3β1 are important for cell adhesion and migration on LN332 (Hamelers et al. 
2005, Nguyen et al. 2000).  However, it is important to note that these 
differences may be influenced by differences in antibody concentrations and 
specificities.         
 
Previous experiments (Chapter 3 and 4) identified differences in the way TGF-β 
isoforms influence collective cell migration during scratch assay ‘wound repair’.  
There also appeared to be a link between the effects of TGF-β isoforms on the 
deposition of LN332.  As mentioned above, integrins mediate cell interactions 
with LN332 in order to both facilitate migration and also as a control mechanism 
for the continued deposition of LN332 (Zhang and Kramer 1996, Hamelers et al. 
2005, Decline and Rousselle 2001, Nguyen et al. 2000).  Increased deposition 
of LN332 during skin regeneration is concurrent with an upregulated expression 
of integrin chains α2, α3, α5, β1 and α6 (Breitkreutz et al. 1997).   
 
Results from the present study found that all TGF-β isoforms significantly 
increased the expression of α3, α2, α5, β1 and β4 subunits when compared to 
controls.  Previous studies concur that TGF-β1 increases expression of α5, α2 
 156 
  
and β4 in either normal or transformed human keratinocytes (NHKs) (Sollberg 
et al. 1992, Sung et al. 1998, Decline et al. 2003).  Expression of the α3 subunit 
on the other hand is known to vary depending on the cells examined.  HaCaT 
cells incubated with TGF-β1 over a 24 hour period did not change the levels of 
the α3, while in NHKs expression was down regulated after 24 hours and further 
more at 48 hours (Jeong and Kim 2004, Decline et al. 2003).  These 
contradictory results may be, in the case of the HaCaT cell study, due to the 
length of incubation time.  TGF-β influences integrin expression in a time 
dependent manner (Decline et al. 2003, Wahl et al. 1993).  The present study 
exposed HaCaT cells to TGF-β1 over a 4 day period and this additional time 
may be the cause of the increased α3 expression seen here.   With regards to 
the decreased expression previously seen with NHKs; this contradiction in 
results may be due to differences in the response of cell lines when compared 
to primary cells.   
 
The influence of α3β1 in keratinocyte migration is controversial.  Decline and 
colleagues suggest that in primary keratinocytes, the α3β1-LN332 interactions 
are diminished during TGF-β1 induced migration.  They propose that TGF-β1 
induces keratinocyte migration by switching the repertoire of integrins resulting 
in a decreased expression of those that bind to LN332 (Decline et al. 2003).  In 
contrast the α3β1 integrin has been identified as a regulator of LN332 
production and deposition and thus important in cell migration (Hamelers et al. 
2005).  Interestingly, a recent study examining the role of α3β1 in collective 
HaCaT cell migration and protein expression found that the down-regulation of 
α3β1 produced similar cell behaviours as seen under the influence of TGF-β in 
the present study.   The knock-down of α3β1 in HaCaT cells was found to 
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cause a less coherent migration of monolayer cells at the leading edge of cell 
colonies; instead, cells tended to migrate away from the margins more 
independently (Wen et al. 2010), as seen following TGF-β treatment in Chapter 
3.  The down- regulation of α3β1 also caused an increased expression of 
precursor LN332, as seen with TGF-β in Chapter 4 of the present study (Wen et 
al. 2010).  This concurs with findings of Decline and colleagues; i.e. if TGF-β 
produces the same results as the knock down of α3β1, this seems to supports 
the theory that TGF-β down regulates α3β1.  However, it may be possible that 
the increased expression of LN332 and enhanced migration found in α3β1 
knock-out HaCaT cells may have been a result of another integrin receptor and 
not necessarily due to the absence of negative regulation by α3β1.  Integrins 
are multifaceted and are able to compensate for the loss of other subunits by 
enhanced expression (Wilhelmsen et al. 2006, Wen et al. 2010).  
 
In the present study the most dramatic increase in integrin expression was seen 
with the α3 subunit.  The β1 subunit was also significantly increased following 
TGF-β treatments, suggesting that α3β1 is involved in TGF-β induced HaCaT 
cell migration, albeit possibly with an altered role.  It may be the case that under 
control conditions α3β1 acts to maintain cell contacts and inhibit LN332 
deposition, however, under the influence of TGF-β; this integrin receptor may 
have a different function.  For example, α3β1 has been shown to negatively 
regulate the TGF-β inhibitor Smad7 therefore allowing TGF-β signalling to 
activate cell migration (Reynolds et al. 2008).   
 
When comparing integrin expression between TGF-β isoforms, the findings did 
not provide a clear, obvious explanation for the differences seen in wound 
 158 
  
closure and LN332 deposition induced by TGF-β2 and 3.  Having said this, 
there were identifiable trends and in a few cases integrin expression 
significantly differed between TGF-β isoforms.  There were also indications of 
possible differences that may have shown to be statistically significant had the 
sample size been larger.  Significant differences are often lost if sample sizes 
are too small.  Unfortunately the sample size of the present study was limited by 
both time and financial constraints.  As described in the results, TGF-β3 
seemed to cause an increase in expression of α3 integrin subunit when 
compared to TGF- β1 and 2.  There was also a slight increase in β1 expression 
following TGF-β2 and 3 treatments when compared to TGF-β1.  For subunits 
α2, α5 and β4, expression increased slightly with each isoform TGF-β1, 2 and 3 
respectively.  These increases were significant for α2 and β4 (TGF-β3 only) 
(p<0.001).  These results suggest that TGF-β isoforms may differentially 
influence HaCaT cell behaviour through alterations in integrin expression.  As 
part of α6β4 the β4 subunit plays a dual role in mediating cell adhesion on 
processed LN332 whilst also promoting cell motility over unprocessed LN332.    
During migration, the ligation of beta4 with LN332 triggers downstream 
signalling resulting in the utilization of α3β1 by keratinocytes.  The binding of 
α3β1 to LN332 initiates further signalling which stimulates the further production 
of LN332 in a positive feedback manner (Hamelers et al. 2005).  The β4 subunit 
is also involved in the organisation of LN332 matrices, an important feature in 
determining cell motility (Sehgal et al. 2006).  As TGF-β3 was shown to 
significantly increase β4 expression, it could be suggested that the increase in 
laminin deposition and rate of cell migration induced by TGF-β3 was a result of 
an elevated expression of β4 and possibly α3.  Similarly, as the integrin α2β1 
interacts with LN332 during keratinocyte migration (Decline and Rousselle 
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2001); the differing levels of this integrin subunit in response to each TGF-β 
isoforms may contribute to differences seen in cell migration.  TGF-β2 and 3 
significantly increased the levels of α2 subunit, wound closure rates and laminin 
deposition when compared to both TGF-β1 and control.  It would therefore be 
interesting to investigate the role of α2 in the deposition of LN332 which 
appears to influence rates of migration.    
 
While levels of integrin expression are important, it is worth noting that the 
expression of integrin receptors does not necessarily reflect their role in cell 
adhesion and migration.  In order for integrins to facilitate cell 
adhesion/migration the recruitment of F-actin and focal contact protein to focal 
contact sites is required (Vicente-Manzanares et al. 2009).  This integrin 
controlled cytoskeleton organisation has also been associated with the ability of 
integrins to regulate the function of other receptors.  In α3 null keratinocytes, for 
example, cells are better able to adhere to fibronectin and collagen as a result 
of the redistribution of actin-associated proteins and stress fibres toward other 
integrin subunits (Hodivala-Dilke et al. 1998).  In these cells, the lack of α3 
expression had no influence on the expression of other integrins, only on the 
function of these receptors, suggesting that expression of an integrin receptor 
does not necessarily mean it is influencing the cell cytoskeleton.  
 
The differences seen in migration rates during wound closure may also be 
influenced by the way integrins are distributed at the cell surface.  All TGF-β 
isoforms were shown to increase the intensity of α3 staining toward the front 
and rear of cells which may account for the significant increase in α3 
expression.  The same clustering of staining for α2 following TGF-β2 and 3 may 
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also explain the significant difference in absorbance reading for these isoforms 
when compared to TGF-β1 and control.  Interestingly, the α3 staining pattern 
seen in Figure 5.1, i.e. the intense perinuclear staining together with staining at 
the front and rear of the cell, is similar to the pattern of cell-surface interactions 
seen with the WSPR imaging following TGF-β3 treatment in Chapter 2.  This 
suggests that the cell-surface interactions seen during WSPR are due to the 
expression and/or reorganisation of integrin following TGF-β treatment.  These 
results suggest that rather than altering expression levels, each TGF-β isoform 
may differentially influence reorganisation of receptor subunits giving cells 
polarity.  Cell polarisation is an important feature of cell migration, it can occur 
as a result of cytoskeleton reorganisation in response to chemical signals from 
the ECM.       
 
Lastly, as TGF-β3 was shown to decrease cell proliferation (Chapter 3), it could 
be possible that β4 integrin is involved in this response.  Following interactions 
with mature/processed LN332, β4 is responsible for the promotion of 
keratinocyte proliferation (Nikolopoulos et al. 2005).  Under TGF-β culture 
conditions however, LN332 is maintained in the precursor form and therefore β4 
would not cause the same cell response.  While the TGF-β induced reduction in 
cell proliferation could be solely due to TGF-β associated signalling pathways, 
e.g. Smad signalling, it may also be possible that integrins such as β4 play a 
dual role in controlling cell cycle activities, in a similar way as seen with cell 
motility.  Interactions with unprocessed LN332 may alter the signalling pathways 
influenced by β4. 
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Although not conclusive and limited by sample sizes, this comparative 
examination of the way TGF-β1, 2 and 3 influences the expression of integrin 
subunits has highlighted a possible role for these receptors in the differences 
seen in wound closure, proliferation and LN332 deposition between isoforms.    
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CONCLUSION 
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The aims of this thesis were to address the following null hypothesis: 
 
TGF-β3 facilitates scarless healing by enhancing the speed of migration of 
keratinocytes, as a result of its effect on the deposition of laminin.  These 
cellular responses are mediated via the upregulation of integrin receptors α3β1 
and downregulation of those receptors responsible for interactions with collagen 
type I and fibronectin, namely α2β1 and α5β1.   
 
The hypothesis also states that TGF-β isoforms 1, 2 and 3 differ in their effects 
on cellular response to laminin and cell deposition of laminin.  It is expected that 
TGF-β3 will increase the deposition of laminin relative to TGF-β1 and 2 
therefore enhancing cell migration and thus the wound repair process.          
 
Specific aims were as follows: 
 
1. To study the behaviour of cultured keratinocyte (HaCaT) cells in response to 
treatment with TGF-β3.  Cell adhesion and distribution of focal contacts was 
examined using a cell adhesion assay and widefield surface plasmon 
microscopy (WSPR).   
2. To study the responses of HaCaT cells to extracellular matrix proteins, 
fibronectin, laminin and collagen type I, patterned onto glass substrate. 
3. To study the effects of TGF-β3 in relation to the alignment of HaCaT cells 
cultured on the above mentioned microcontact printed extracellular matrix 
patterns.  
4. To study how different extracellular matrix proteins and TGF-β1, 2 and 3 
influence cell proliferation and collective migration.  
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5. To qualitatively and quantitatively assess laminin secretion in vitro in relation 
to treatment with the different TGF-β isoforms.  
6. To determine which integrins were up and down regulated in response to the 
different TGF-β isoforms.   
 
Findings 
 
Although TGF-β isoforms share 70-80% homology there are clear differences in 
the way these cytokines affect physiological processes.  TGF-β isoforms are 
implicated in the wound healing process; TGF-β1 and 2 are associated with the 
inflammatory response and scar formation, while TGF-β3 has been identified as 
a mediator of scarless healing (Shah et al. 1994, Shah et al.1995, Ferguson et 
al. 2009).  While these contrasting responses have been studied in vivo, little 
research has addressed the way in which these cytokines, particularly TGF-β3 
influences keratinocyte cell behaviour.  There are also very few studies 
comparing the effects of TGF-β isoforms at a basic cellular level.  In an attempt 
to identify any possible differences in the way TGF-βs influence HaCaT cell 
keratinocytes, a variety of experiments were carried out investigating basic 
cellular behaviours.  A simplified summary of results are presented in Table 6.1.   
 
In Chapter 2, the influence of TGF-β3 on HaCaT cell behaviours, including cell 
adhesion and alignment to ECM proteins, was examined.  On culturing HaCaT 
cells with TGF-β3 it was determined that 4 days was an optimal incubation 
period with which to identify clear phenotypic changes in cell behaviour, namely 
enhanced migratory phenotype.  Using WSPR it was possible to examine the 
cell-substrate interactions of TGF-β3 treated HaCaT cells.  While cells tended to 
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spread over a larger area of the substrate, the points of contact with the 
substrate were restricted to the centre and perimeter of the cell.  Control cells 
were less spread and points of contact covered a larger proportion of the cell 
area.  This suggested that cells were less adherent, or had fewer adhesion sites 
following TGF-β3 treatment, possibly due to more dynamic cell-ECM 
interactions.  In order to further investigate the affect of TGF-β3 on cell 
adhesion, trypsinisation assays were performed.  Results found that TGF-β3 
caused a reduction in the time taken for cells to ‘round up’ in response to the 
protease, thereby supporting the WSPR findings.   
 
Understanding how TGF-β3 influences cell-ECM interactions is important if we 
are to gain further insight into the role of TGF-β3 in re-epithelialisation.  
Experiments went on to examine cell alignment to ECM proteins fibronectin, 
laminin and collagen type I and how these responses were altered by TGF-β3.  
HaCaT cells were most responsive to 50μm laminin and fibronectin patterns 
demonstrating that these cells expressed receptors that favoured adhesion on 
these proteins.  TGF-β3 reduced cell alignment to all proteins, a response 
presumed to be due to alterations in integrin expression and/or deposition of 
proteins which masked underlying protein patterns.  TGF-β is known to cause 
the deposition of laminin in keratinocytes, as seen during re-epithelialisation 
(Korang et al. 1995).  Immunostaining suggested that TGF-β3 caused the 
deposition of laminin trails demonstrating that reduced cell alignment was in 
part as a result of the deposition of laminin.   
 
As previously mentioned, there is evidence in the literature that TGF-β isoforms 
influence the processes of wound repair differently (Shah et al. 1994, Shah et 
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al. 1995, Ferguson et al. 2009).  Therefore, all further experiments compared 
TGF-β isoforms at a concentration of 5ng/ml.  Chapter 3 examined the influence 
of ECM proteins (as above) and TGF-β1, 2 and 3 on HaCaT cell proliferation 
and collective cell migration, both important features of re-epithelialisation.  
Cells grown on different protein coated substrates proliferated at different rates 
over a 6 day period.  It was found that laminin caused an increase in cell 
numbers by day 6; however this increase was only significantly different in 
comparison to fibronectin treatment.  Wound closure or ‘scratch’ assays were 
used to measure the rate of collective cell migration of cell monolayers plated 
on the protein coated substrates.  The rate of wound closure on the laminin-
coated substrate was significantly slower when compared to control and both 
fibronectin and collagen type I substrates.  Neither fibronectin nor collagen type 
I influenced rates of wound closure differently from control.  Results were not 
influenced by any differences in monolayer densities as scratch assays were 
carried out following only 2 days of cell growth.  These wound closure assays 
highlighted laminin as a limiting factor in the rates of collective cell migration.  
As TGF-β3 was shown to deposit laminin, further experiments went on to 
investigate how wound closure would respond to TGF-β isoforms.      
 
Wound closure was compared for each TGF-β isoform.  Of the three isoforms, 
TGF-β2 and 3 increased the rate of wound closure while TGF-β1 did not differ 
from the closure rate of control cells.  This rapid wound closure seen with TGF-
β2 and 3 was associated with the migration of cells moving out from the ‘wound 
margins’ in a more independent manner as opposed to the more orderly 
advancement of wound margins as seen with control cell monolayers.  This 
highlighted possible differences in the way TGF-β influence cellular signalling 
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involved in the detachment of cell-cell adhesions and the promotion of 
independent migration, or cell scattering.  While TGF-β causes the deposition of 
laminin, this laminin did not limit the rate of wound closure in the same way as 
the laminin coated substrates.   As wound closure rates in response to TGF-β 2 
and 3 were increased when compared to control; this supports previous 
evidence that TGF-β maintains deposited laminin in a promigratory form 
(Decline and Rouselle 2001).  
 
TGF-β is known to reduce the rates of cell proliferation in keratinocytes.  Cell 
proliferation assays carried out in the present study, following a 4 day 
incubation period, found that while all isoforms caused a reduced cell count 
compared to control, only TGF-β3 treated cells were significantly lower in 
numbers.  To ensure that any differences in cell monolayer densities were not 
influencing wound closure rates, scratch assays were carried out on 
monolayers of varying densities.  It was shown that with increasing cell density, 
wound closure rates were also increased.  These findings indicated that the 
increased wound closure rate seen in the TGF-β3 treated cultures seemed to 
be due to another mechanism; as TGF-β3 reduced cell proliferation rates.  The 
evidence so far seems to suggest that TGF-β3 enhances wound repair by 
inhibiting proliferation, enhancing laminin secretion and enhancing the transition 
of keratinocytes into a migratory phenotype.  This change in cell phenotype 
indicated possible changes in matrix deposition and integrin expression. This 
view is supported by evidence in the literature; TGF-β is known to influence 
ECM deposition and integrin expression in keratinocytes (Decline et al. 2003, 
Amano et al. 2004, Jeong and kim 2004) however there has been little 
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investigation into whether these variables are influenced differently by different 
TGF-β isoforms.   
 
In an attempt to address this gap in the literature, the present study applied 
immunofluorescence staining techniques and ELISA based quantification 
methods to examine possible differences in the way TGF-β1, 2 and 3 influence 
laminin332 (LN332) deposition and α3, α2, α5, β1 and β4 subunit expression.  It 
was determined that, while all TGF-β isoforms increased LN332 deposition, 
TGF-β2 and 3 elicited the greatest response.  Such differences highlighted a 
possible reason for the increased rates of cell migration seen during wound 
closure assays.    These newly deposited LN332 matrices may have provided 
cues for leading edge cells, causing wound margins to advance at a faster rate.  
These results suggest that there may be a link between the amount of LN332 
deposited and the rate of cell migration during re-epithelialisation in vivo.   
Important mediators of cell migration are the integrin receptors.  All TGF-β 
isoforms significantly increased the expression of α3, α2, α5, β1 and β4 
subunits when compared to controls.  For subunits α2, α5 and β4 there 
appeared to be a trend whereby expression increased slightly with each isoform 
TGF-β1, 2 and 3 respectively.  These increases were significant for α2 and β4 
(TGF-β3 only).  These integrin subunits are involved in interactions with LN332 
and α2 also binds dermal collagen, both interactions are known to stimulate 
LN332 deposition (Scharffetter-Kochanck et al. 1992, Decline and Rouselle 
2001, Hamelers et al. 2005, Sehgal et al. 2006).  This suggests that TGF-β3 
enhances re-epithelialisation by preparing keratinocytes for interactions with 
dermal collagen and laminin, thereby facilitating further laminin deposition.    
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At this point, it is important to acknowledge the limitations of this study as 
possible contributing factors to the differences seen between TGF-β isoforms.    
For all experiments comparing TGF-β isoforms, the differences in results could 
be due to the concentration of TGF-β used.  In order to standardise 
experiments, each isoform was used at the same concentration (5ng/ml), 
however, this may not have been the optimal working concentration for each 
TGF-β.  In order to identify optimal working concentrations for each TGF-β 
isoform, experiments would have needed to be carried out at a range of 
concentrations for each variable (e.g. wound closure, laminin deposition) 
examined.  This volume of experiments was not practical due to the cost of 
these cytokines.  Secondly, it would have been preferable for the present study 
to have been carried out using primary keratinocytes; however, acquiring 
primary cells is an expensive and lengthy process.   It would also have limited 
the number of experimental repeats carried out in the given time frame.  Using 
the HaCaT cell line provided a convenient way in which to produce in vitro 
models.  Although by no means conclusive/definitive, the findings from these 
HaCaT models provide an indication as to the differences between TGFβ 
isoforms on keratinocyte behaviour during the process of re-epithelialisation.   
 
In addressing the initial hypothesis; TGF-β3 was found to enhance the speed of 
migration during monolayer wound closure which coincided with an increased 
deposition of LN332 and an upregulation of integrin receptors responsible for 
cell migration over these newly deposited LN332 matrices.  There was, 
however, no evidence of the downregulation of integrin receptors commonly 
associated with adhesion on collagen type I and fibronectin.  As part of its role 
in promoting scarless healing, TGF-β3 may facilitate a more rapid re-
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epithelialisation of the wound bed which in itself may contribute to the overall 
quality of wound healing.  If this were the case, how would a more rapid 
resurfacing of the wound bed impact on the clearance of debris, foreign bodies 
and damaged cells?  Is it possible that humans have evolved to have a slower 
rate of re-epithelialisation in order to allow time for the immune cells to clear the 
wound and any damaged cells and debris that may later be detrimental? 
  
When comparing TGF-β isoforms, the expected differences were not observed; 
such differences were expected to reflect the findings of in vivo studies.  In 
general, TGF-β1 and 2 are seen as promoters of scarring during wound healing 
whereas TGF-β3 is being used as a therapeutic for the reduction of scarring.  It 
was therefore expected that TGF-β1 and 2 would produce similar results and 
that these results would differ from TGF-β3.  While there were differences in cell 
responses to each isoforms, TGF-β3 did not stand out from the other two 
isoforms.  Interestingly, TGF-β2 shared more similarities with TGF-β3 than it did 
with TGF-β1, in its role in enhancing wound closure and LN332 deposition 
(Table 6.1).   
 
 
 
 Control TGF-β1 TGF-β2 TGF-β3 
Wound Closure - - ++ ++ 
Laminin Deposition - + + ++ 
Integrin Expression:     
α3 - + + + 
α2 - + ++ ++ 
α5 - + + + 
β1 - + + + 
β4 - + + +++ 
Table 6.1: Simplified overview of the effects of TGFβ isoforms on wound closure 
rates, laminin deposition and integrin expression. ‘+’ represents a difference from 
control, ‘++’ represents a difference from control and TGF-β1, ‘+++’ represents a 
difference from all other treatments (based on significant differences). 
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These comparative studies raise several questions; firstly, what causes TGF-β 
isoforms to influence HaCaT cell behaviour differently, more precisely, which 
signalling pathways are mediating the differential increases in ECM deposition 
and integrin expression.  Secondly, how would these different cell responses 
impact the overall wound repair process; for example, how would an increased 
deposition of LN332 during re-epithelialisation influence the behaviour of 
fibroblast cells.  In order to address these questions, further experiments would 
need to be carried out.  Some suggestions are discussed below.   
 
Further Work   
 
As previously mentioned, for every experiment comparing TGF-β isoforms, 
TGF-β concentrations were standardised at 5ng/ml.  It would be useful to 
identify the optimal working concentration of each isoform for each wound 
closure, laminin deposition and integrin expression.  After clarification of optimal 
working concentrations for each isoform, the above parameters should be 
determined using primary keratinocytes.  This would give a more accurate 
representation of how keratinocytes respond to TGF-β isoforms in vivo.      
 
In the present study wound closure rates were influenced by the migration of 
cells away from the wound margins in a more independent manner.  This was 
seen to a greater extent following treatment with TGF-β2 and 3.  Similar 
behaviours have been seen with the overexpression of Slug, a transcription 
factor known to be regulated by TGF-β (Choi et al. 2007).  It may therefore be 
useful to investigate whether the responses seen with TGF-β2 and 3 where in 
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fact due to an upregulation of Slug protein and if so, do TGF-β isoforms 
differentially regulate Slug protein expression.   
       
In the present study, TGF-β3 significantly increased the expression of integrin 
subunit α2 along with an increased in wound closure rate and laminin 
deposition.  The α2β1 receptor mediates interactions with dermal collagen as 
keratinocytes move out into the wound bed; integrin switching then occurs and 
cells begin to deposit laminin (Nguyen et al. 2000, Hamelers et al. 2005).  As 
TGF-β isoforms were shown to differentially regulate α2 subunit expression this 
suggests that TGF-β isoforms would differentially regulate keratinocyte 
migration over collagen type I substrates.     
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Transforming growth factor -β3 causes decreased HaCaT cell alignment to 
extracellular matrix proteins Fibronectin, Laminin and Collagen type I as 
a result of an enhanced migratory phenotype 
 
R.Berends1, M. Youseffi2, M. Denyer1  
1Institute of Pharmaceutical Innovation, 2School of Engineering, Design & Technology, University of Bradford, 
BD7 1DP, UK 
 
Abstract—There has been much focus on the 
role of transforming growth factor-β (TGF-β) 
and more specifically TGF-β3 in wound healing, 
with a variety of cell types being studied. There 
is however, little understanding of the actions of 
TGFβ3 on keratinocytes and how this particular 
isoforms mediates its scarless healing effects. 
Studying cellular responses to different 
extracellular matrix proteins enables the 
identification of candidate integrins that may be 
up/down regulated in response to such growth 
factors.  In this study, microcontact printing was 
used to assess the responses of a human 
keratinocyte cell line (HaCaT cells) to 
fibronectin, laminin and collagen type I 
patterned on glass substrates via microcontact 
printing and how these responses were changed 
by treatment with TGF-β3. We demonstrate 
that HaCaT cell alignment to patterned ECM 
molecules is decreased by treatment with 
TGFβ3 and that this response is mediated by an 
increased keratinocyte migration associated 
with an enhanced deposition of laminin onto the 
culture substrate.  
 
Keywords- Micro-Contact Printing, Fibronectin, 
Laminin, Collagen Type I, TGF-β3, Cell 
guidance and migration.  
 
 
I. INTRODUCTION  
 
Following injury to the skin, keratinocytes within 
the epidermis migrate and proliferate to fill the 
wound bed, a process known as re-epithelialisation. 
These cellular activities rely on specific 
interactions with the changing extracellular matrix 
(ECM). Major proteins within the extracellular 
matrix include collagen type I, fibronectin and 
laminin. In terms of scaring, reepithelialisation has 
been somewhat overlooked as a possible 
contributing factor. There is little evidence that 
enables us to form a clear understanding of the role 
reepithelialisation has in scarring and how 
keratinocytes interact with their surroundings as 
part of the wound healing process. Studying 
cellular responses to different ECM proteins will 
allows us to identify which integrins are up/down 
regulated in response to growth factors.  
 
 
 
One group of growth factors shown to play a 
significant role in wound repair are the 
transforming growth factor-β isoforms 1, 2 and 3. It 
has been shown that the elimination of TGFβ1 and 
2 or the addition of TGF-β3 at the wound site 
results in scarless healing [1, 2]. Previous studies 
[1, 2] have indicated that TGF-β3 can enhance 
scarless healing in skin. Unfortunately, the 
biochemical and cell signalling mechanisms 
responsible for the functioning of TGF-β3 in 
wound repair are not fully understood.  
 
The aim of this study was to gain an insight into the 
role of TGF-β3 in modulation of cell-extracellular 
matrix interactions. This was achieved by 
examining HaCaT cell responses to microcontact 
printed ECM molecules with and without treatment 
with TGF-β3.  
 
 
II. MATERIALS AND METHODS 
 
Cell culture  
 
HaCaT cell lines were maintained in HEPES 
modified Rosewell Park Memorial Institute media 
(RPMI, SIGMA UK) at 37°c in standard plug seal 
cap 25cm2 culture flasks (Corning USA). RPMI 
media was supplemented with 10% fetal calf serum 
(Promo Cell® GmbH, Germany), 2% L-Glutamine, 
1% Penicillin-Streptomycin and 0.2% Fungizone 
(Amphotericin B).  
 
Microcontact printing assay: Effects of TGFβ3 on 
cell alignment to Fibronectin, laminin and 
Collagen type I  
 
A variety of Sylgard elastomer (DOW Corning 
GmbH, Wiesbaden Germany) stamps with parallel 
gratings ranging from 1.8 to 100μm in width were 
produced. These stamps were used to pattern 
fibronectin, laminin and collagen type I onto pre-
cleaned glass substrates. Fibronectin (Sigma UK) 
and laminin (Sigma UK) were used at working 
concentrations of 200μg/ml and 50μl/ml 
respectively. Collagen type I from rat tail (Sigma 
UK) was used at 0.01%. All proteins were diluted 
using sterile tissue culture grade water.  
 
Following stamp patterning substrates were placed 
in petri dishes and cells were seeded at 3 x103 
cell/ml of RPMI media with and without TGF-β3. 
50μl of reconstituted TGF-β3 was added to the 
media to give 4ml final volume working 
concentration of 50ng/ml. Cells were incubated at 
37°C for 24 hours and imaged using a phase 
contrast microscope and Visicapture software. Cell 
length, width and angle of alignment to the patterns 
was analysed using Image J software as described 
by Jamil et al [3].  
 
HaCaT cell culture with TGF-β3  
 
HaCaT cells were also grown in culture flasks with 
and without TGF-β3. Normal culture conditions 
were used. Cells were seeded at approximately 4 x 
104/ml RPMI media. Again, 50μl of reconstituted 
TGF-β3 was added to the media to give 4ml final 
volume and a TGF-β3 working concentration of 
50ng/ml. Cells were imaged every day up until Day 
4.  
 
HaCaT cell migration: Immunoperoxidase staining 
for laminin  
 
Under sterile conditions HaCaT cells were seeded 
into 6mm Petri dishes at a density of approximately 
7.5x103/ml per glass cover slip. Substrates were 
cultured in normal 10% FCS RPMI or in 50ng/ml 
TGF-β3 containing media at 37°C for 4 days and 
then fixed with 1% formaldehyde for 10 minutes. 
Subsequent immunostaining for laminin was 
achieved using a Laminin Immunohistology kit 
(Sigma UK). Immunostaining with this kit involved 
quenching endogenous peroxidise with 3% 
hydrogen peroxide for 5 minutes before washing 
the cells in HBSS and incubation with 4% bovine 
serum albumin for 15 minutes to prevent unspecific 
binding. Following this blocking step, cells were 
incubated with the primary antibody, rabbit anti-
Laminin, for 60minutes, washed and incubated 
with the biotinylated secondary antibody, goat anti-
rabbit IgG, for 20 minutes. Cells were washed and 
incubated with peroxidise reagent for a further 20 
minutes. During the final wash step, the Substrate 
reagent was prepared in the mixing vile provided. 
Reagents were added to the vile in the following 
order; 4ml deionised water, 2 drops acetate buffer, 
1 drop AEC Chromogen and 1 drop 3% hydrogen 
peroxide. Substrate reagent was then added to cells 
and the chromogen was allowed to develop for 10 
minutes before a final wash in water. All 
incubations were performed in a humidity chamber 
to avoid the evaporation of reagents.  
 
 
III. RESULTS AND DISCUSSION 
 
Microcontact printing assay: Effects of TGF-β3 on 
cell alignment to Fibronectin, laminin and 
Collagen type I  
 
The patterning of extracellular matrix proteins onto 
glass substrate allowed HaCaT cell responses to be 
examined. Of the six different pattern sizes (1.8-
100μm) used, HaCaT cell alignment favoured the 
50μm pattern for each protein.  
 
In the absence of TGF-β3, the best average 
alignment was seen with the 50μm laminin pattern 
(6.52°±1.33), closely followed by the 50μm 
fibronectin pattern (7.52°±1.73). Microcontact 
printing of collagen type I (17.97°±3.42) failed to 
achieve good alignment as seen with laminin and 
fibronectin. This suggests that cultured 
keratinocytes adhere with integrins that favour 
laminin and fibronectin over collagen type I. 
During the initial stages of reepithelialisation 
leading edge keratinocytes are exposed to dermal 
collagen (collagen type I). In response to this 
interaction with collagen type I, cells begin to 
produce and deposit laminin [4]. Laminin-332 is 
secreted by keratinocytes in its precursor form. The 
binding of keratinocytes to precursor laminin-332 
via α3β1 has been suggested to increase cell 
motility in wounds [4, 5]. Shortly after secretion, 
this precursor protein trimer, made up of α3 β3 and 
γ2 chains undergoes proteolytic processing to form 
the mature laminin-332 found in the basement 
membrane and this of course masks the underlying 
collagen type I rich matrix. The rapid restoration of 
the basement membrane by leading edge cells 
means that keratinocyte exposure to collagen type I 
is short lived and is limited to those cells at the 
wound periphery, this may explain the lesser 
response to collagen type I during the cell 
alignment assay.  
 
As the 50μm pattern produced the best alignment 
for each protein, this pattern size was selected for 
the experiments with TGF-β3. For fibronectin, 
laminin and collagen type I the mean angle of cell 
alignment to the 50μm pattern following incubation 
with TGF-β3 were 18.13° ± 2.94, 15.52° ± 3.19 
and 23° ± 3.39 respectively. Again, laminin 
achieved the best alignment, followed by 
fibronectin and lastly collagen type I. HaCaT cells 
showed a reduced response to each protein 
patterned substrates i.e. the average angle of 
alignment for the sample of cells measured was 
greater when compared to the control. A similar 
study looking at the effects of TGF-β1 on cell-
ECM interactions, in this case laminin, also found 
that treatment with TGF-β1 caused decreased 
keratinocyte adhesion [6]. Figure 1 shows a 
comparison of average cell alignment to each 
protein with and without treatment with TGF-β3.  
Figure 1: Graph shows comparison of cell alignment (°) to 
each protein for the control and the TGF-β3 treated cells. 
TGF-β3 caused a decreased in cell alignment to each protein 
when compared to the control. Standard error bars are also 
shown. 
 
HaCaT cells in culture with and without TGF-β3 
  
To further investigate the effects of TGF-β3 on 
keratinocytes, HaCaT cells were grown in culture with 
TGF-β3. TGF-β3 has been shown to reduce 
proliferation and enhance migration in small intestine 
(IEC-6) and colonic (T84) epithelial cell lines [7]. The 
present study has confirmed that TGF-β3 effects skin 
keratinocytes in the same way.  
 
 
 
 
 
 
Figure 2: Images A-D show HaCaT cells in culture under 
control conditions on days 1-4 respectively. Images E-H show 
cells treated with TGF-β3 on days 1-4 respectively. Scale bar 
= 100μm approx.  
Figure 2 shows HaCaT cells in culture with and without 
TGF-β3 treatment. There are no apparent 
morphological differences between treated cells and the 
control with day 1 cells. On Day 2, treated cells appear 
less grouped than control cells. Day 1 and 2 cells appear 
relatively similar in terms of cell density. By Day 3 
there is a marked difference in cell density with fewer 
treated cells compared to the control indicating that 
TGF-β3 causes a reduction in cell proliferation. By day 
3 and 4 treated cells appear morphologically different 
from normal culture cells. Treated cells take on a 
migratory phenotype; spreading over a greater area and 
becoming more elongated.  
 
HaCaT cell migration: Immunoperoxidase stain for 
Laminin  
 
Transforming growth factor-β is known to enhance cell 
migration, a rate limiting event in wound healing. TGF-
β1 has been shown to be strongly expressed at the 
leading edge of the migratory epithelial sheet [8]. 
During keratinocyte migration cells deposit laminin [4]. 
The deposition of laminin 5 is necessary for 
keratinocyte migration to occur [9]. In order to 
determine whether TGF-β3 effects laminin secretion 
and thus effects cell migration, substrates were stained 
for the deposition of laminin.  
 
Non treated cells were shown to cluster in groups and 
remain attached to the surface with little evidence of 
migration. Cells and the immediate surrounding area 
stained positive for laminin (brownish red colour).  
 
 
 
 
Figure 3 shows immunoperoxidase staining of glass substrate 
on which HaCaT cells have been cultured for 5 days with (B) 
and without (A) TGF-β3. Image A was taken using x10 
objective and the scale bar represents approximately100μm. 
Image B was taken using x25 objective and the scale bar 
represents approximately 50μm 
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Treated cells on the other hand did not appear to 
cluster in groups and showed enhanced spreading 
on the substrate. Positive staining via the laminin 
staining kit of cell laminin trails provided evidence 
of cell migration, a feature not seen with non 
treated cells.  
  
The TGF-β3 induced migratory phenotype 
associated with the secretion of laminin provides a 
reason for the decreased alignment to extracellular 
matrix proteins, fibronectin, laminin and collagen 
type I. The deposition of laminin onto the surface 
of the glass substrate masks the underlying 
microcontact printed ECM molecules and therefore 
alters cell responses to these patterned proteins. 
This finding could have significant implications in 
terms of determining the function of TGF-β3 in 
scarless healing. It is possible that in the wound site 
TGF-β3 increases laminin secretion, which in turn 
enables cells to migrate into the wound site more 
readily and repair the basement membrane more 
quickly. It would be assumed that if this were the 
case TGFβ3 may also be associated with 
upregulation of those integrins associated with cell 
coupling to laminin. Thus future work will focus on 
identifying the suite of integrins upregulated in 
HaCaT keratinocytes in response to TGF-β3 
treatment.  
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ABSTRACT 
 
Transforming growth factor-β (TGF-β) has been implicated in scarless healing seen in the fetus.  Addition of 
exogenous TGF-β3 and the neutralisation of TGF-β1 and 2 has been shown to reduce scar formation in adult 
wounds and clinical trials are currently underway.  Although known to be important the mechanisms by which 
these growth factors mediate their effects have yet to be fully elucidated.  Also there has been little focus on 
comparing the effects of TGF-β1, 2 and 3 and more specifically how these different isoforms affect keratinocyte 
cell behaviour during reepithelialisation.  We have shown that TGF-β isoforms are different in their effects on 
keratinocyte cell behaviour in culture.  Our results found that TGF-β2 and 3 increase the rate of wound closure 
and laminin 332 deposition in HaCaT cell monolayers.  The addition of TGF-β1 to HaCaT cells in culture did 
increase laminin deposition however it had little effect on the rate of wound repair when compared to controls.  
This highlights the possibility that these different TGFβ isoforms have different effects on the repertoire of 
integrins expressed by keratinocyte type cells thereby influencing their response to the newly deposited 
extracellular matrix.  
 
INTRODUCTION 
 
Interestingly, fetal wounds heal without the development of scar tissues (1, 2, 3).  While there are many factors 
that make the fetal wound environment different to that of the adult, the expression of TGF-β1, 2 and 3 have 
been found to be central to the scarless healing feature of fetal wound repair (4,5,6).  During fetal wound repair 
the pattern of TGF-β expression is different from that of an adult.  It has been shown that TGF-β1 2 and 3 are 
expressed at low levels in fetal wounds whilst in the adult wound on the other hand, all 3 isoforms are strongly 
expressed (5). These differences are mainly attributed to the lesser immune response in the fetus (1).  In the 
adult, TGF-βs play a role in the inflammatory response that follows injury. Platelets and macrophages release 
TGF-β1 and 2 that mediate further chemotaxis of immune cells, stimulate cell motility, extracellular matrix 
synthesis and remodelling (7).  
 
Many studies have addressed the influence of TGF-β on the wound healing process (8,9,10,11) .  Using a wound 
model it has been shown that increasing the expression of TGF-β1 causes fetal skin to heal with a scar (11).  The 
balance of TGF-β isoform expression has also been shown to influence wound repair.  It has been reported that 
when the ratio of TGF-β3 to TGF-β1 is high wound healing is improved (12).  These studies highlighted TGFβ 
isoforms as having an obvious role in the development of anti-scarring treatments.  Avotermin (active human 
recombinant TGF-β3) is currently undergoing clinical trials and has been shown to reduce scaring when added 
to the wound site. Incision wounds pre and post treated with avotermin (50ng/100ul/linear cm wound margin) 
showed improved healing with less abnormal orientation of collagen fibres in the dermis compared to placebo 
(13).  In contrast to this, the removal of TGF-β1 and 2 using neutralising antibodies has been shown to have 
similar anti-scarring effects (10).   
 
Although TGF-βs are known to be important in wound healing, it is not clear as to why these different forms of 
TGF-β affect the repair process so differently. The mechanisms by which the scarless healing effects are 
mediated, i.e. the extracellular matrix proteins, integrins and signalling pathways under TGF-β control, have yet 
to be fully elucidated.  Also, there is a gap in the literature with regards to the effects of each TGF-β isoforms on 
the behaviour of different cell types present in skin.  The study of cell behaviour in terms of scarring has tended 
to focus on fibroblasts, as these cells are associated with collagen remodelling (14, 15).  There has been little 
focus on the role of keratinocytes and their influence on scarring as a result of their activities during 
reepithelialisation.  The aim of this study was to start to examine the effects of TGF-β1, and 3 on human 
 
 
keratinocytes.  More specifically, we address the effect of each TGF-β isoforms on cell proliferation, migration 
and the deposition of laminin 332.   
 
MATERIALS AND METHODS 
 
Cell culture 
 
HaCaT cell lines were maintained in HEPES modified Rosewell Park Memorial Institute media (RPMI) (Sigma-
Aldrich, Gillingham, UK) at 37°c in standard plug seal cap 25cm2 culture flasks (Corning USA).  RPMI media 
was supplemented with 10% fetal calf serum (Promo Cell GmbH, Heidelberg, Germany), 2% L-Glutamine, 
1% Penicillin-Streptomycin and 0.2% Fungizone (Amphotericin B) (Sigma-Aldrich, St. Louis, USA).   
 
Reagents and antibodies 
 
Mouse monoclonal antibody against human laminin 332 was obtained from R&D Systems and used at a 
concentration of 10µg/ml.  Secondary antibody Goat anti-mouse IgG peroxidise conjugate was obtained from 
Sigma and was used at a 1:1000 dilution.  Alexa Fluor® 488 Goat Anti-Mouse SFX Kit was obtained from 
Ivitrogen.  The Alexa Fluor secondary was diluted to a concentration of 2.5µl/ml. All antibodies were diluted in 
1% BSA in PBS.  TGF-β isoforms were obtained from Promokine and were reconstituted with a carrier protein 
(BSA) as according to product guidelines.  Final working concentrations of TGF-β1, 2 and 3 in 10% FCS RPMI 
were each 5ng/ml.  DAPI (4’,6-Diamidino-2-phenylindole dihydrochloride) (Sigma-Aldrich, St. Louis, USA) 
was diluted in PBS and was used at a concentration of 60ng/ml. 
 
Cell Proliferation assays for TGF-β 
 
HaCaT cells were seeded at a density of 3.5x103/cm2 with each TGF-β isoforms for 4 days. For cell counts, cell 
monolayers were washed with HBSS and incubated with trypsin for up to 5 minutes or until all cells were lifted 
from the surface of the flasks.  Serum containing RPMI media was added to neutralise the trypsin and cells were 
counted using a counting chamber. 
 
Wound closure assays with TGF-β 
 
Under sterile conditions HaCaT cells were cultured in 25cm2 flasks with each TGF-β isoforms for 4 days until 
confluent.  This 4 day time period was used as our previous experiments (data not shown) have suggested that 4 
days were optimal for an altered cell phenotype to appear.   Following the incubation period cell monolayers 
were ‘wounded’ by scratching the surface of the flask using a 1ml pipette.  Wound sites were imaged using 
Visicapture software every 2 hours.  Wound widths were measured at each time point using Image J software.   
 
Immunostaining for laminin 332 following TGF-β treatment 
 
Under sterile conditions HaCaT cells were seeded into 6mm Petri dishes at a density of approximately 2x104/ml 
per glass cover slip.  Substrates were cultured in 4ml normal 10% FCS RPMI or in TGF-β1, 2 or 3 containing 
media at 37°C for 48 hours or 4 days.  Cells were rinsed in PBS and fixed with 4% formaldehyde for 6 minutes.  
Fixation was followed by three 5 minute washes in PBS, the second of which contained 0.1M glycine in order to 
prevent any autofluorescence. Cells were then blocked with 4 drops Image-iT™ FX signal enhancer (Invitrogen, 
Paisley UK) for 30 minutes followed by a thorough washing in PBS. The primary antibody, mouse anti-human 
laminin 332 (R&D Systems, Abingdon UK) was added for 60 minutes at room temperature followed by the 
secondary antibody Alexa Fluor® 488 (Invitrogen, Paisley UK) for a further 60 minutes at room temperature in 
the dark.  All incubations were performed in a humidity chamber to avoid the evaporation of reagents.  Stained 
coverslips were incubated in DAPI for 15 minutes and mounted onto microscope slides.  Cells were imaged 
using confocal microscopy.     
 
Elisa based method for detection of laminin 332 
 
Cells were cultured in 25cm2 culture flasks under control conditions or with either TGF-β1, 2 or 3.  On day 3 
cells were trypsinised and seeded into a 96 well plate at a density of 10,000 cells per well for a further 24 hours.  
Following this 24 hour period cells were stained for laminin 332.  Media was rinsed and cells and proteins were 
fixed with 4% formaldehyde for 6 minutes.  Cells were washed again in PBS and any endogenous peroxide was 
quenched using 3% hydrogen peroxide for 5 minutes.  Following another wash 1% BSA was added for 15 
minutes to prevent unspecific binding.  Cells were incubated with the primary antibody, mouse anti-human 
 
 
laminin 332 for 60 minutes at room temperature.  Wells were rinsed and the secondary antibody anti-mouse IgG 
peroxidise conjugate was added for a further 30 minutes at room temperature.  To ensure that any differences in 
laminin deposition where not due to differences in cell proliferation rates, a 24 hour proliferation studies was 
carried out under the same conditions as described above.    
 
RESULTS 
 
TGF-β3 causes a more dramatic decrease in cell proliferation compared to 1 and 2 
 
TGF-β is known to cause growth arrest in some cell types (16, 17).  We cultured HaCaT cells with each TGF-β 
isoform for 4 days.  On day 4 cells were trypsinized and counted using a haemocytometer.  Average cell counts 
(x104) for each growth factor after 4 days are shown in Figure 1.  TGF-β3 was shown to cause a decrease in the 
cell proliferation rate compared to control (p<0.05).  Although TGF-β1 and 2 also appeared to cause a slight 
decrease when compared to control, these differences were not shown to be significant at the 95% significance 
level. 
 
 
 
Fig 1.  Effects of TGF-β1, 2 and 3 on HaCaT cell proliferation following 24 hour (A) and 4 day incubations (B).  
After a 24 hour period there are no significant differences in cell numbers between each treatment group.  
However after 4 days incubation TGF-β3 was shown to reduce the cell proliferation rate compared to control 
(p<0.05).  Standard error bars are shown for each data set and n=6.     
 
 
TGF-β2 and 3 increase rate of wound closure in HaCaT cell monolayers in vitro. 
 
TGF-β is known to induce keratinocyte cell migration (8).  In order to compare the influence of each TGF-β 
isoforms on cell migration during wound repair we adopted the commonly used in vitro scratch assay; HaCaT 
cell monolayers were ‘wounded’ and the rate of wound closure following different treatments was assessed.  
 
Within the first 2 hours following ‘wounding’ there was an adjustment period during which the wound size 
either widened or did not alter at all.  This widening has been described before and is perhaps a result of the 
damage to cells following scratching (18).  Including the data collected in the first 2 hours would have affected 
trend lines and therefore wound closure was measured from the 2 hour point and was called 100%.   
 
Raw measurements (µm) of the wound at each time point were normalised and average data was plotted as 
shown in Figure 2A. TGF-β2 treated cells had advanced more than the other groups at the 6 hour point with a 
percentage wound closure of approximately 46% (54% gap still remaining) compared to approximately 27%, 
 
 
32% and 36% for control, TGF-β1 and TGF-β3 respectively.   At the 8 hour point these differences had 
increased except for TGF-β3 treated cells which were starting to advance at a rate more similar to TGF-β2.  At 
this stage percentage wound closure figures for control, TGF-β1, 2 and 3 were as follows; 50%, 54%, 81% and 
69% (approx.) respectively.  
 
Trend lines were added for each normalised data set.  The equation y=mx+c and R2 values for each trend line 
were used to determine the gradient (value of ‘m’) and reliability (R2) of the trend line.  Mean gradient values 
were used to compare the rate of wound closure for each isoforms (Figure 2).  Average R2 values for the control, 
TGF-β1, 2 and 3 were 0.98, 0.98, 0.97 and 0.97 respectively.  As these R values are close to 1 we can assume 
that the trend lines representing the actual data plots are an accurate measure and that therefore the gradient 
values are a fair representation of the raw data.  From Figure 2B we can see there are clear differences between 
monolayer wound closure rates following treatment with TGF-β2 and 3 when compared to the control and TGF-
β1 (p<0.01).  These differences are apparent at the 6 hour time point (Figure 3).    
 
 
 
Fig 2.  Effects of TGF-β1, 2 and 3 on wound closure rate of HaCaT cell monolayers.  After 4 day 
incubation with each growth factor, HaCaT cell monolayers were ‘wounded’ and the rate of wound 
closure was measured.  Fig 2 A shows percentage wound closure starting at 2 hour post wounding.  
Using these data series, trend lines were added and the equation of the trend line was used to 
determine the rate of closure (i.e. y=mx+c where ‘m’ is the gradient of the line or in this case, rate of 
closure).  Fig 2B represents the average values for gradient, or rate of closure.   Standard error bars 
are shown, n=18. * p<0.05 ** p<0.01 *** p<0.001 (a) TGF-β2 vs control (b) TGF-β3 vs control. 
 
 
 
 
 
 
 
Fig 3.  Effects of TGF-β on wound closure  Fig 3 shows a comparison of control cells (A-C) and TGF-β2 
treated cells (D-F) at the 2, 4 and 6 hour points.  TGF-β2 and 3 (images not shown) treated cells repair the 
wound more rapidly than control cells. Scale bar=100μm.     
 
 
Cell behaviour at the wound edges appeared to differ between control and TGF-β treated monolayers (Fig 4).  
At around the 8 hour point TGF-β, particularly TGF-β3, caused cells to migrate into the ‘wound bed’ in a more 
random scattered fashion.  Control cell monolayers on the other hand advanced in a much more orderly manner.   
 
 
 
Fig 4.  Effects of TGF-β on cell behaviour during wound closure.  Figure 4 shows control (A) and TGF-β1, 2 
and 3 (B, C, D respectively) treated HaCaT cell monolayers at 8 hours stage of wound closure.  TGF-β treated 
cells migrate into the wound in a more random and independent manner. The closure of control wounds occurs 
more uniformly with fewer cells migrating out from the wound margins. Scale bar=100μm.     
 
TGF-β2 and 3 and to a lesser extent TGF-β1 increase laminin 332 deposition 
 
During cell migration keratinocytes are known to deposit laminin 332 in order to restore the basement 
membrane, a feature central to wound repair. TGF-β is known to stimulate cell migration and the resulting 
deposition of laminin332 (19).  In order to compare the effects of TGF-β1, 2 and 3 treatment on laminin 332 
deposition HaCaT cells were fixed and stained with anti-human laminin 332 followed by secondary antibody 
Alexa Fluor® 488.    Positive staining for laminin 332 could be detected following treatment with each TGF-β 
isoforms and also for control cells.  Immunofluorescence staining appeared brighter and more prolific for TGF-β 
treated cells (Figure 5).   
 
In order to compare laminin deposition between TGF-β treatments, HaCaT cells were incubated with TGF-β1, 2 
or 3 for a total of 4 days before being fixed and stained for laminin 332deposition.  Figure 5E shows absorbance 
readings at 630nm for each treatment.  All TGF-β treated cells were shown to deposit more laminin 332 
compared to control (p<0.01).  TGF-β2 and 3 were also shown to cause an increased deposition relative to TGF-
β1 (p<0.05).  Figure 1 shows cell counts after 24 hours incubation with TGF-β.  This 24 hour cell count was 
carried out to ensure that the differences in laminin deposition between treatments were not due to dramatic 
differences in the cell numbers.  Cell counts following 24 hours were not significantly different at the 95% level 
and therefore any differences in laminin deposition were not a result of differences in cell numbers.      
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Fig 5.  Effects of TGF-β1, 2 and 3 on laminin 332 deposition.  HaCaT cells were cultured with each growth 
factor for 4 days.  Fig 5 (A-D) shows immunofluorescence staining of laminin 332 for control (A), TGF-β1 (B), 
TGF-β2 (C) and TGF-β3 (D).  Each of the TGF-β isoforms appeared to increase laminin 332 deposition.  Fig 5 
E shows optical density readings (630nm) following immunoperoxidase staining of deposited laminin 332.  All 
TGF-β treated cells were shown to deposit more laminin 332 compared to control (p<0.001).  TGF-β3 were 
also shown to cause an increased deposition relative to TGF-β1 (p<0.001).  Standard error bars are shown, 
n=6.  Scale bar=100μm.   
 
   
DISCUSSION 
 
TGF-β isoforms are known to play a multifunctional role, acting as ‘on/off’ switches depending on the context 
of their environment.  For example, TGF-β3 is a more potent inhibitor of hematopoietic progenitor cells when 
compared to TGF-β1 and 2, whilst TGF-β2 and 3, but not 1, inhibit the survival of cultured embryonic chick 
ciliary ganglionic neurons (20, 21).  Although studies have examined the expression of TGF-β isoforms in 
wound repair models, there has been little investigation into comparing their effects on skin cells during the 
wound repair process. The majority of work carried out has focused mainly on the role of TGF-β1.  For these 
reasons the present study chose to compare the influence of TGF-β isoforms at a basic cell science level looking 
specifically at keratinocytes and the effects of these growth factors on proliferation, migration and laminin 332 
deposition, the key features of reepithelialisation. 
 
In intact skin, keratinocytes in the basal layer of the epidermis form strong cell-cell and cell-basement 
membrane attachments.  These basal layer keratinocytes sit above the basement membrane where they bind 
mature laminin 332 via α3β1 and more predominately α4β6 (22,23).  As a result of injury to the skin, 
keratinocytes are exposed to a different array of proteins and growth factors that stimulate the process of 
reepithelialisation.  Laminin 332 is a major component of the basement membrane zone and its deposition by 
migrating keratinocytes is central to reepithelialisation (19).  Initially, this laminin is deposited in its 
unprocessed, or precursor form which is thought to stimulate cell migration (24).  The 190kD alpha3 chain of 
precursor laminin 332 later undergoes plasmin-mediated processing to produce the 160kD alpha3 chain of 
mature laminin 332 (25).  It is the latter form of laminin 332 to which cells bind via hemidesmosomes (26, 27).   
 
In culture, HaCaT cells have been shown to couple tightly to their surface and to one another with many focal 
adhesions (28).  Although under normal conditions keratinocytes are not readily migratory cells, our study 
 
 
shows wound closure of HaCaT cell monolayers was achieved within approximately 12 hours (data not shown).  
It has been suggested that sudden release of available surface following ‘wounding’ is sufficient to trigger 
collective motility, independent of proliferation, in monolayers (29).  This collective motility has been studied in 
MDCK epithelial cell monolayers in which wound closure was said to be the result of actively migrating cells 
up to hundreds of microns back from the wound margin (30).  Also, the serum present in our RPMI media may 
have small amounts of growth factors that stimulate migration.  For the purpose of comparing TGF-β isoforms 
we felt it unnecessary to remove serum from the media.  As the media was standardised for each treatment 
group any differences could be attributed to the effects of additional TGF-β.     
 
Our study found that during wound closure control cell monolayers remained tightly coupled together and 
wound margins progressed in a very orderly and uniform manner.  The monolayer moved together as a 
collective sheet of cells with very few cells separating from the leading edge to move into the free space or 
‘wound bed’ independently.  Conversely, wound closure following TGF-β treatment caused a less ordered 
response.  TGF-β treated cells were more spread and not as tightly coupled together as seen with control.  
Wound closure following treatment, more so with TGF-β2 and 3, was shown to involve the active migration of 
individual cells into the wound bed in an independent manner.  This enhanced migratory phenotype is associated 
with the reorganisation of cell surface attachments (24, 28).   
 
From our wound closure model we found TGF-β2 and 3 but not 1, increased the speed of cell migration when 
compared to control (p<0.01).  Wound closure in TGF-β1 treated monolayers was more comparable to that of 
the control when compared to TGF-β2 and 3 treated cells.  The latter two treatments involved a steep increase in 
the rate of wound closure (μm/hr) between the 6 and 8 hour points.  Whilst the control and TGF-β1 cells also 
show an increased rate of wound closure as time progressed, this increase was much steadier.   
 
These findings are interesting when put into context of previous research that studied the expression of TGF-β 
isoforms during fetal development.  During early gestation, TGFβ-1, 2 and 3 are expressed at fairly similar 
levels and this correlates with scarless healing. As fetal development proceeds and reaches the late gestation 
stage the differences between the expression of TGF-β1, 2 and 3 become much more pronounced.  By late 
gestation the expression of TGF-β1 mRNA has been shown to be double that of TGF-β2 and 3 which also 
coincides with scar formation during healing (31).     
 
Keratinocyte migration is associated with the deposition of laminin 332 (19).  In order to examine the effect of 
each TGF-β isoforms on HaCaT cells further, we compared the deposition of laminin 332 following 4 days in 
culture with TGF-β1, 2 and 3. Our study found that TGF-β 2 and 3 were the most influential of the three 
isoforms with regards to laminin deposition.  Comparing optical density readings following immunoperoxidase 
staining showed TGF-β2 and 3 to be significantly higher than TGF-β1 (p<0.05) with all three isoforms 
producing more laminin than control cells (p<0.01).  We suggest that the enhanced mobility of cells following 
TGF-β2 and 3 treatments is the result of an enhanced laminin 332 deposition and processing by the cells.       
 
It is generally accepted that the reepithelialisation of a wound bed involves a combination of keratinocyte cell 
migration and proliferation (32).  However, the combination of these cell activities, their timing and the 
locations in which they occur is not yet clear.  Some studies have shown that wound closure in different models 
results from either mostly cell proliferation or mostly migration. Keratinocytes have been shown to behave 
differently in different wound models.  Cells at the edge of chronic ulcers are highly proliferative (Ki67 
proliferation marker), have an activated phenotype (K16), do not stain for keratins involved in epidermal 
differentiation (K10 and K2), and show a reduced expression of LM-3A32 (uncleaved, precursor of the α3 chain 
of laminin 332), a key molecule present on migrating epithelium. In contrast, keratinocytes in normal acute 
wound migrating epithelium do not express the proliferation marker Ki67 but do express K10, K2, and LM-
3A32 (33).  
 
We show that the enhanced migratory phenotype caused by TGF-β3 was accompanied by decreases in cell 
proliferation rates. Comparing the influence of TGF-β isoforms on cell turnover rates over a 4 day period, we 
found that all TGF-β isoforms appeared to cause a decrease in cell proliferation compared to control.  However, 
following statistical analysis, only TGF-β3 was shown to differ significantly from control (p<0.05).  Having 
shown that cell density in a monolayer is markedly reduced following treatment with TGF-β3 this demonstrates 
that cell proliferation is not responsible for the enhanced wound closure rate shown here.         
 
From our data, we have shown that the evolving picture is not a clear or predictable one.  We have shown that 
TGF-β2 and 3, but not 1, caused faster cell migration during wound closure.  TGF-β2 and 3 had the most 
dramatic effect on increasing laminin deposition, yet TGFβ 1 was also shown to differ significantly from control 
 
 
cells.  Here, one may have expected that TGF-β1 would mirror the results of control again.  These isoforms 
differed yet again with cell proliferation results, with only TGF-β3 having a significant effect.  From this we can 
see that there are clear differences in the way that TGF-β1, 2 and 3 influence HaCaT cell keratinocytes in vitro.  
The migration rate of keratinocytes during wound healing is dependent on the expression of integrins and the 
way in which these receptors interact with the altering levels of ligands in the extracellular matrix (34).  Whilst 
TGF-β1 was able to enhance laminin 332 production it had little effect on the rate of wound closure.  This 
suggests that the TGF-β isoforms are unique in the way they alter the cells ability to respond to its surroundings.  
Further work will aim to compare the way in which these TGF-β isoforms differ in their control of integrin 
expression and/or reorganisation. 
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